JPH0379059B2 - - Google Patents
Info
- Publication number
- JPH0379059B2 JPH0379059B2 JP58022989A JP2298983A JPH0379059B2 JP H0379059 B2 JPH0379059 B2 JP H0379059B2 JP 58022989 A JP58022989 A JP 58022989A JP 2298983 A JP2298983 A JP 2298983A JP H0379059 B2 JPH0379059 B2 JP H0379059B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- hydrogen
- lipid
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002632 lipids Chemical class 0.000 claims description 154
- -1 carboxy, sulfo, amino Chemical group 0.000 claims description 144
- 239000008187 granular material Substances 0.000 claims description 97
- 125000000217 alkyl group Chemical group 0.000 claims description 51
- 239000008346 aqueous phase Substances 0.000 claims description 47
- 125000004423 acyloxy group Chemical group 0.000 claims description 40
- 239000006185 dispersion Substances 0.000 claims description 39
- 239000001257 hydrogen Substances 0.000 claims description 38
- 229910052739 hydrogen Inorganic materials 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 35
- 125000004432 carbon atom Chemical group C* 0.000 claims description 32
- 239000000787 lecithin Substances 0.000 claims description 29
- 235000010445 lecithin Nutrition 0.000 claims description 28
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 24
- 229940067606 lecithin Drugs 0.000 claims description 19
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 18
- 239000002356 single layer Substances 0.000 claims description 17
- 125000003545 alkoxy group Chemical group 0.000 claims description 15
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims description 14
- 150000002431 hydrogen Chemical class 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 125000003342 alkenyl group Chemical group 0.000 claims description 12
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 11
- 125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 claims description 10
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 8
- ZPDQFUYPBVXUKS-YADHBBJMSA-N 1-stearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC[C@H](N)C(O)=O ZPDQFUYPBVXUKS-YADHBBJMSA-N 0.000 claims description 6
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 5
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 5
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 claims 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 69
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- 239000000243 solution Substances 0.000 description 39
- 239000000203 mixture Substances 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- 239000008344 egg yolk phospholipid Substances 0.000 description 21
- 239000010410 layer Substances 0.000 description 19
- 239000013543 active substance Substances 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 239000012071 phase Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 7
- 235000008504 concentrate Nutrition 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 238000001493 electron microscopy Methods 0.000 description 7
- WTJKGGKOPKCXLL-VYOBOKEXSA-N 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC WTJKGGKOPKCXLL-VYOBOKEXSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 4
- KILNVBDSWZSGLL-UHFFFAOYSA-O 2-[2,3-di(hexadecanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-UHFFFAOYSA-O 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- CITHEXJVPOWHKC-UHFFFAOYSA-N dimyristoyl phosphatidylcholine Chemical compound CCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UHFFFAOYSA-N 0.000 description 4
- 229960003724 dimyristoylphosphatidylcholine Drugs 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000004611 spectroscopical analysis Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- OPVZUEPSMJNLOM-ZCXUNETKSA-N (1-hexadecanoyloxy-3-phosphonooxypropan-2-yl) (z)-octadec-9-enoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OPVZUEPSMJNLOM-ZCXUNETKSA-N 0.000 description 3
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- OZSITQMWYBNPMW-GDLZYMKVSA-N 1,2-ditetradecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCC OZSITQMWYBNPMW-GDLZYMKVSA-N 0.000 description 2
- FAZBDRGXCKPVJU-MRXNPFEDSA-N 1-myristoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O FAZBDRGXCKPVJU-MRXNPFEDSA-N 0.000 description 2
- YNDYKPRNFWPPFU-UHFFFAOYSA-N 1-palmitoylglycerol 3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP(O)(O)=O YNDYKPRNFWPPFU-UHFFFAOYSA-N 0.000 description 2
- 125000005999 2-bromoethyl group Chemical group 0.000 description 2
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229960003750 ethyl chloride Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000008202 granule composition Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000008103 phosphatidic acids Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- OKLASJZQBDJAPH-UHFFFAOYSA-N (2-dodecanoyloxy-3-phosphonooxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCCCCCC OKLASJZQBDJAPH-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 102000015790 Asparaginase Human genes 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- LDKDGDIWEUUXSH-UHFFFAOYSA-N Thymophthalein Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C LDKDGDIWEUUXSH-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 238000013103 analytical ultracentrifugation Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 125000004097 arachidonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical group BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 229960000958 deferoxamine Drugs 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 125000006534 ethyl amino methyl group Chemical group [H]N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 125000005644 linolenyl group Chemical group 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- UOXRPRZMAROFPH-IESLQMLBSA-N lysophosphatidylinositol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC1[C@H](O)[C@@H](O)C(O)[C@@H](O)[C@H]1O UOXRPRZMAROFPH-IESLQMLBSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006610 n-decyloxy group Chemical group 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Description
ãã®çºæã¯ãæ°Žæ§çžäžåå±€è質é¡ç²ã®è£œé æ¹æ³
ã«é¢ããã è質é¡ç²ã«ã€ããŠã¯æç®äžã«å€ãã®èšèŒãèŠã
ããããã®è£œé åã³äœ¿çšã¯å€ãã®ç 究ã®å¯Ÿè±¡ãšãª
ã€ãŠãããïŒã€ã®è質äºéèãæããåå±€è質é¡
ç²ã¯ãçç¶ã«é 眮ãããè€æ°ã®è質äºéèãæã
ãå€å±€è質é¡ç²ããåºå¥ãããã åå±€è質é¡ç²ã¯ïŒã€ã®çç¶è¢«èãæãããããŠ
äŸãã°çŽ200ã50000â«ã奜ãŸããã¯çŽ200ã30000
â«ã®çŽåŸãæãããçç¶è¢«èã¯ãè質æåãäŸã
ã°äž¡èŠªåªæ§è質ãäŸãã°çè質ãäŸãã°ãã¹ãã¢
ããžã³é žãã¬ã·ãã³åã¯ã±ãã¢ãªã³ããããŠå Žå
ã«ãã€ãŠã¯äžæ§è質ãäŸãã°ã³ã¬ã¹ãããŒã«ã®äº
éèããæãããã®äºéèã¯ãïŒã€ã®æ°Žæ§çžãã
æãå éšç©ºéãå å²ããŠãããåå±€è質é¡ç²ã¯
åããå°èããšã称ãããã è質é¡ç²ã®ãçš®ã ã®æŽ»æ§ç©è³ªã®æ äœãšããŠã®å»
è¬ãžã®äœ¿çšã«å€§ããªé¢å¿ãå¯ããããŠãããããª
ãã¡ãè質é¡ç²ã¯ãèçœè³ªãäŸãã°æäœãããã¯
é žçŽ ããã«ã¢ã³ããã¿ãã³åã¯éºäŒåã®æ äœãšã
ãŠããããã¯æšèãããååç©ã®æ äœãšããŠåæ
ç®çãžã®äœ¿çšãææ¡ãããŠãããäŸãã°ãç±³åœç¹
蚱第3993754å·ã«ãããŠã¯ãæ äœãšããŠè質é¡ç²
ã䜿çšããè «ç现èã®åŠçã«ããååŠçæ³ãèšèŒ
ãããŠããã æå®ã®æŽ»æ§ç©è³ªã¯ãè質é¡ç²ã®åœ¢æã®éã«åã¯
ãã®åŸæ¡æ£ã«ããå°å ¥ãããè質é¡ç²ã®åœ¢æãšæŽ»
æ§ç©è³ªã®å°å ¥ã¯çš®ã ã®æ¹æ³ã«ããè¡ããã
Carcer Treatment ReviewsïŒ1981ïŒïŒã27ã50
ã®ã¹ã¿ã³ã¬âB.ã«ã€ãšïŒSt.B KeyeïŒçã®ç·èª¬
ãLiposomeaâProblems and promise
asselective drug carriersãã«èšèŒãããŠããã
åæ§ã«ã掻æ§ç©è³ªã®å°å ¥ãç®çãšããè質é¡ç²ã®
å€ãã®è£œé æ¹æ³ãããã¬ã³ãã«ãïŒBarenholzïŒ
çã«ããBiochemistryã第16å·»ã第12å·ã2806
ã2810ã䞊ã³ã«ç¬åœç¹èš±å ¬éïŒDOSïŒç¬¬2818655
å·ãå第2902672å·ãå第2532317å·åã³å第
2842608å·ãç±³åœç¹èš±ç¬¬4053585å·æ现æžãåã³ãš
ãŒãããç¹èš±åºé¡ç¬¬36676å·æ现æžã«èšèŒãããŠ
ããã äŸãã°ãè質æåãäŸãã°çè質ãäŸãã°ãã¹
ãã¢ããžã³é žãã¬ã·ãã³åã¯ã±ãã¢ãªã³ãåã³å Ž
åã«ãã€ãŠã¯äžæ§è質ãäŸãã°ã³ã¬ã¹ãããŒã«ã
ææ©æº¶åªãäŸãã°ã¯ãããã«ã åã¯ãã³ãŒã³ã«æº¶
解ãããèžçºã®åŸã該åœããè質æåã®å質局ã
äŸãã°èå±€ãæ®çããã次ã«ãã®è質æåããäŸ
ãã°æ¹æããªãããæå®ã®æŽ»æ§ç©è³ªãå«æããæ°Ž
æ§å±€ã«åæ£ãããããããã«ç¶ãè¶ é³æ³¢åŠçã«ã
ã掻æ§ç©è³ªãå°å ¥ããåå±€è質é¡ç²ã圢æãã
ãã å€ãã®åžžçšæ³ã«ãããŠã¯ãåå±€è質é¡ç²åã³å€
å±€è質é¡ç²ã®æ··åç©ã䌎ãªãæ°Žæ§çžã§ãã€ãŠã該
è質é¡ç²ã®æ§é åã³å€§ãããäžãããã§ãã€ãŠã
ã»ãšãã©åœ±é¿ãåããããããŠèããå€åããå¯
èœæ§ã®ãããã®ãåŸãããããã®çºæã®æ¹æ³ã«ã
ãã°ãç°¡åãªæ¹æ³ã§å€ãã®ããããŠã»ãšãã©å®é
çãªéã®åå±€è質é¡ç²ã䌎ãªãæ°Žæ§çžã圢æãã
ããšãã§ãããã®è質é¡ç²ã«ã¯ãçŽåŸçŽ200ã600
â«ãæããå°åœ¢åå±€è質é¡ç²ïŒKULïŒåã³çŽåŸ
çŽ600ã3000â«ãæãã倧圢åå±€è質é¡ç²
ïŒGULïŒãå«ãŸããããã®çºæã®æ¹æ³ã®ç¹æã®å©
ç¹ã¯ãçžå¯Ÿçã«åäžãªå€§ããã®KULåã³GULã
åŸãããšãã§ãããããŠåæ£çžäžã®KULãšGUL
ã®éæ¯ãå€ããããšãã§ããç¹ã«ãããé©åœãªå
é¢æ段ãäŸãã°ã²ã«éæ³åã¯éå€éæ³ã«ãã
倧圢åå±€è質é¡ç²ããå°åœ¢åå±€è質é¡ç²ãåé¢ã
ãããšãã§ããã ãã®çºæã¯ã a1 次ã®åŒ(A) ãåŒäžãïœã¯ïŒã§ããïŒåºR1åã³R2ã®å ã®
ïŒã€ã¯æ°ŽçŽ åã¯ããããã·åºã§ããä»æ¹ã®åºã¯
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«
ãªãã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«ãª
ãã·åºã§ããïŒR3ã¯æ°ŽçŽ ã§ããïŒãããŠR4ã¯
æ°ŽçŽ ãççŽ ååæ°ïŒãïŒåã®ã¢ã«ãã«åºãåã¯
ççŽ ååæ°ïŒãïŒåã®ã¢ã«ãã«åºïŒã«ã«ãã
ã·ãã¹ã«ããã¢ãããäœçŽã¢ã«ãã«ã¢ããããž
âäœçŽã¢ã«ãã«ã¢ãããã«ã«ããã·åã³ã¢ã
ããéé¢ãããã¯ãšã¹ãã«åããããããã
ã·ãããã²ã³ãäœçŽã¢ã«ã³ãã·ã«ã«ããã«ãå
ã¯äœçŽã¢ã«ã«ã³ã¹ã«ããã«ã«ãã眮æãããŠã
ãïŒã§ãããã§è¡šããããè質åã³é©åœãªè¿œå
ã®è質ãPHå€ã11ããé«ãæ°Žæ§çžã«åæ£ãã
ãããããã¯ã a2ïŒ ïœãïŒã§ããïŒR1åã³R2ãçžäºã«ç¬ç«ã
ãŠãããããççŽ ååæ°10ã20åã®ã¢ã«ãã«
åºãã¢ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«
ã±ãã«ãªãã·åºåã¯ççŽ ååæ°10ã20åã®ã¢ã·
ã«ãªãã·åºã§ããïŒR3åã³R4ãæ°ŽçŽ ã§ããåŒ
(A)ã®è質åã³å Žåã«ãã€ãŠã¯é©åœãªè¿œå ã®è質
ãPHå€ã11ããé«ãæ°Žæ§çžã«åæ£ãããããã
ãã¯ã b1ïŒ ïœãïŒã§ããïŒåºR1åã³R2ã®å ã®ïŒã€ã
æ°ŽçŽ åã¯ããããã·åºã§ãã€ãŠä»æ¹ã®åºããã
ããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢ã«ã±
ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«ãªã
ã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«ãªãã·
åºã§ããïŒR3ãæ°ŽçŽ ã§ããïŒãããŠR4ã¯ã¢ã³
ã¢ããªåºã§çœ®æãããäœçŽã¢ã«ãã«åºã§ããåŒ
(A)ã®è質ãåã³å Žåã«ãã€ãŠã¯è¿œå ã®è質ãPH
å€ãïŒããäœãæ°Žæ§çžã«åæ£ããããããã
ã¯ã b2ïŒ ïœãïŒã§ããïŒR1åã³R2ãçžäºã«ç¬ç«ã«ã
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãããã¯ã¢ã«ã±ãã«ãªãã·åºãåã¯
ççŽ ååæ°10ã20åã®ã¢ã·ã«ãªãã·åºã§ããïŒ
R3ãæ°ŽçŽ ã§ããïŒãããŠR4ãã¢ã³ã¢ããªäœçŽ
ã¢ã«ãã«ã¢ã³ã¢ããªåºã§çœ®æãããäœçŽã¢ã«ã
ã«åºã§ããåŒ(A)ã®è質ãåã³é©åœãªè¿œå ã®è質
ãPHå€ãïŒããäœãæ°Žæ§çžã«åæ£ãããã ãããŠå¿ èŠã§ããã°ãåèšïœïŒåã¯ïœïŒæ®µéã®
åŸãæ°Žæ§çžãäžåãããããŠææã«ããåŸããã
åå±€è質é¡ç²ãæ¿çž®ããããŠïŒåã¯åé¢ããããš
ãç¹åŸŽãšããåå±€è質é¡ç²ã®è£œé æ¹æ³ã«é¢ããã æ¬çºæã«ããã°ãåèšïŒa1ïŒïŒïŒa2ïŒïŒïŒb1ïŒå
ã³ïŒb2ïŒã«ç€ºãè質ã®çµåããã«ãããŠãïŒa1ïŒ
åã³ïŒa2ïŒã«ãããŠã¯æ°Žæ§çžã®PHã11ããé«ã
ãããããŠïŒb1ïŒåã³ïŒb2ïŒã«ãããŠã¯æ°Žæ§çž
ã®PHãïŒããäœãããå Žåã«ãåå±€è質é¡ç²ã®æ¯
çã®é«ãåæ£äœãåŸãããã ãã®æ现æžã«ãããŠãåèšã®ãããŠåŸèšã®äžè¬
çèšèŒã¯æ¬¡ã®æå³ãæããã æ¹æ³ïŒa1ïŒåã³ïŒa2ïŒ ã¢ã«ãã«åºR1åã¯R2ã¯ã奜ãŸããã¯ïœâã
ã·ã«åºãïœâãŠã³ãã·ã«åºãïœâããã·ã«åº
ïŒã©ãŠãªã«åºïŒãïœâããªãã·ã«åºãïœâããã©
ãã·ã«åºïŒããªã¹ãã«åºïŒãïœâãã³ã¿ãã·ã«
åºãïœâãããµãã·ã«åºïŒã»ãã«åºïŒãïœâãª
ã¯ã¿ãã·ã«åºïŒã¹ãã¢ãªã«åºïŒåã¯ïœâãšã€ã³
ã·ã«åºïŒã¢ã©ããã«åºïŒãããã«ã¯ïœâããã¿
ãã·ã«åºåã¯ïœâãããã·ã«åºã§ããã ã¢ã«ã±ãã«åºR1åã¯R2ã¯ã奜ãŸããã¯ïŒâ
ã·ã¹âããã»ãã«åºïŒã©ãŠãã¬ã€ã«åºïŒãïŒâ
ã·ã¹âããã©ãã»ãã«åºïŒããªã¹ãã¬ã€ã«åºïŒã
ïŒâã·ã¹âãããµãã»ãã«åºïŒãã«ããã¬ã€ã
ã«åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã«åºïŒããã
ã»ãªãã«åºïŒãïŒâãã©ã³ã¹âãªã¯ã¿ãã»ãã«
åºïŒãããã»ã©ã€ãžãã«åºïŒãïŒâã·ã¹âãªã¯
ã¿ãã»ãã«åºïŒãªã¬ã€ã«åºïŒãïŒâãã©ã³ã¹â
ãªã¯ã¿ãã»ãã«åºïŒãšã©ã€ãžãã«åºïŒåã¯ïŒâ
ã·ã¹âãšã€ã³ã»ãã«åºïŒã¬ãã¬ã€ãã«åºïŒãã
ãã«ïŒâãã»ãã«åºãïŒâãŠã³ãã»ãã«åºãïŒ
âããã»ãã«åºãïŒâããªãã»ãã«åºãïŒâã
ãã©ãã»ãã«åºãïŒâãã³ã¿ãã»ãã«åºãïŒâ
ãããµãã»ãã«åºãïŒâããã¿ãã»ãã«åºãïŒ
âãªã¯ã¿ãã»ãã«åºãïŒâã·ã¹â12âãã©ã³ã¹
âãªã¯ã¿ãã«ãžãšãã«åºïŒãªããªã«åºïŒãïŒâ
ãã©ã³ã¹â12âãã©ã³ã¹âãªã¯ã¿ãã«ãžãšãã«
åºïŒãªãã©ã€ãžãã«åºïŒãïŒâã·ã¹â12âã·ã¹
âãªã¯ã¿ãžãšãã«åºïŒãªãã¬ã€ã«åºïŒãïŒâã·
ã¹â11âãã©ã³ã¹â13âãã©ã³ã¹âãªã¯ã¿ãã«
ããªãšãã«åºïŒÎ²âãšãã€ã¹ãã¢ãªãã«åºïŒã
ïŒâã·ã¹â12âã·ã¹â15âã·ã¹âãªã¯ã¿ãã«ã
ãªãšãã«åºïŒãªãã¬ãã«åºïŒãïŒâïŒ11âïŒ13
âïŒ15âãªã¯ã¿ãã«ããã©ãšãã«ïŒããªããªã«
åºïŒãïŒâãããã»ãã«åºãïŒâãšã€ã³ã»ãã«
åºãïŒâïŒ11âïŒ14âãšã€ã³ãµããªãšãã«åã¯
ïŒâïŒïŒâïŒ11âïŒ14âãšã€ã³ãµããã©ãšãã«
åºïŒã¢ã©ãããã«åºïŒã§ããã ã¢ã«ã³ãã·åºR1åã¯R2ã¯ã奜ãŸããã¯ïœâ
ãã·ã«ãªãã·åºãïœâããã·ã«ãªãã·åºïŒã©ãŠ
ãªã«ãªãã·åºïŒãïœâããã©ãã·ã«ãªãã·åº
ïŒããªã¹ãã«ãªãã·åºïŒãïœâãããµãã·ã«ãªã
ã·åºïŒã»ãã«ãªãã·åºïŒãïœâãªã¯ã¿ãã·ã«ãª
ãã·åºïŒã¹ãã¢ãªã«ãªãã·åºïŒãåã¯ïœâãšã€
ã³ã·ã«ãªãã·åºïŒã¢ã©ããã«ãªãã·åºïŒããã
ã«ïœâãŠã³ãã·ã«ãªãã·åºãïœâããªãã·ã«ãª
ãã·åºãïœâãã³ã¿ãã·ã«ãªãã·åºãïœâãã
ã¿ãã·ã«ãªãã·åºåã¯ïœâãããã·ã«ãªãã·åº
ã§ããã ã¢ã«ã±ãã«ãªãã·åºR1åã¯R2ã¯ã奜ãŸãã
ã¯ïŒâã·ã¹âããã»ãã«ãªãã·åºïŒã©ãŠãã¬ã€
ã«ãªãã·åºïŒãïŒâã·ã¹âããã©ãã»ãã«ãªã
ã·åºïŒããªã¹ãã¬ã€ã«ãªãã·åºïŒãïŒâã·ã¹â
ãããµãã»ãã«ãªãã·åºïŒãã«ããã¬ã€ãã«ãª
ãã·åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã«ãªãã·åº
ïŒãããã»ãªãã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãª
ã¯ã¿ãã»ãã«ãªãã·åºïŒãããã»ã©ã€ãžãã«ãª
ãã·åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã«ãªãã·åº
ïŒãªã¬ã€ã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãªã¯ã¿ã
ã»ãã«ãªãã·åºïŒãšã©ã€ãžãã«ãªãã·åºïŒãå
ã¯ïŒâã·ã¹âãšã€ã³ã»ãã«åºïŒã¬ãã¬ã€ãã«ãª
ãã·åºïŒãããã«ã¯ïŒâãã»ãã«ãªãã·åºãïŒ
âãŠã³ãã»ãã«ãªãã·åºãïŒâããã»ãã«ãªã
ã·åºãïŒâããªãã»ãã«ãªãã·åºãïŒâããã©
ãã»ãã«ãªãã·åºãïŒâãã³ã¿ãã»ãã«ãªãã·
åºãïŒâãããµãã»ãã«ãªãã·åºãïŒâããã¿
ãã»ãã«ãªãã·åºãïŒâãªã¯ã¿ãã»ãã«ãªãã·
åºãïŒâã·ã¹â12âãã©ã³ã¹âãªã¯ã¿ãã«ãžãš
ãã«ãªãã·åºïŒãªããªã«ãªãã·åºïŒãïŒâãã©
ã³ã¹â12âãã©ã³ã¹âãªã¯ã¿ãã«ãžãšãã«ãªã
ã·åºïŒãªãã©ã€ãžãã«ãªãã·åºïŒãïŒâã·ã¹â
12âã·ã¹âãªã¯ã¿ãžãšãã«ãªãã·åºïŒãªãã¬ã€
ã«ãªãã·åºïŒãïŒâã·ã¹â11âãã©ã³ã¹â13â
ãã©ã³ã¹âãªã¯ã¿ãã«ããªãšãã«ãªãã·åºïŒÎ²
âãšã¬ãªã¹ãã¢ãªãã«ãªãã·åºïŒãïŒâã·ã¹â
12âã·ã¹â15âã·ã¹âãªã¯ã¿ãã«ããªãšãã«ãª
ãã·åºïŒãªãã¬ãã«ãªãã·åºïŒãïŒâïŒ11âïŒ
13âïŒ15âãªã¯ã¿ãã«ããã©ãšãã«ãªãã·åº
ïŒããªããªã«ãªãã·åºïŒãïŒâãããã»ãã«ãªã
ã·åºãïŒâãšã€ã³ã»ãã«ãªãã·åºãïŒâïŒ11
âïŒ14âãšã€ã³ãµããªãšãã«ãªãã·åºåã¯ïŒ
âïŒïŒâïŒ11âïŒ14âãšã€ã³ãµããã©ãšãã«ãª
ãã·åºïŒã¢ã©ãããã«ãªãã·åºïŒã§ããã ã¢ã·ã«ãªãã·åºR1åã¯R2ã¯ã奜ãŸããã¯ã¢
ã«ã«ãã€ã«ãªãã·åºãäŸãã°ïœâãã«ãã€ã«ãª
ãã·åºãïœâããã«ãã€ã«ãªãã·åºïŒã©ãŠãã€
ã«ãªãã·åºïŒãïœâããã©ãã«ãã€ã«ãªãã·åº
ïŒããªã¹ãã€ã«ãªãã·åºïŒãïœâãããµãã«ãã€
ã«ãªãã·åºãïœâãããµãã«ãã€ã«ãªãã·åº
ïŒãã«ããã€ã«ãªãã·åºïŒãïœâãªã¯ã¿ãã«ãã€
ã«ãªãã·åºïŒã¹ãã¢ãã€ã«ãªãã·åºïŒåã¯ïœâ
ãšã€ã³ãœã€ã«ãªãã·åºïŒã¢ã©ããã€ã«ãªãã·
åºïŒãããã«ã¯ïœâãŠã³ãã«ãã€ã«ãªãã·åºã
ïœâããªãã«ãã€ã«ãªãã·åºãïœâãã³ã¿ãã«
ãã€ã«ãªãã·åºãïœâããã¿ãã«ãã€ã«ãªãã·
åºåã¯ïœâãããã«ãã€ã«ãªãã·åºã§ããã ã¢ã·ã«ãªãã·åºR1åã¯R2ã¯ã奜ãŸããã¯ã¢
ã«ã±ãã€ã«ãªãã·ãäŸãã°ïŒâã·ã¹âããã»ã
ã«ãªãã·åºïŒã©ãŠãã¬ãªã€ã«ãªãã·åºïŒãïŒâ
ã·ã¹âããã©ãã»ãã€ã«ãªãã·åºïŒããªã¹ãã¬
ãªã€ã«ãªãã·åºïŒãïŒâã·ã¹âãããµãã»ãã€
ã«ãªãã·åºïŒãã«ããã¬ã€ãã€ã«ãªãã·åºïŒã
ïŒâã·ã¹âãªã¯ã¿ãã»ãã€ã«ãªãã·åºïŒããã
ã»ãªãã€ã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãªã¯ã¿
ãã»ãã€ã«ãªãã·åºïŒãããã»ã©ã€ãžãã€ã«ãª
ãã·åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã€ã«ãªãã·
åºïŒãªã¬ãªã€ã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãª
ã¯ã¿ãã»ãã€ã«ãªãã·åºïŒãšã©ã€ãžãã€ã«ãªã
ã·åºïŒåã¯ïŒâã·ã¹âãšã€ã³ã»ãã€ã«åºïŒã¬ã
ã¬ã€ãã€ã«ãªãã·åºïŒãããã«ïŒâã·ã¹â12â
ãã©ã³ã¹âãªã¯ã¿ãžãšãã€ã«ãªãã·åºïŒãªãã
ã€ã«åºïŒãïŒâãã©ã³ã¹â12âãã©ã³ã¹âãªã¯
ã¿ãã«ãžãšãã€ã«ãªãã·åºïŒãªãã©ã€ãžãã€ã«
ãªãã·åºïŒãïŒâã·ã¹â12âã·ã¹âãªã¯ã¿ãžãš
ãã€ã«ãªãã·åºïŒãªãã¬ãªã€ã«ãªãã·åºïŒãïŒ
âã·ã¹â11âãã©ã³ã¹â13âãã©ã³ã¹âãªã¯ã¿
ãã«ããªãšãã€ã«ãªãã·åºïŒãªãã¬ãã€ã«ãªã
ã·åºïŒãïŒâïŒ11âïŒ13âïŒ15âãªã¯ã¿ãã«ã
ãã©ãšãã€ã«ãªãã·åºïŒããªããã€ã«ãªãã·
åºïŒãïŒâïŒ11âïŒ14âãšã€ã³ãµããªãšãã€ã«
ãªãã·åºãåã¯ïŒâïŒïŒâïŒ11âïŒ14âãšã€ã³
ãµããã©ãšãã€ã«ãªãã·åºïŒã¢ã©ãããã€ã«ãª
ãã·åºïŒã§ããã ççŽ ååæ°ïŒãïŒåãæããäœçŽã¢ã«ãã«åº
R4ã¯ãäŸãã°ã¡ãã«åºããšãã«åºãã€ãœãã
ãã«åºãïœâãããã«åºãã€ãœããã«åºåã¯ïœ
âããã«åºã§ããã 眮æãããççŽ ååæ°ïŒãïŒåã®äœçŽã¢ã«ã
ã«åºR4ã¯ã奜ãŸããã¯ã«ã«ããã·äœçŽã¢ã«ã
ã«åºãäŸãã°ã«ã«ããã·ã¡ãã«åºãïŒâã«ã«ã
ãã·ãšãã«åºãããã¯ïŒâã«ã«ããã·âïœâã
ããã«åºãã¢ããäœçŽã¢ã«ãã«åºãäŸãã°ã¢ã
ãã¡ãã«åºãïŒâã¢ãããšãã«åºãããã¯ïŒâ
ã¢ããâïœâãããã«åºãäœçŽã¢ã«ãã«ã¢ãã
äœçŽã¢ã«ãã«åºãäŸãã°ã¡ãã«ã¢ããã¡ãã«åº
ãããã¯ãšãã«ã¢ããã¡ãã«åºãïŒâã¡ãã«ã¢
ãããšãã«åºããããã¯ïŒâã¡ãã«ã¢ããâïœ
âãããã«åºããžäœçŽã¢ã«ãã«ã¢ããäœçŽã¢ã«
ãã«åºãäŸãã°ãžã¡ãã«ã¢ããã¡ãã«åºããã
ã¯ãžãšãã«ã¢ããã¡ãã«åºãïŒâãžã¡ãã«ã¢ã
ããšãã«åºããããã¯ïŒâãžã¡ãã«ã¢ããâïœ
âãããã«åºãÏâã¢ããâÏâã«ã«ããã·äœ
çŽã¢ã«ãã«åºãäŸãã°ïŒâã¢ããâïŒâã«ã«ã
ãã·ãšãã«åºãããã¯ïŒâã¢ããâïŒâã«ã«ã
ãã·âïœâãããã«åºãããããã·äœçŽã¢ã«ã
ã«åºãäŸãã°ïŒâããããã·ãšãã«åºãããã¯
ïŒïŒïŒâãžããããã·ãããã«åºãäœçŽã¢ã«ã³
ãã·äœçŽã¢ã«ãã«åºãäŸãã°ã¡ããã·ã¡ãã«åº
ãããã¯ãšããã·ã¡ãã«åºãïŒâã¡ããã·âãš
ãã«åºããããã¯ïŒâã¡ããã·âïœâãããã«
åºãåã¯ããã²ã³äœçŽã¢ã«ãã«åºãäŸãã°å¡©å
ã¡ãã«åºãããã¯èåã¡ãã«åºãïŒâã¯ãããš
ãã«åºãããã¯ïŒâããã¢ãšãã«åºãïŒâãã
ãã¯ïŒâã¯ããâïœâãããã«åºããããã¯ïŒ
âãããã¯ïŒâããã¢âïœâãããã«åºã§ã
ãã é©åœãªè¿œå ã®è質ã¯ãäŸãã°ïœãïŒã§ããã
R1åã³R2ãçžäºã«ç¬ç«ã«ãããããççŽ åå
æ°10ã20åã®ã¢ã«ãã«åºãã¢ã«ã±ãã«åºãã¢ã«
ã³ãã·åºåã¯ã¢ã«ã±ãã«ãªãã·åºãåã¯ççŽ å
åæ°10ã20åã®ã¢ã·ã«ãªãã·åºã§ããããããŠ
R3ãæ°ŽçŽ ã§ããã R1ïŒR2åã³R3ã¯åè¿°ã®æå³ãæãããR4ã«
ã¯ããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªåºãäŸãã°ããª
ã¡ãã«ã¢ã³ã¢ããªã«ãã眮æãããäœçŽã¢ã«ã
ã«åºãäŸãã°ïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«
åºïŒã³ãªãã«åºïŒãããã é©åœãªè¿œå ã®è質ã«ã¯ãäŸãã°ãR1åã³R2
ãã¢ã·ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ããã
ãããŠR4ãïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«
åºåã¯ïŒâã¢ãããšãã«åºã§ããåŒ(A)ã®è質ã
ããã ãããã®è¿œå ã®è質ã¯ãR4ãïŒâããªã¡ã
ã«ã¢ã³ã¢ããªãšãã«åºã§ããå Žåã«ã¯å€©ç¶ã¬ã·
ãã³ãäŸãã°åµâã¬ã·ãã³åã¯å€§è±ã¬ã·ãã³ã§
ãããR4ãïŒâã¢ãããšãã«åºã§ããå Žåã«
ã¯å€©ç¶ã±ãã¢ãªã³ãäŸãã°åµâã±ãã¢ãªã³åã¯
倧è±ã±ãã¢ãªã³ã§ããã ãã®ã»ãã«ãè¿œå ã®è質ãšããŠãåŒ(A)ã®åæ
ã¬ã·ãã³é¡ïŒR4ïŒïŒâããªã¡ãã«ã¢ã³ã¢ããª
ãšãã«åºïŒåã³åæã±ãã¢ãªã³é¡ïŒR4ïŒïŒâ
ã¢ãããšãã«åºïŒãæããããšãã§ããããã
ã¯å¥œãŸããã¯ãR1åã³R2ãåäžã®ã¢ã·ã«ãªã
ã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºããªã¬ãªã€ã«
ãªãã·åºããªãã€ã«ãªãã·åºããªãã¬ãªã€ã«ãª
ãã·åºãããã¯ã¢ã©ããã€ã«ãªãã·åºãè¡šãã
äŸãã°ãžã©ãŠãã€ã«âããžããªã¹ãã€ã«âããž
ãã«ããã€ã«âããžã¹ãã¢ãã€ã«âããžã¢ã©ã
ãã€ã«âããžãªã¬ãªã€ã«âããžãªãã€ã«âããž
ãªãã¬ãªã€ã«âããããã¯ãžã¢ã©ããã€ã«ã¬ã·
ãã³ãããã¯âã±ãã¢ãªã³ãR1åã³R2ãç°ã
ã¢ã·ã«ãªãã·åºãäŸãã°R1ããã«ããã€ã«ãª
ãã·åºã§R2ããªã¬ãªã€ã«ãªãã·åºã§ããäŸã
ã°ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«âã¬ã·ã
ã³ãããã¯âã±ãã¢ãªã³ãR1åã³R2ãåäžã®
ã¢ã«ã³ãã·åºãäŸãã°ããã©ãã·ã«ãªãã·åºã
ããã¯ãããµãã·ã«ãªãã·åºã§ããäŸãã°ãžã
ãã©ãã·ã«âãããã¯ãžãããµãã·ã«âã¬ã·ã
ã³ãããã¯âã±ãã¢ãªã³ãR1ãã¢ã«ã±ãã«åº
ã§ããR2ãã¢ã·ã«ãªãã·åºã§ããäŸãã°ãã©
ãºãããŒã²ã³ïŒR4ïŒããªã¡ãã«ã¢ã³ã¢ããªãš
ãã«åºïŒãåã¯R1ãã¢ã·ã«ãªãã·åºãäŸãã°ã
ãªã¹ãã€ã«ãã·åºãããã¯ãã«ããã€ã«ãªãã·
åºã§ããR2ãããããã·ã«åºã§ããäŸãã°å€©
ç¶ãããã¯åæãªãœã¬ã·ãã³ãããã¯ãªãœã±ã
ã¢ãªã³ãäŸãã°ïŒâããªã¹ãã€ã«âãããã¯ïŒ
âãã«ããã€ã«ãœã¬ã·ãã³ãããã¯âã±ãã¢ãª
ã³ã§ããããããã«ãããŠR3ã¯æ°ŽçŽ ã§ããã 奜ãŸããã¯ãæ°Žæ§åæ£äœã«ã¯ãïœãïŒã§ã
ãïŒR1ãã¢ã«ãã«åºãäŸãã°ïœâããã·ã«åº
ïŒã©ãŠãªã«åºïŒãïœâããªãã·ã«åºãïœâããã©
ãã·ã«åºïŒããªã¹ãã«åºïŒãïœâãã³ã¿ãã·ã«
åºãïœâãããµãã·ã«åºïŒã»ãã«åºïŒãïœâã
ãã¿ãã·ã«åºãããã¯ïœâãªã¯ã¿ãã·ã«åºïŒã¹
ãã¢ãªã«åºïŒãã¢ã«ã³ãã·åºãäŸãã°ïœâãã
ã·ã«ãªãã·åºïŒã©ãŠãªã«ãªãã·åºïŒãïœâãã
ã©ãã·ã«ãªãã·åºïŒããªã¹ãã«ãªãã·åºïŒãïœ
âãããµãã·ã«ãªãã·åºïŒã»ãã«ãªãã·åºïŒã
ããã¯ïœâãªã¯ã¿ãã·ã«ãªãã·åºïŒã¹ãã¢ãªã«
ãªãã·åºïŒãåã¯ã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠ
ãã€ã«ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«
ããã€ã«ãªãã·åºãããã¯ã¹ãã¢ãã€ã«ãªãã·
åºã§ããïŒR2ãæ°ŽçŽ åã¯ããããã·åºã§ã
ãïŒR3ãæ°ŽçŽ åã¯äœçŽã¢ã«ãã«åºãäŸãã°ã¡
ãã«åºã§ããïŒãããŠR4ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«åºãäŸãã°ã¡ãã«åºãããã¯ãšãã«åºãã«ã«
ããã·ã«åºåã³ã¢ããåºã«ãã眮æãããäœçŽ
ã¢ã«ãã«åºãäŸãã°Ïâã¢ããâÏâã«ã«ãã
ã·äœçŽã¢ã«ãã«åºãäŸãã°ïŒâã¢ããâïŒâã«
ã«ããã·ãšãã«åºãããã¯ïŒâã¢ããâïŒâã«
ã«ããã·âïœâãããã«åºãããããã·äœçŽã¢
ã«ãã«åºãäŸãã°ïŒâããããã·ãšãã«åºãã
ãã¯ïŒïŒïŒâããããã·ãããã«åºãããã²ã³
åäœçŽã¢ã«ãã«åºãäŸãã°ïŒâã¯ããâããã
ã¯ïŒâããã¢ãšãã«åºã§ããåŒ(A)ã®è質ãåã³
R1åã³R2ãã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€
ã«ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«ãã
ã€ã«ãªãã·åºåã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ã
ãïŒR3ãæ°ŽçŽ ã§ããïŒãããŠR4ãïŒâããªã¡
ãã«ã¢ã³ã¢ããªãšãã«åºãããã¯ïŒâã¢ãããš
ãã«åºã§ããåŒ(A)ã§ç€ºãããè¿œå ã®è質ãå«æ
ãããããåã¯ãæ°Žæ§åæ£äœã«ã¯ãR1åã³R2
ãã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·
åºãããªã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªã
ã·åºãããã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ããã
R3ãæ°ŽçŽ ã§ããããããŠR4ãæ°ŽçŽ ã§ããåŒ(A)
ã®è質ãåã³å Žåã«ãã€ãŠã¯ãR1åã³R2ãã¢
ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãã
ãªã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªãã·åºå
ã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§
ããããããŠR4ãïŒâããªã¡ãã«ã¢ã³ã¢ããª
ãšãã«åºãåã¯ïŒâã¢ãããšãã«åºã§ããåŒ(A)
ã§ç€ºãããè¿œå ã®è質ãå«æããããããšãã§
ããã 奜ãŸããã¯ãæ°Žæ§åªäœã«ã¯ããªãã¹ãã¢ããž
ã³é žãäŸãã°å€©ç¶ãªãœãã¹ãã¢ããžã³é žãäŸã
ã°åµâãªãœãã¹ãã¢ããžã³é žããããã¯åæãª
ãœãã¹ãã¢ããžã³é žãäŸãã°ïŒâã©ãŠãã€ã«â
ãªãœãã¹ãã¢ããžã³é žãïŒâããªã¹ãã€ã«ãªãœ
ãã¹ãã¢ããžã³é žãããã¯ïŒâãã«ããã€ã«ãª
ãœãã¹ãã¢ããžã³é žããªãœãã¹ãã¢ããžã«ã»ãª
ã³ãäŸãã°å€©ç¶ãªãœãã¹ãã¢ããžã«ã»ãªã³ãäŸ
ãã°çè³ãªãœãã¹ãã¢ããžã«ã»ãªã³ããããã¯
åæãªãœãã¹ãã¢ããžã«ã»ãªã³ãäŸãã°ïŒâã
ãªã¹ãã€ã«ãªãœãã¹ãã¢ããžã«ã»ãªã³ãããã¯
ïŒâãã«ããã€ã«ãªãœãã¹ãã¢ããžã«ã»ãªã³ã
ãªãœãã¹ãã¢ããžã«ã°ãªã»ãªã³ãåã¯ãªãœãã¹
ãã¢ããžã«ã€ãã·ããŒã«ããããŠããã«ãã¬ã·
ãã³ãäŸãã°å€©ç¶ã¬ã·ãã³ãäŸãã°åµâã¬ã·ã
ã³ãåäžã®ã¢ã·ã«ãªãã·åºãæããã¬ã·ãã³ã
äŸãã°ãžããªã¹ãã€ã«ã¬ã·ãã³ãããã¯ãžãã«
ããã€ã«ã¬ã·ãã³ãç°ãªãã¢ã·ã«ãªãã·åºãæ
ããã¬ã·ãã³ãäŸãã°ïŒâãã«ããã€ã«âïŒâ
ãªã¬ãªã€ã«ã¬ã·ãã³ãåã¯ããã«ã±ãã¢ãªã³ã
äŸãã°å€©ç¶ã±ãã¢ãªã³ãäŸãã°åµâã±ãã¢ãª
ã³ããããã¯ç°ãªãã¢ã·ã«ãªãã·åºãæããã±
ãã¢ãªã³ãäŸãã°ïŒâãã«ããã€ã«âïŒâãªã¬
ãªã€ã«ã±ãã¢ãªã³ãå«æããããã 奜ãŸããã¯æ°Žæ§åæ£äœã«ã¯ã倩ç¶ãã¹ãã¢ã
ãžã³é žãäŸãã°åµâãã¹ãã¢ããžã³é žãåæã
ã¹ãã¢ããžã³é žãäŸãã°ãžã©ãŠãã€ã«ãã¹ãã¢
ããžã³é žããžããªã¹ãã€ã«ãã¹ãã¢ããžã³é žã
ãžãã«ããã€ã«ãã¹ãã¢ããžã³é žãããã¯ïŒâ
ãã«ããã€ã«âïŒâãªã¬ãªã€ã«ãã¹ãã¢ããžã³
é žããããŠå Žåã«ãã€ãŠã¯ããã«ãã¬ã·ãã³ã
äŸãã°å€©ç¶ã¬ã·ãã³ãäŸãã°åµâã¬ã·ãã³ãå
äžã®ã¢ã·ã«ãªãã·åºãæããã¬ã·ãã³ãäŸãã°
ãžããªã¹ãã€ã«ã¬ã·ãã³ãããã¯ãžãã«ããã€
ã«ã¬ã·ãã³ããããã¯ç°ãªãã¢ã·ã«ãªãã·åºã
æããã¬ã·ãã³ãäŸãã°ïŒâãã«ããã€ã«âïŒ
âãªã¬ãªã€ã«ã¬ã·ãã³ãåã¯ã±ãã¢ãªã³ãäŸã
ã°å€©ç¶ã±ãã¢ãªã³ãäŸãã°åµâã±ãã¢ãªã³ãã
ããã¯ç°ãªãã¢ã·ã«ãªãã·åºãæããã±ãã¢ãª
ã³ãäŸãã°ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«
ã±ãã¢ãªã³ãå«æããããããšãã§ããã åå±€è質é¡ç²ã補é ããããã«ããŸãè質æ
åã®å質局ã調補ãããå質局ã®èª¿è£œã¯ããã
èªäœå ¬ç¥ã®æ¹æ³ã«ããè¡ãããšãã§ãããã®æ
现æžã«ãããŠããè質æåã®å質局ã®èª¿è£œãã®
é ã«è©³çŽ°ã«èšèŒããã å質局ãæ°Žæ§çžã«åæ£ãããããããŠæ¬¡ã«ïŒ
çš®é¡ã®ã¿ã®è質æåãäŸãã°çŽãã¹ãã¢ããžã³
é žãåæ£ããããæ°Žæ§çžã®PHãçŽ11以äžã«äžæ
ããããããã®æäœã¯ãäŸãã°ãæç¹æ³åã¯PH
ã¡ãŒã¿ã«ããPHå€ãç£èŠããªãããçççã«èš±
容ãããå¡©åºæ§æº¶æ¶²ãäŸãã°çŽ0.01ã0.2Nã奜
ãŸããã¯çŽ0.1Nã®æ°Žé žåãããªãŠã åã¯æ°Žé ž
åã«ãªãŠã åžæ°Žæº¶æ¶²ãæ·»å ããããšã«ããè¡
ãã 奜ãŸããæ æ§ã«ãããŠã¯ãè質æåã®å質局
ããïŒããé«ãPHãæããæ°Žæ§çžãäŸãã°çç
çã«èš±å®¹ãããå¡©åºæ§æº¶æ¶²ãäŸãã°çŽ0.01ã
0.2Nãç¹ã«0.1Nã®æ°Žé žåãããªãŠã åã¯æ°Žé ž
åã«ãªãŠã åžæ°Žæº¶æ¶²ã«åæ£ãããããïŒã€ã®è
質æåãäŸãã°çŽãã¹ãã¢ããžã³é žã¯çŽ12以äž
ã®PHãæããæ°Žæ§çžã«åæ£ããããã æ¹æ³b1åã³b2 ïœãïŒã§ãããåºR1åã³R2ã®å ã®ïŒã€ãæ°ŽçŽ
åã¯ããããã·ã«åºã§ãã€ãŠä»æ¹ã®åºãããã
ãççŽ ååæ°10ã20åãæããã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«
ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ããããããŠR4
ãã¢ã³ã¢ããªåºã«ãã眮æãããäœçŽã¢ã«ãã«
åºã§ããåŒ(A)ã®è質ã«ãããŠãR1åã³R2ã¯æ¹
æ³ïŒa1ïŒåã³ïŒa2ïŒã«ãããŠãã§ã«èšèŒãã
æå³ãæããã ã¢ã³ã¢ããªåºã«ãã眮æãããäœçŽã¢ã«ãã«
åºR4ã¯ãäŸãã°ãããªäœçŽã¢ã«ãã«ã¢ã³ã¢ã
ãªåºãäŸãã°ããªã¡ãã«âåã¯ããªãšãã«ã¢ã³
ã¢ããªåºã«ãã眮æãããäœçŽã¢ã«ãã«åºãäŸ
ãã°ïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«åºåã¯ïŒ
âããªãšãã«ã¢ã³ã¢ããªãšãã«åºã§ããã ïœãïŒã§ãããR1åã³R2ãçžäºã«ç¬ç«ã«ã
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºããããã¯ã¢ã«ã±ã
ã«ãªãã·åºãåã¯ççŽ ååæ°10ã20ã®ã¢ã·ã«ãª
ãã·åºã§ãããR3ãæ°ŽçŽ ã§ããããããŠR4ã
ã¢ã³ã¢ããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªåºã«ãã眮
æãããäœçŽã¢ã«ãã«åºã§ããåŒ(A)ã®è質ã«ã
ããŠãR1åã³R2ã¯å¥œãŸããã¯æ¹æ³ïŒa1ïŒåã³
ïŒa2ïŒã«ãããŠè©³çŽ°ã«èšèŒããç¹å®ã®æå³ãæ
ããã ã¢ã³ã¢ããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªåºã«ãã
眮æãããäœçŽã¢ã«ãã«åºã¯ãäŸãã°ãïŒâ
ãïŒïŒ®âãžäœçŽã¢ã«ãã«ââïŒïŒâNâ²ïŒNâ²ïŒ
Nâ²âããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªãšãã«ïŒâã¢
ã³ã¢ããªãâãšãã«åºãäŸãã°ïŒâãïŒïŒ®âãž
ã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒNâ²âããªã¡ãã«ã¢
ã³ã¢ããªãšãã«ïŒâã¢ã³ã¢ããªãâãšãã«åºã§ã
ãã é©åœãªè¿œå ã®è質ã¯ãæ¹æ³ïŒa1ïŒåã³ïŒa2ïŒ
ã«ãããŠè©³çŽ°ã«èšèŒããè¿œå ã®è質ã§ããã 奜ãŸããã¯ãæ°Žæ§åæ£äœã«ã¯ãïœãïŒã§ã
ããR1ãã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«
ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«ããã€
ã«ãªãã·åºåã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ããã
R2ãããããã·åºã§ãããR3ãæ°ŽçŽ ã§ããã
ãããŠR4ãïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«
åºã§ããåŒ(A)ã®è質ã䞊ã³ã«R1åã³R2ãã¢ã·
ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãããª
ã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªãã·åºåã¯
ã¹ãã¢ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ã
ãããããŠR4ãïŒâã¢ãããšãã«åºåã¯ïŒâ
ããªã¡ãã«ã¢ã³ã¢ããªãšãã«åºã§ããåŒ(A)ã®é©
åœãªè¿œå ã®è質ãå«æãããããåãæ°Žæ§åæ£
äœã«ã¯å¥œãŸããã¯ãR1åã³R2ãã¢ã·ã«ãªãã·
åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãããªã¹ãã€ã«
ãªãã·åºããã«ããã€ã«ãªãã·åºãåã¯ã¹ãã¢
ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ãããã
ããŠR4ãïŒâãïŒïŒ®âãžã¡ãã«ââïŒïŒâ
Nâ²ïŒNâ²ïŒNâ²âããªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒâ
ã¢ã³ã¢ããªãâãšãã«åºã§ããåŒ(A)ã®è質ã䞊
ã³ã«å Žåã«ãã€ãŠã¯ãR1åã³R2ãã¢ã·ã«ãªã
ã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãããªã¹ãã€
ã«ãªãã·åºããã«ããã€ã«ãªãã·åºåã¯ã¹ãã¢
ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ãããã
ããŠR4ãïŒâã¢ãããšãã«åºåã¯ïŒâããªã¡
ãã«ã¢ã³ã¢ããªãšãã«åºã§ããåŒ(A)ã®è¿œå ã®è
質ãå«æããããããšãã§ããã 奜ãŸããã¯ãæ°Žæ§åæ£äœã«ã¯ãªãœãã¹ãã¢ã
ãžã«ã³ãªã³ïŒãªãœã¬ã·ãã³ïŒåã³å€©ç¶ã¬ã·ã
ã³ãäŸãã°åµâã¬ã·ãã³ãå«æããããã奜ãŸ
ããã¯ãæ°Žæ§åæ£äœã«ã¯ãã¹ãã¢ããžã«âïŒâ
ãïŒïŒ®âãžã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒNâ²â
ããªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒâã¢ã³ã¢ããªãâ
ãšãã«ã¯ããªããåã³å Žåã«ãã€ãŠã¯å€©ç¶ã¬ã·
ãã³ãäŸãã°åµâã¬ã·ãã³ãå«æããããã åå±€è質é¡ç²ã補é ããããã«ããŸããè質
æåãäŸãã°ãªãœã¬ã·ãã³åã¯ãã¹ãã¢ããžã«
âïŒâãïŒïŒ®âãžã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒ
Nâ²âããªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒâã¢ã³ã¢ã
ãªãâãšãã«ã¯ããªãã®å質局ã調補ããã å質局ã®èª¿è£œã¯ããèªäœå ¬ç¥ã®æ¹æ³ã«ããè¡
ãããšãã§ãããã®æ现æžã®ãè質æåã®å質
å±€ã®èª¿è£œãã®é ã§è©³çŽ°ã«èšèŒããã å質局ãæ°Žæ§çžã«åæ£ãããããããŠãäŸã
ã°æç¹æ³åã¯PHã¡ãŒã¿ã«ããPHå€ã調補ããªã
ããPHãçŽïŒåã¯ããããäœãäžããããã®æ
äœã¯äŸãã°çççã«èš±å®¹ãããé žãäŸãã°é±é ž
ã®åžæ°Žæº¶æ¶²ãäŸãã°ç¡«é žãå¡©é žåã¯çé žã®åžæ°Ž
溶液ãæ·»å ããããšã«ããè¡ãã 奜ãŸããæ æ§ã«ãããŠã¯ãè質æåã®å質局
ããPHçŽïŒåã¯ããããäœãç¯å²ã®æ°Žæ§çžãäŸ
ãã°é±é žåžæ°Žæº¶æ¶²ãäŸãã°ç¡«é žãå¡©é žåã¯çé ž
ã®åžæ°Žæº¶æ¶²ã«ãPHå€ãåæçã«èª¿æŽããªããæ·»
å ããã 次ã«è¡ãæ°Žæ§çžã®äžåã¯ãæ¹æ³ïŒa1ïŒåã³
ïŒa2ïŒã«ãããŠPHå€ã11ããé«ãããå Žåãåã¯
æ¹æ³ïŒb1ïŒåã³ïŒb2ïŒã«ãããŠPHå€ãïŒããäœ
ãããå Žåã«å¿ é ã§ããããã®æäœã¯ãPHå€ã®äž
æåã¯äœäžã®çŽåŸã«å¡©åºæ§åã¯é žæ§æ¡ä»¶äžã§æŽ»æ§
ç©è³ªåã³ïŒåã¯è質é¡ç²ãç Žå£ãããã®ãé²æ¢ã
ãããã«è¡ããå¡©åºæ§åããæ°Žæ§çžã¯ãé©åœãªç
ççã«èš±å®¹ãããé žåã¯ç·©è¡æ¶²ãäŸãã°PHïŒãïŒ
ã®çé žç·©è¡æ¶²ã«ããäžåãããé©åœãªé žãšããŠ
ã¯ãäŸãã°åèšã®é±é žæ°Žæº¶æ¶²åã³åŒ±ææ©é žãäŸã
ã°è»é žãåã¯é ¢é žãæãããããé žæ§æ°Žæ§çžã¯ã
å¡©åºæ§æ°Žæº¶æ¶²ãäŸãã°æ°Žé žåãããªãŠã åã¯æ°Žé ž
åã«ãªãŠã ã®åžæ°Žæº¶æ¶²ãæ·»å ããããšã«ããäžå
ãããäžåã¯PHå€ã®åæç調æŽã®äžã§è¡ãã è質ã¯ãæ°Žæ§çžäžã«70ïŒ ããå€ããŸã§ã®æ¿åºŠã§
åæ£ãããããæ¿åºŠç¯å²ã¯çŽïŒïŒ ãçŽ20ïŒ ãšãã
ã®ã奜ãŸããã宀枩åã¯ããããé«ã枩床ãäŸã
ã°çŽ60âãŸã§ã®æž©åºŠã§è¡ãã®ã奜éœåã§ãããå°
å ¥ãã¹ã掻æ§ç©è³ªã®æåæ§ã®ããã«å¿ èŠãããå Ž
åã«ã¯ãå·åŽäžããããŠå Žåã«ãã€ãŠã¯äžæŽ»æ§æ°
äœé°å²æ°äžãäŸãã°çªçŽ é°å²æ°äžã§è¡ãã æ¹æ³ïŒa1ïŒåã³ïŒa2ïŒäžŠã³ã«ïŒb1ïŒåã³ïŒb2ïŒ
ã®ãããã«ãããŠããåå±€è質é¡ç²ã®åœ¢æã¯èªçº
çã«ïŒèªçºçé¡ç²åœ¢æïŒãããªãã¡å€éšããè¿œå
ã®ãšãã«ã®ãŒãå ããããšãªãããããŠå€§ããªé
床ã§è¡ãããã åŸãããåå±€è質é¡ç²ã¯æ°Žæ§çžäžã§æ¯èŒç倧ã
ãªå®å®æ§ãæãããäŸãã°ãæ°Žæ§çžäžã«ååšãã
åµâãã¹ãã¢ããžã³é žãåã¯åµâãã¹ãã¢ããžã³
é žãšåµâã¬ã·ãã³ãšããæãåå±€è質é¡ç²ã¯ãïŒ
âã«ãŠ14æ¥ä»¥äžçœ®ããŠãå®å®ã«ç¶æãããããã®
çºæã®æ¹æ³ã«åŸã€ãŠè£œé ãããè質é¡ç²ãæãã
æ°Žæ§çžã¯ããšãŒãããç¹èš±åºé¡ç¬¬0065292å·ã«èš
èŒãããŠããæ¹æ³ã«ãã貯èµå®å®ã«ãããã åå±€è質é¡ç²ã®åœ¢æãšæ°Žæ§çžäžã«ããããã®é
ã¯ãããèªäœå ¬ç¥ã®æ¹æ³ã«ãããçš®ã ã®æ¹æ³ãäŸ
ãã°é»åé¡åŸ®é¡ã«ããèŠèŠç芳å¯ãåæçšè¶ é å¿
åé¢ã«ãã質é枬å®ããããŠç¹ã«ã¹ãã¯ãã«æ³ã
äŸãã°æ žå ±é³Žã¹ãã¯ãã«ïŒ1Hã13Cåã³31PïŒã«åº
ããŠæž¬å®ããããšãã§ãããäŸãã°ãæ žå ±é³Žã¹ã
ã¯ãã«ã®éãã·ã°ãã«ã¯å°åœ¢åå±€è質é¡ç²ã®åœ¢æ
ãšé¢é£ãããç³»ã«ãããå°åœ¢åå±€è質é¡ç²ã®æ¯ç
ã¯ã·ã°ãã«ã®åŒ·åºŠããç®åºããããšãã§ãããéœ
åæ žå ±é³Žã¹ãã¯ãã«ã«ãããŠããã¹ãã¢ããžã³é ž
ãã圢æãããå°åœ¢åå±€è質é¡ç²ã®å ŽåÎŽïŒ
1.28ppmã«ãããéãã¡ãã¬ã³ã·ã°ãã«ãšÎŽïŒ
0.89ppmã«ãããéãã¡ãã«ã·ã°ãã«ãç¹ç°çã§
ããããã¹ãã¢ããžã³é žåã³ã¬ã·ãã³ãã圢æã
ããå°åœ¢åå±€è質é¡ç²ããã¯ãåæ§ã«ã¡ãã¬ã³ã·
ã°ãã«åã³ã¡ãã«ã·ã°ãã«ã§ããÎŽïŒ1.28ppmå
ã³0.89ppmã®ã·ã°ãã«ãšãããã«ã¬ã·ãã³ã®ããª
ã¡ãã«ã¢ã³ã¢ããªåºã«åž°å±ããÎŽïŒ3.23ppmã®ã¡
ãã«ã·ã°ãã«ãçããã 圢æãããåå±€è質é¡ç²ã®å€§ããã¯ãç¹ã«è質
æåã®æ§é ãè質æåã®æ··åæ¯ããããã®è質æ
åã®æ°Žæ§çžäžã§ã®æ¿åºŠãåã³å°å ¥ãã¹ã掻æ§ç©è³ª
ã®éãšæ§é ã«äŸåãããåŸã€ãŠãäŸãã°ãæ°Žæ§çž
äžã®è質æåã®æ¿åºŠãå€ããããšã«ãã€ãŠãé«ã
æ¯çã§å°åœ¢åå±€è質é¡ç²åã¯å€§åœ¢åå±€è質é¡ç²ã
補é ããããšãã§ãããäŸãã°ãåæ£çžã«åµâã
ã¹ãã¢ããžã³é žãæ·»å ããããšã«ããå°åœ¢åå±€è
質é¡ç²ïŒKULïŒã®æ¯çãé«ããããšãã§ããã
åãåæ£çžäžã®å€§åœ¢åå±€è質é¡ç²ïŒGULïŒã®æ¯
çã¯ãå¡©ãäŸãã°NaClåã¯KClãæ·»å ããããš
ã«ããé«ããããšãã§ãããäŸãã°ãã¹ãã¢ããž
ã³é žãåã¯ãã¹ãã¢ããžã³é žãšã¬ã·ãã³ãšãã圢
æãããKULã¯çŽ200ã600â«ã®çŽåŸãæããã
ãã®ãããªå€§ãããæããKULã®å°å ¥å®¹éã¯å
ããè質æåã®ïŒã¢ã«åœããçŽ0.5ãïŒã§ããã KULã®ä»ã«å€§åœ¢åå±€è質é¡ç²ïŒGULâçŽåŸçŽ
50000â«ä»¥äžïŒã圢æãããããã®ãã®ã¯å ãã
è質æåïŒã¢ã«åœãããã倧ããªå°å ¥å®¹éãæ
ãããã®ããããã倧ããªåçã§å°å ¥ããã®ã«é©
ãããããŠå®¹ç©ã®å€§ããæéãäŸãã°ãŠã€ã«ã¹ã
现èåã¯çŽ°èåšç®¡ãå°å ¥ããã®ã«é©ããã GULããKULã®åé¢ã¯ãåžžçšã®åé¢æ³ãäŸã
ã°ã²ã«éæ³ãäŸãã°ã»ãã¢ããŒãº4Bãæ äœãš
ããŠäœ¿çšããã²ã«éæ³ãåã¯160000ïœã®è¶ é å¿
ã«ããGULã®æ²éã«ããè¡ãããšãã§ãããäŸ
ãã°ãåèšã®éåå Žã«ãããŠæ°æéãäŸãã°çŽïŒ
æéé å¿åé¢ããããšã«ããGULãæ²éããä»
æ¹KULã¯åé¢ãããŸãŸã§ããããã«ã³ãã«ãã
åãåºãããšãã§ããã ããã«ãã²ã«éã«ãããæ°Žæ§çžäžã«ååšãã
çŽåŸã600â«ãã倧ãããã¹ãŠã®è質é¡ç²ãäŸã
ã°GULåã¯å€å±€è質é¡ç²ã䞊ã³ã«å°å ¥ãããŠã
ãªã掻æ§ç©åã³æ®åãåæ£ããŠããè質ãåé¢
ãããããŠå€§ãããæ¯èŒçåäžãªKULåºåã䌎
ãæ°Žæ§çžãåŸãããšãã§ããã ãã®çºæã®è質é¡ç²ïŒKULåã³GULïŒã¯ãé©
åœãªæ äœç³»ã§ãã€ãŠããã®æ äœç³»ã¯èŠªèæ§ç©è³ªã
äŸãã°è溶æ§è²çŽ ã®æ°Žæ§çžäžãžã®å¯æº¶åãå æ°Žå
解æåæ§ååç©ãäŸãã°ããã¹ã¿ã°ã©ã³ãžã³ã®å®
å®åã害è«é§é€å€ã®å°å ¥ãäŸãã°ãžã¯ãããã¹ã®
掻æ§ã¹ãã¯ãã«ã®å€æŽãé£åæ·»å ç©ã®å°å ¥ãäŸã
ã°ãã¿ãã³ãããã¯è²çŽ ã®åžåæ§ãå€ããããšã
ç®çãšããå Žåãåã¯å°å ¥ããã掻æ§ç©è³ªãäŸã
ã°é µçŽ ãæäœããã«ã¢ã³ãéºäŒåããŠã€ã«ã¹ãã
ã¿ãã³ãããã¯çŽ°èåšå®ã®å¹é€çŽ°èãžã®å°å ¥ã«äœ¿
çšãããã 掻æ§ç©è³ªãå°å ¥ãããã®çºæã®è質é¡ç²ãå«æ
ããæ°Žæ§çžã¯æè¬ç³»ãæ§æããå Žåã«ãã€ãŠã¯ã
äŸãã°è¶ é å¿åé¢ã«ããé¡ç²ã®æ¿çž®åã¯åé¢ãè¡
ã€ãåŸãçµå£ïŒP.OïŒæäžãéçµå£ïŒéèå ãç
èå ããããã¯è ¹è å ïŒæäžãåã¯å±ææäžã®ã
ãã®å»çç®çã«é©ããã çµå£æäžã«ãããŠãè質é¡ç²ã«åºç€ã眮ãæè¬
ç³»ã«ãããæ¶å管äžã§äžå®å®ãªæŽ»æ§ç©è³ªäŸãã°ã€
ã³ã¹ãªã³ã¯ä¿è·ãããåã¯ãã®åžåãæ¹åãã
ãã çµå£æäžã®ããã«ã¯ãè質é¡ç²å«ææ°Žæ§çžã¯ã
å»è¬ãšããŠèš±å®¹ãããåžéå€ãããã¯æ äœãåã¯
åžžçšã®æ·»å å€ãäŸãã°è²çŽ ãããã¯å奜å€ãšæ··å
ããŠãã·ãããåã¯ã«ãã»ã«ã®åœ¢ã§æäžããããš
ãã§ããã éçµå£æäžã®å Žåãè質é¡ç²ã«åºç€ã眮ãæè¬
ç³»ã«ãããäŸãã°ãã¹ããšãªãªããµãã³ãã°ã€ã«
ã¡ããïŒGuilmetleïŒR.AçãLife Sci.22(4)ã313
ã320ã1978幎ãåã¯ã²ã³ã¿ãã€ã·ã³ãã·ãšã«ã
ïŒScheldïŒW.M.çãClin.Res.26ïŒNo.ïŒã59Aã
1978幎ãã®äœå æ»çæéã延é·ããããåæ§ã«ã
å°å ¥ããããã¬ãŒãå€ãäŸãã°EDTAïŒãšãã¬ã³
ãžã¢ãã³ããã©é ¢é žïŒã®äœå æ»çæéãé·ã³ãã
ãã«ããããã¬ãŒã圢æã«ãããç¹ã«èèãèŸ
èãåã¯è èããééå±ãé€å»ããããšãã§ãã
ãã©ãŒãã³ïŒRahmannïŒçãScienceãVol 180ã
300ã302ã1973幎ãåã³J.Lab.Clin.Med.640ã
647ã1974幎ããè質é¡ç²ã«åºç€ã眮ãæè¬æ³ã«ã
ã掻æ§ç©è³ªãå¿çäžã«æ¿çž®ããããšãã§ãããã©
ã³ãã¹ãã³ïŒLandesmannïŒçãScience
Vol.198ã737ã738ã1977幎ããæççäœçšå€ãäŸ
ãã°ã³ãŒããŸã«ïŒNature271ãNo.5643ã372ã73ã
1978幎ïŒãåã¯ãããã¢ãŒãŒé»å®³å€ïŒAnal.
Biochem.89ãNo.ïŒã400ã07ã1978幎ïŒãé¢ç¯æ¶²
äžã«ãé现èå€ãè «ççµç¹äžã«ãCancer
Treatment Reviews8ã27ã50ã1981幎ã®ã«ã€ãš
ïŒKayeïŒSL.B.ã®ç·èª¬ãåã³ããã§åŒçšãããŠã
ãïŒã€ã®æç®ãæ¿çž®ããããšãã§ãããã¬ã³æ²»ç
ã«ãããå€ãã®ååŠçæ³å€ã¯ããããè質é¡ç²ã«
å°å ¥ããŠæäžããå Žåãæ¯æ§ãããå°ãªããªãã
ããã«äœã«å¯ŸããŠç©åã«ãªããäŸãã°è質é¡ç²ã«
å°å ¥ãããã¢ãªãããã€ã·ã³ïŒ€ãã©ãŒãã³
ïŒRahmanïŒçãProceedings of the Society
for Exprimental Biologyãåã³Medicine146ã
1173ã1176ã1974幎ããã¡ãœãã¬ãã»ãŒããã¬ã¶
ãŒãã³ïŒLesermannïŒL.D.çãProc.Natl.Acad.
Sci.77ãNo.ïŒã4089ã93ã1980幎ãããã³ãã©ã¹
ãã³ãããŠããã€ã·ã³åã¯ã·ãã·ã³ã¢ã©ããã·ã
ãããŠãŒã¬ã³ã·ãŒãã³ïŒMušhlensiepenïŒçã
Cancer Res.41ãNo.ïŒã1602ã07ã1981幎ããã
ãã§ãããè質é¡ç²ã¯ã掻æ§æåãäŸãã°é µçŽ ã
ãããããã«ã¢ã³ãéºäŒååã¯ãŠã€ã«ã¹ã®çäœçŽ°
èã®çŽ°è質äžãžã®å°å ¥ã«ãäŸãã°ã¢ã¹ãã©ã®ããŒ
ãŒãJ.Lipid ResearchãVol19ã1978幎ã289ã
303äžã®ãã€ã³ã±ã«ã¹ã¿ã€ã³ïŒFinkelsteinïŒïŒå
ã³ã¯ã€ã¹ãã³ïŒWeismannïŒG.ã®ç·èª¬ããã¢ãã
ã°ã«ã³ã·ããŒãŒãã°ã¬ãŽãªã¢ãžã¹ïŒGregoriadisïŒ
G.åã³ãªãã³ïŒRymanïŒB.E.ãEur.J.
Biochem.24ïŒ1972幎ïŒã481ã491ããåã¯ããŠãŒã
ããããŒãŒãã°ã¬ãŽãªã¢ãžã¹çãBiochem.J.
ïŒ1974幎ïŒ140ã232ã330ãã®å°å ¥ã«ãç¹ç°çèå¥
ååãäŸãã°çš®ã ã®æšç现èã«éžæçã«å°å ¥ãã
ããã®ã¢ãã¯ããŒã³æäœãåºå®ããããã«ãã¬ãŒ
ãŒã«ãã³ïŒLesermannïŒçãNature292ïŒ5829ïŒã
226ã228ã1981幎ããäŸãã°ãªãŒã·ãŠããã¢ã«å¯Ÿ
ããæ¥çš®ã®éã®ã¢ãžãŠãã³ããšããŠå ç«åºæ¿ã®ã
ãã«ãããŠãŒïŒNewïŒR.R.C.çNature272ïŒ5648ïŒ
55ã56ã1978幎ããåã¯ãäŸãã°ççãèµ·ããçµ
ç¹ã«ããã枩床ã®äžæãåã¯PHå€ã®å€åã®ããšã
ä¿¡å·ã«ãã掻æ§ç©è³ªã®éé¢ãèªå°ããããã«äœ¿çš
ããããéçµå£æäžã®ããã«ãæ¿çž®ããåã¯åé¢
ããè質é¡ç²ããé©åœãªæ äœæ¶²ãäŸãã°æ®ºèãã
èžçæ°Žåã¯çççé£å¡©æ°Žæº¶æ¶²äžã«æžæ¿ããããšã
ã§ããã è質æåã®å質局ã®èª¿è£œ è質æåã®å質局ã®èª¿è£œã¯ãããèªäœå ¬ç¥ã®æ¹
æ³ã«ããè¡ãããšãã§ãããäŸãã°ããŸããåŒ(A)
ã®è質åã¯è質混åç©ãäŸãã°çŽç²ãªåµâãã¹ã
ã¢ããžã³é žãåã¯åµâãã¹ãã¢ããžã³é žãšåµâã¬
ã·ãã³ãšã®æ··åç©ããå Žåã«ãã€ãŠã¯ãè質é¡ç²
ã®åœ¢æã®éã«è質局ã«å°å ¥ããã芪èæ§æŽ»æ§ç©
質ãäŸãã°èçœè³ªãšå ±ã«ãææ©æº¶å€äžã«æº¶è§£ã
ãã奜ãŸããã¯ç空äžãåã¯äžæŽ»æ§æ°äœãäŸãã°
çªçŽ ã®éæ°ã«ããææ©æº¶æãé€å»ããããšã«ãã
è質æåã®å質局ãåŸãã 溶å€ã®éžæã¯ãããã«æº¶è§£ããè質æåã®æº¶è§£
床ã«äŸåããŠè¡ããé©åœãªæº¶å€ãšããŠã¯ãäŸãã°
眮æãããŠããªãåã¯çœ®æãããŠãããäŸãã°ã
ãã²ã³åããããèèªæã®ãç°ç¶èèªæã®ãè³éŠ
æã®åã¯è³éŠæâèèªæã®çåæ°ŽçŽ ãäŸãã°ãã³
ãŒã³ããã«ãšã³ãå¡©åã¡ãã¬ã³ããããã¯ã¯ãã
ãã«ã ãã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«ãããã¯
ãšã¿ããŒã«ãäœçŽã¢ã«ã«ã³ã«ã«ãã³é žãšã¹ãã«ã
äŸãã°é ¢é žãšãã«ããšãŒãã«ãäŸãã°ãžãšãã«ãš
ãŒãã«ããžãªããµã³ãããã¯ããã©ããããã©
ã³ãåã¯ãããã®æº¶å€ã®æ··åç©ãæããããšãã§
ããã åèšããè質ã¯å ¬ç¥ã®ãã®ã§ãããåã¯ããã
æ°èŠã®ãã®ã§ããå Žåã«ã¯ããã€ãïŒKnightïŒ
C.G.ã®æšæºçæ¹æ³ïŒLiposomesãElsevier1981
幎ã第ïŒç« ïŒäžã«èšèŒãããŠããåŠæ¹ã«åŸã€ãŠã
ãèªäœå ¬ç¥ã®æ¹æ³ã«ãã補é ããããšãã§ããã
èšèŒãããã¹ãŠã®è質ã¯ãæ°Žæ§åæ£äœäžã§å åŠç
ã«æŽ»æ§ãªèªå°äœåã¯ã©ã»ãäœãšããŠååšãåŸãã
次ã«äŸã«ãããã®çºæã詳现ã«èª¬æãããããã
ã«ãããã®çºæã®ç¯å²ãéå®ãããã®ã§ã¯ãªãã
枩床ã¯ïŒâã§è¡šãããæ··åæ¯ã¯å®¹éæ¯ã§ããã äŸ ïŒ (a) ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
20mlã«ïŒïœã®åµâãã¹ãã¢ããžã³é žã溶解ãã
ãããŠç空æ¡ä»¶äžããŒã¿ãªãŒèžçºè£ 眮ã§æº¶å€ã
èžçºãããããèç¶ã®æ®æž£ããïŒåéæ¹æããª
ãã20mlã®èžçæ°Žã«åæ£ããããPHãçŽïŒã«èª¿
æŽããã次ã«ãåå±€è質é¡ç²ã圢æãããã
ã«ãPHã¡ãŒã¿ãŒã§ç£èŠããªãã宀枩ã«ãããŠã
PHã11ã«ãªããŸã§åæ£çžã«0.1Næ°Žé žåãããª
ãŠã 溶液ãå ããã次ã«ã0.1NHClãæ·»å ã
ãããšã«ããæ°Žæ§çžã®PHã11ããçŽïŒã«èª¿æŽã
ããããããŠèä¹³çœè²ãæããæ°Žæ§çžãåŸãã 圢æãããåå±€è質é¡ç²ã¯é»åé¡åŸ®é¡ã§èŠ³å¯
ããããšãã§ããã次ã«ãè質é¡ç²åæ£äœãåžž
çšã®å·ååé¢æ³ïŒåçµåå¥æ³ïŒã«ããããçŽåŸ
ã«ãã€ãŠæ¬¡ã®ããã«åºå¥ãããåå±€è質é¡ç²ã®
äž»ããïŒçš®é¡ã®éå£ãåŸããããããªãã¡ã ïŒ å°åœ¢åå±€è質é¡ç²ïŒKULïŒïŒçŽåŸçŽ200ã
600â«ãåã³ ïŒ å€§åœ¢åå±€è質é¡ç²ïŒGULïŒïŒçŽåŸçŽ1000ã
10000â«ã ã§ãããKULã¯ãéœåâNMRâã¹ãã¯ãã«ã«
ãããŠã·ã°ãã«ÎŽïŒ1.28ïŒã¡ãã¬ã³ïŒåã³ÎŽïŒ
0.89ppmïŒã¡ãã«ïŒã«ãã確èªããããKULã®
åéã¯ã·ã°ãã«ã®åŒ·åºŠã«ããè©äŸ¡ããããçŽ56
ïŒ ã§ããã (b) äŸïŒ(a)ãšåæ§ã«ããŠãã¯ãããã«ã ïŒã¡ã¿ã
ãŒã«æ··å液ïŒïŒïŒïŒïŒ0.2mlã«10mgã®åµâãã¹
ãã¢ããžã³é žã溶解ãããã®ãïŒåçšæããã
ããŠæº¶å€ãç空èžçºãããããèç¶ã®æ®æž£ãã
ïŒåéæ¹æããªããïŒmlã®èžçæ°Žã«åæ£ããã
ããåå±€è質é¡ç²ã圢æãããããããPHã¡ãŒ
ã¿ã§ç£èŠããªããããããã®åæ£çžã«0.1Næ°Ž
é žåãããªãŠã 溶液ãå ããPHãããããïŒã
ïŒã11.3åã³11.6ãšãããKULã®åçã¯ããã
ãã®PHã«ãããŠïŒïŒ ã24ïŒ ã57ïŒ åã³60ïŒ ã§ã
ãã äŸ ïŒ (a) ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
20mlã«ïŒïœã®åµâãã¹ãã¢ããžã³é žã溶解ãã
ãããŠãã®æº¶å€ãç空èžçºãããããèç¶æ®æž£
ã0.01Næ°Žé žåãããªãŠã 溶液ã«50mlã«æ¹æã
ãªããåæ£ãããããæ°Žæ§çžã®PHã¯çŽ12ãšãª
ãã次ã«æ°Žæ§åæ£äœã®PHã0.1Nå¡©é žæº¶æ¶²ãæ·»
å ããããšã«ããçŽïŒãïŒã«èª¿æŽãããKUL
ã®åçã¯çŽ100ïŒ ã§ããã (b) äŸïŒ(a)ãšåæ§ã«ãã¯ãããã«ã ïŒã¡ã¿ããŒã«
æ··å液ïŒïŒïŒïŒïŒ0.2mlã«10mgã®åµâãã¹ãã¢
ããžã³é žã溶解ããããããïŒåçšæãã溶å€
ãç空èžçºããããããããã®è©Šæããããã
ãPHã7.3ã8.0ã9.4åã³10.0ãšãªãããã«
0.01Næ°Žé žåãããªãŠã 溶液ãšèžçæ°Žãšãæ¹æ
ããªããåæ£ãããããKULã®åçã¯ããã
ãã®PHã«ã€ããŠã33ïŒ ã46ïŒ ã65ïŒ åã³81ïŒ ã§
ããã äŸ ïŒ ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒïŒ
mlã«0.1ïœã®ãžã©ãŠãªã«ãã¹ãã¢ããžã³é žã溶解
ãããããŠæº¶å€ãç空èžçºãããããèç¶æ®æž£ã
50mlã®0.01Næ°Žé žåãããªãŠã 溶液ã«æ¹æããªã
ãåæ£ãããããããã«ããçæããåæ£äœã®PH
ã¯çŽ12ãšãªãã次ã«ã0.1Nå¡©é žæº¶æ¶²ãå ããã
ãšã«ããæ°Žæ§åæ£äœã®PHãçŽïŒãïŒã«èª¿æŽããã
KULïŒçŽåŸçŽ300ã800â«ïŒã®åçã¯73ïŒ ã§ããã äŸ ïŒ (a) ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
0.5mlã«ïŒmgã®åµâãã¹ãã¢ããžã³é žãšïŒmgã®
åµâã¬ã·ãã³ã溶解ãã溶å€ãç空èžçºããã
ãã宀枩ã«ãŠïŒåéæ¹æããããšã«ãããèç¶
ã®æ®æž£ãïŒmlã®èžçæ°Žã«åæ£ãããããããã«
ããPHã¯çŽïŒãšãªãã次ã«åå±€è質é¡ç²ã圢æ
ããããããã«ãPHã¡ãŒã¿ã«ãŠç£èŠããªãã宀
æž©ã«ãããŠãPHãçŽ11.2ã«ãªãããã«0.1Næ°Žé ž
åãããªãŠã 溶液ãå ããã次ã«ãçé žç·©è¡æ¶²
ãå ããããšã«ããæ°Žæ§å±€ã®PHãçŽïŒã«èª¿æŽã
ããããããŠãèãä¹³çœè²ãæããæ°Žæ§çžãåŸ
ããåå±€è質é¡ç²ã®çæã¯ãNMRâã¹ãã¯ã
ã«ã«ãããã·ã°ãã«ÎŽïŒ1.28ïŒã¡ãã¬ã³ïŒãÎŽïŒ
0.89ïŒã¡ãã«ïŒåã³ÎŽïŒ3.23ïŒïŒ®âCH3ïŒã«ãã
確èªããããé»åé¡åŸ®é¡èŠ³å¯ã«ãããçŽåŸã«ã
ã€ãŠåºå¥ãããåå±€è質é¡ç²ã®äž»ããïŒçš®é¡ã®
éå£ã確èªããããããªãã¡ã ïŒ KULïŒçŽåŸçŽ200ã800â«ãåã³ ïŒ GULïŒçŽåŸçŽ1000ã10000â«ã ã§ãããKULã®åçã¯45ïŒ ã§ããã (b) (a)ã«èšèŒããæ¹æ³ã«åŸã€ãŠãã¯ãããã«ã ïŒ
ã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ0.5mlã«çš®ã ã®æ¿
床ã«ãªãããã«åµãã¹ãã¢ããžã³é žåã³åµã¬ã·
ãã³ããããã溶解ãããããŠãããã®æº¶æ¶²ã
ç空æ¿çž®ãããïŒåéæ¯ãšãããããšã«ããã
ããããã®èç¶æ®æž£ãïŒmlã®æ°Žã«åæ£ããã
ããPHã¡ãŒã¿ã§ã®ç£èŠäžã§æ¯ãšãããªãããæ
çµPHãçŽ11.2ã«ããã®ã«ååãªéã®0.1Næ°Žé žå
ãããªãŠã 溶液ãããããã®åæ£çžã«å ããã
ãšã«ããåå±€è質é¡ç²ã圢æãããåµâãã¹ã
ã¢ããžã³é žã®æ¿åºŠãå¢å ããã«åŸã€ãŠKULã®
åçã¯æ¬¡ã®ããã«ãªãã
ã«é¢ããã è質é¡ç²ã«ã€ããŠã¯æç®äžã«å€ãã®èšèŒãèŠã
ããããã®è£œé åã³äœ¿çšã¯å€ãã®ç 究ã®å¯Ÿè±¡ãšãª
ã€ãŠãããïŒã€ã®è質äºéèãæããåå±€è質é¡
ç²ã¯ãçç¶ã«é 眮ãããè€æ°ã®è質äºéèãæã
ãå€å±€è質é¡ç²ããåºå¥ãããã åå±€è質é¡ç²ã¯ïŒã€ã®çç¶è¢«èãæãããããŠ
äŸãã°çŽ200ã50000â«ã奜ãŸããã¯çŽ200ã30000
â«ã®çŽåŸãæãããçç¶è¢«èã¯ãè質æåãäŸã
ã°äž¡èŠªåªæ§è質ãäŸãã°çè質ãäŸãã°ãã¹ãã¢
ããžã³é žãã¬ã·ãã³åã¯ã±ãã¢ãªã³ããããŠå Žå
ã«ãã€ãŠã¯äžæ§è質ãäŸãã°ã³ã¬ã¹ãããŒã«ã®äº
éèããæãããã®äºéèã¯ãïŒã€ã®æ°Žæ§çžãã
æãå éšç©ºéãå å²ããŠãããåå±€è質é¡ç²ã¯
åããå°èããšã称ãããã è質é¡ç²ã®ãçš®ã ã®æŽ»æ§ç©è³ªã®æ äœãšããŠã®å»
è¬ãžã®äœ¿çšã«å€§ããªé¢å¿ãå¯ããããŠãããããª
ãã¡ãè質é¡ç²ã¯ãèçœè³ªãäŸãã°æäœãããã¯
é žçŽ ããã«ã¢ã³ããã¿ãã³åã¯éºäŒåã®æ äœãšã
ãŠããããã¯æšèãããååç©ã®æ äœãšããŠåæ
ç®çãžã®äœ¿çšãææ¡ãããŠãããäŸãã°ãç±³åœç¹
蚱第3993754å·ã«ãããŠã¯ãæ äœãšããŠè質é¡ç²
ã䜿çšããè «ç现èã®åŠçã«ããååŠçæ³ãèšèŒ
ãããŠããã æå®ã®æŽ»æ§ç©è³ªã¯ãè質é¡ç²ã®åœ¢æã®éã«åã¯
ãã®åŸæ¡æ£ã«ããå°å ¥ãããè質é¡ç²ã®åœ¢æãšæŽ»
æ§ç©è³ªã®å°å ¥ã¯çš®ã ã®æ¹æ³ã«ããè¡ããã
Carcer Treatment ReviewsïŒ1981ïŒïŒã27ã50
ã®ã¹ã¿ã³ã¬âB.ã«ã€ãšïŒSt.B KeyeïŒçã®ç·èª¬
ãLiposomeaâProblems and promise
asselective drug carriersãã«èšèŒãããŠããã
åæ§ã«ã掻æ§ç©è³ªã®å°å ¥ãç®çãšããè質é¡ç²ã®
å€ãã®è£œé æ¹æ³ãããã¬ã³ãã«ãïŒBarenholzïŒ
çã«ããBiochemistryã第16å·»ã第12å·ã2806
ã2810ã䞊ã³ã«ç¬åœç¹èš±å ¬éïŒDOSïŒç¬¬2818655
å·ãå第2902672å·ãå第2532317å·åã³å第
2842608å·ãç±³åœç¹èš±ç¬¬4053585å·æ现æžãåã³ãš
ãŒãããç¹èš±åºé¡ç¬¬36676å·æ现æžã«èšèŒãããŠ
ããã äŸãã°ãè質æåãäŸãã°çè質ãäŸãã°ãã¹
ãã¢ããžã³é žãã¬ã·ãã³åã¯ã±ãã¢ãªã³ãåã³å Ž
åã«ãã€ãŠã¯äžæ§è質ãäŸãã°ã³ã¬ã¹ãããŒã«ã
ææ©æº¶åªãäŸãã°ã¯ãããã«ã åã¯ãã³ãŒã³ã«æº¶
解ãããèžçºã®åŸã該åœããè質æåã®å質局ã
äŸãã°èå±€ãæ®çããã次ã«ãã®è質æåããäŸ
ãã°æ¹æããªãããæå®ã®æŽ»æ§ç©è³ªãå«æããæ°Ž
æ§å±€ã«åæ£ãããããããã«ç¶ãè¶ é³æ³¢åŠçã«ã
ã掻æ§ç©è³ªãå°å ¥ããåå±€è質é¡ç²ã圢æãã
ãã å€ãã®åžžçšæ³ã«ãããŠã¯ãåå±€è質é¡ç²åã³å€
å±€è質é¡ç²ã®æ··åç©ã䌎ãªãæ°Žæ§çžã§ãã€ãŠã該
è質é¡ç²ã®æ§é åã³å€§ãããäžãããã§ãã€ãŠã
ã»ãšãã©åœ±é¿ãåããããããŠèããå€åããå¯
èœæ§ã®ãããã®ãåŸãããããã®çºæã®æ¹æ³ã«ã
ãã°ãç°¡åãªæ¹æ³ã§å€ãã®ããããŠã»ãšãã©å®é
çãªéã®åå±€è質é¡ç²ã䌎ãªãæ°Žæ§çžã圢æãã
ããšãã§ãããã®è質é¡ç²ã«ã¯ãçŽåŸçŽ200ã600
â«ãæããå°åœ¢åå±€è質é¡ç²ïŒKULïŒåã³çŽåŸ
çŽ600ã3000â«ãæãã倧圢åå±€è質é¡ç²
ïŒGULïŒãå«ãŸããããã®çºæã®æ¹æ³ã®ç¹æã®å©
ç¹ã¯ãçžå¯Ÿçã«åäžãªå€§ããã®KULåã³GULã
åŸãããšãã§ãããããŠåæ£çžäžã®KULãšGUL
ã®éæ¯ãå€ããããšãã§ããç¹ã«ãããé©åœãªå
é¢æ段ãäŸãã°ã²ã«éæ³åã¯éå€éæ³ã«ãã
倧圢åå±€è質é¡ç²ããå°åœ¢åå±€è質é¡ç²ãåé¢ã
ãããšãã§ããã ãã®çºæã¯ã a1 次ã®åŒ(A) ãåŒäžãïœã¯ïŒã§ããïŒåºR1åã³R2ã®å ã®
ïŒã€ã¯æ°ŽçŽ åã¯ããããã·åºã§ããä»æ¹ã®åºã¯
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«
ãªãã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«ãª
ãã·åºã§ããïŒR3ã¯æ°ŽçŽ ã§ããïŒãããŠR4ã¯
æ°ŽçŽ ãççŽ ååæ°ïŒãïŒåã®ã¢ã«ãã«åºãåã¯
ççŽ ååæ°ïŒãïŒåã®ã¢ã«ãã«åºïŒã«ã«ãã
ã·ãã¹ã«ããã¢ãããäœçŽã¢ã«ãã«ã¢ããããž
âäœçŽã¢ã«ãã«ã¢ãããã«ã«ããã·åã³ã¢ã
ããéé¢ãããã¯ãšã¹ãã«åããããããã
ã·ãããã²ã³ãäœçŽã¢ã«ã³ãã·ã«ã«ããã«ãå
ã¯äœçŽã¢ã«ã«ã³ã¹ã«ããã«ã«ãã眮æãããŠã
ãïŒã§ãããã§è¡šããããè質åã³é©åœãªè¿œå
ã®è質ãPHå€ã11ããé«ãæ°Žæ§çžã«åæ£ãã
ãããããã¯ã a2ïŒ ïœãïŒã§ããïŒR1åã³R2ãçžäºã«ç¬ç«ã
ãŠãããããççŽ ååæ°10ã20åã®ã¢ã«ãã«
åºãã¢ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«
ã±ãã«ãªãã·åºåã¯ççŽ ååæ°10ã20åã®ã¢ã·
ã«ãªãã·åºã§ããïŒR3åã³R4ãæ°ŽçŽ ã§ããåŒ
(A)ã®è質åã³å Žåã«ãã€ãŠã¯é©åœãªè¿œå ã®è質
ãPHå€ã11ããé«ãæ°Žæ§çžã«åæ£ãããããã
ãã¯ã b1ïŒ ïœãïŒã§ããïŒåºR1åã³R2ã®å ã®ïŒã€ã
æ°ŽçŽ åã¯ããããã·åºã§ãã€ãŠä»æ¹ã®åºããã
ããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢ã«ã±
ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«ãªã
ã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«ãªãã·
åºã§ããïŒR3ãæ°ŽçŽ ã§ããïŒãããŠR4ã¯ã¢ã³
ã¢ããªåºã§çœ®æãããäœçŽã¢ã«ãã«åºã§ããåŒ
(A)ã®è質ãåã³å Žåã«ãã€ãŠã¯è¿œå ã®è質ãPH
å€ãïŒããäœãæ°Žæ§çžã«åæ£ããããããã
ã¯ã b2ïŒ ïœãïŒã§ããïŒR1åã³R2ãçžäºã«ç¬ç«ã«ã
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãããã¯ã¢ã«ã±ãã«ãªãã·åºãåã¯
ççŽ ååæ°10ã20åã®ã¢ã·ã«ãªãã·åºã§ããïŒ
R3ãæ°ŽçŽ ã§ããïŒãããŠR4ãã¢ã³ã¢ããªäœçŽ
ã¢ã«ãã«ã¢ã³ã¢ããªåºã§çœ®æãããäœçŽã¢ã«ã
ã«åºã§ããåŒ(A)ã®è質ãåã³é©åœãªè¿œå ã®è質
ãPHå€ãïŒããäœãæ°Žæ§çžã«åæ£ãããã ãããŠå¿ èŠã§ããã°ãåèšïœïŒåã¯ïœïŒæ®µéã®
åŸãæ°Žæ§çžãäžåãããããŠææã«ããåŸããã
åå±€è質é¡ç²ãæ¿çž®ããããŠïŒåã¯åé¢ããããš
ãç¹åŸŽãšããåå±€è質é¡ç²ã®è£œé æ¹æ³ã«é¢ããã æ¬çºæã«ããã°ãåèšïŒa1ïŒïŒïŒa2ïŒïŒïŒb1ïŒå
ã³ïŒb2ïŒã«ç€ºãè質ã®çµåããã«ãããŠãïŒa1ïŒ
åã³ïŒa2ïŒã«ãããŠã¯æ°Žæ§çžã®PHã11ããé«ã
ãããããŠïŒb1ïŒåã³ïŒb2ïŒã«ãããŠã¯æ°Žæ§çž
ã®PHãïŒããäœãããå Žåã«ãåå±€è質é¡ç²ã®æ¯
çã®é«ãåæ£äœãåŸãããã ãã®æ现æžã«ãããŠãåèšã®ãããŠåŸèšã®äžè¬
çèšèŒã¯æ¬¡ã®æå³ãæããã æ¹æ³ïŒa1ïŒåã³ïŒa2ïŒ ã¢ã«ãã«åºR1åã¯R2ã¯ã奜ãŸããã¯ïœâã
ã·ã«åºãïœâãŠã³ãã·ã«åºãïœâããã·ã«åº
ïŒã©ãŠãªã«åºïŒãïœâããªãã·ã«åºãïœâããã©
ãã·ã«åºïŒããªã¹ãã«åºïŒãïœâãã³ã¿ãã·ã«
åºãïœâãããµãã·ã«åºïŒã»ãã«åºïŒãïœâãª
ã¯ã¿ãã·ã«åºïŒã¹ãã¢ãªã«åºïŒåã¯ïœâãšã€ã³
ã·ã«åºïŒã¢ã©ããã«åºïŒãããã«ã¯ïœâããã¿
ãã·ã«åºåã¯ïœâãããã·ã«åºã§ããã ã¢ã«ã±ãã«åºR1åã¯R2ã¯ã奜ãŸããã¯ïŒâ
ã·ã¹âããã»ãã«åºïŒã©ãŠãã¬ã€ã«åºïŒãïŒâ
ã·ã¹âããã©ãã»ãã«åºïŒããªã¹ãã¬ã€ã«åºïŒã
ïŒâã·ã¹âãããµãã»ãã«åºïŒãã«ããã¬ã€ã
ã«åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã«åºïŒããã
ã»ãªãã«åºïŒãïŒâãã©ã³ã¹âãªã¯ã¿ãã»ãã«
åºïŒãããã»ã©ã€ãžãã«åºïŒãïŒâã·ã¹âãªã¯
ã¿ãã»ãã«åºïŒãªã¬ã€ã«åºïŒãïŒâãã©ã³ã¹â
ãªã¯ã¿ãã»ãã«åºïŒãšã©ã€ãžãã«åºïŒåã¯ïŒâ
ã·ã¹âãšã€ã³ã»ãã«åºïŒã¬ãã¬ã€ãã«åºïŒãã
ãã«ïŒâãã»ãã«åºãïŒâãŠã³ãã»ãã«åºãïŒ
âããã»ãã«åºãïŒâããªãã»ãã«åºãïŒâã
ãã©ãã»ãã«åºãïŒâãã³ã¿ãã»ãã«åºãïŒâ
ãããµãã»ãã«åºãïŒâããã¿ãã»ãã«åºãïŒ
âãªã¯ã¿ãã»ãã«åºãïŒâã·ã¹â12âãã©ã³ã¹
âãªã¯ã¿ãã«ãžãšãã«åºïŒãªããªã«åºïŒãïŒâ
ãã©ã³ã¹â12âãã©ã³ã¹âãªã¯ã¿ãã«ãžãšãã«
åºïŒãªãã©ã€ãžãã«åºïŒãïŒâã·ã¹â12âã·ã¹
âãªã¯ã¿ãžãšãã«åºïŒãªãã¬ã€ã«åºïŒãïŒâã·
ã¹â11âãã©ã³ã¹â13âãã©ã³ã¹âãªã¯ã¿ãã«
ããªãšãã«åºïŒÎ²âãšãã€ã¹ãã¢ãªãã«åºïŒã
ïŒâã·ã¹â12âã·ã¹â15âã·ã¹âãªã¯ã¿ãã«ã
ãªãšãã«åºïŒãªãã¬ãã«åºïŒãïŒâïŒ11âïŒ13
âïŒ15âãªã¯ã¿ãã«ããã©ãšãã«ïŒããªããªã«
åºïŒãïŒâãããã»ãã«åºãïŒâãšã€ã³ã»ãã«
åºãïŒâïŒ11âïŒ14âãšã€ã³ãµããªãšãã«åã¯
ïŒâïŒïŒâïŒ11âïŒ14âãšã€ã³ãµããã©ãšãã«
åºïŒã¢ã©ãããã«åºïŒã§ããã ã¢ã«ã³ãã·åºR1åã¯R2ã¯ã奜ãŸããã¯ïœâ
ãã·ã«ãªãã·åºãïœâããã·ã«ãªãã·åºïŒã©ãŠ
ãªã«ãªãã·åºïŒãïœâããã©ãã·ã«ãªãã·åº
ïŒããªã¹ãã«ãªãã·åºïŒãïœâãããµãã·ã«ãªã
ã·åºïŒã»ãã«ãªãã·åºïŒãïœâãªã¯ã¿ãã·ã«ãª
ãã·åºïŒã¹ãã¢ãªã«ãªãã·åºïŒãåã¯ïœâãšã€
ã³ã·ã«ãªãã·åºïŒã¢ã©ããã«ãªãã·åºïŒããã
ã«ïœâãŠã³ãã·ã«ãªãã·åºãïœâããªãã·ã«ãª
ãã·åºãïœâãã³ã¿ãã·ã«ãªãã·åºãïœâãã
ã¿ãã·ã«ãªãã·åºåã¯ïœâãããã·ã«ãªãã·åº
ã§ããã ã¢ã«ã±ãã«ãªãã·åºR1åã¯R2ã¯ã奜ãŸãã
ã¯ïŒâã·ã¹âããã»ãã«ãªãã·åºïŒã©ãŠãã¬ã€
ã«ãªãã·åºïŒãïŒâã·ã¹âããã©ãã»ãã«ãªã
ã·åºïŒããªã¹ãã¬ã€ã«ãªãã·åºïŒãïŒâã·ã¹â
ãããµãã»ãã«ãªãã·åºïŒãã«ããã¬ã€ãã«ãª
ãã·åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã«ãªãã·åº
ïŒãããã»ãªãã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãª
ã¯ã¿ãã»ãã«ãªãã·åºïŒãããã»ã©ã€ãžãã«ãª
ãã·åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã«ãªãã·åº
ïŒãªã¬ã€ã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãªã¯ã¿ã
ã»ãã«ãªãã·åºïŒãšã©ã€ãžãã«ãªãã·åºïŒãå
ã¯ïŒâã·ã¹âãšã€ã³ã»ãã«åºïŒã¬ãã¬ã€ãã«ãª
ãã·åºïŒãããã«ã¯ïŒâãã»ãã«ãªãã·åºãïŒ
âãŠã³ãã»ãã«ãªãã·åºãïŒâããã»ãã«ãªã
ã·åºãïŒâããªãã»ãã«ãªãã·åºãïŒâããã©
ãã»ãã«ãªãã·åºãïŒâãã³ã¿ãã»ãã«ãªãã·
åºãïŒâãããµãã»ãã«ãªãã·åºãïŒâããã¿
ãã»ãã«ãªãã·åºãïŒâãªã¯ã¿ãã»ãã«ãªãã·
åºãïŒâã·ã¹â12âãã©ã³ã¹âãªã¯ã¿ãã«ãžãš
ãã«ãªãã·åºïŒãªããªã«ãªãã·åºïŒãïŒâãã©
ã³ã¹â12âãã©ã³ã¹âãªã¯ã¿ãã«ãžãšãã«ãªã
ã·åºïŒãªãã©ã€ãžãã«ãªãã·åºïŒãïŒâã·ã¹â
12âã·ã¹âãªã¯ã¿ãžãšãã«ãªãã·åºïŒãªãã¬ã€
ã«ãªãã·åºïŒãïŒâã·ã¹â11âãã©ã³ã¹â13â
ãã©ã³ã¹âãªã¯ã¿ãã«ããªãšãã«ãªãã·åºïŒÎ²
âãšã¬ãªã¹ãã¢ãªãã«ãªãã·åºïŒãïŒâã·ã¹â
12âã·ã¹â15âã·ã¹âãªã¯ã¿ãã«ããªãšãã«ãª
ãã·åºïŒãªãã¬ãã«ãªãã·åºïŒãïŒâïŒ11âïŒ
13âïŒ15âãªã¯ã¿ãã«ããã©ãšãã«ãªãã·åº
ïŒããªããªã«ãªãã·åºïŒãïŒâãããã»ãã«ãªã
ã·åºãïŒâãšã€ã³ã»ãã«ãªãã·åºãïŒâïŒ11
âïŒ14âãšã€ã³ãµããªãšãã«ãªãã·åºåã¯ïŒ
âïŒïŒâïŒ11âïŒ14âãšã€ã³ãµããã©ãšãã«ãª
ãã·åºïŒã¢ã©ãããã«ãªãã·åºïŒã§ããã ã¢ã·ã«ãªãã·åºR1åã¯R2ã¯ã奜ãŸããã¯ã¢
ã«ã«ãã€ã«ãªãã·åºãäŸãã°ïœâãã«ãã€ã«ãª
ãã·åºãïœâããã«ãã€ã«ãªãã·åºïŒã©ãŠãã€
ã«ãªãã·åºïŒãïœâããã©ãã«ãã€ã«ãªãã·åº
ïŒããªã¹ãã€ã«ãªãã·åºïŒãïœâãããµãã«ãã€
ã«ãªãã·åºãïœâãããµãã«ãã€ã«ãªãã·åº
ïŒãã«ããã€ã«ãªãã·åºïŒãïœâãªã¯ã¿ãã«ãã€
ã«ãªãã·åºïŒã¹ãã¢ãã€ã«ãªãã·åºïŒåã¯ïœâ
ãšã€ã³ãœã€ã«ãªãã·åºïŒã¢ã©ããã€ã«ãªãã·
åºïŒãããã«ã¯ïœâãŠã³ãã«ãã€ã«ãªãã·åºã
ïœâããªãã«ãã€ã«ãªãã·åºãïœâãã³ã¿ãã«
ãã€ã«ãªãã·åºãïœâããã¿ãã«ãã€ã«ãªãã·
åºåã¯ïœâãããã«ãã€ã«ãªãã·åºã§ããã ã¢ã·ã«ãªãã·åºR1åã¯R2ã¯ã奜ãŸããã¯ã¢
ã«ã±ãã€ã«ãªãã·ãäŸãã°ïŒâã·ã¹âããã»ã
ã«ãªãã·åºïŒã©ãŠãã¬ãªã€ã«ãªãã·åºïŒãïŒâ
ã·ã¹âããã©ãã»ãã€ã«ãªãã·åºïŒããªã¹ãã¬
ãªã€ã«ãªãã·åºïŒãïŒâã·ã¹âãããµãã»ãã€
ã«ãªãã·åºïŒãã«ããã¬ã€ãã€ã«ãªãã·åºïŒã
ïŒâã·ã¹âãªã¯ã¿ãã»ãã€ã«ãªãã·åºïŒããã
ã»ãªãã€ã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãªã¯ã¿
ãã»ãã€ã«ãªãã·åºïŒãããã»ã©ã€ãžãã€ã«ãª
ãã·åºïŒãïŒâã·ã¹âãªã¯ã¿ãã»ãã€ã«ãªãã·
åºïŒãªã¬ãªã€ã«ãªãã·åºïŒãïŒâãã©ã³ã¹âãª
ã¯ã¿ãã»ãã€ã«ãªãã·åºïŒãšã©ã€ãžãã€ã«ãªã
ã·åºïŒåã¯ïŒâã·ã¹âãšã€ã³ã»ãã€ã«åºïŒã¬ã
ã¬ã€ãã€ã«ãªãã·åºïŒãããã«ïŒâã·ã¹â12â
ãã©ã³ã¹âãªã¯ã¿ãžãšãã€ã«ãªãã·åºïŒãªãã
ã€ã«åºïŒãïŒâãã©ã³ã¹â12âãã©ã³ã¹âãªã¯
ã¿ãã«ãžãšãã€ã«ãªãã·åºïŒãªãã©ã€ãžãã€ã«
ãªãã·åºïŒãïŒâã·ã¹â12âã·ã¹âãªã¯ã¿ãžãš
ãã€ã«ãªãã·åºïŒãªãã¬ãªã€ã«ãªãã·åºïŒãïŒ
âã·ã¹â11âãã©ã³ã¹â13âãã©ã³ã¹âãªã¯ã¿
ãã«ããªãšãã€ã«ãªãã·åºïŒãªãã¬ãã€ã«ãªã
ã·åºïŒãïŒâïŒ11âïŒ13âïŒ15âãªã¯ã¿ãã«ã
ãã©ãšãã€ã«ãªãã·åºïŒããªããã€ã«ãªãã·
åºïŒãïŒâïŒ11âïŒ14âãšã€ã³ãµããªãšãã€ã«
ãªãã·åºãåã¯ïŒâïŒïŒâïŒ11âïŒ14âãšã€ã³
ãµããã©ãšãã€ã«ãªãã·åºïŒã¢ã©ãããã€ã«ãª
ãã·åºïŒã§ããã ççŽ ååæ°ïŒãïŒåãæããäœçŽã¢ã«ãã«åº
R4ã¯ãäŸãã°ã¡ãã«åºããšãã«åºãã€ãœãã
ãã«åºãïœâãããã«åºãã€ãœããã«åºåã¯ïœ
âããã«åºã§ããã 眮æãããççŽ ååæ°ïŒãïŒåã®äœçŽã¢ã«ã
ã«åºR4ã¯ã奜ãŸããã¯ã«ã«ããã·äœçŽã¢ã«ã
ã«åºãäŸãã°ã«ã«ããã·ã¡ãã«åºãïŒâã«ã«ã
ãã·ãšãã«åºãããã¯ïŒâã«ã«ããã·âïœâã
ããã«åºãã¢ããäœçŽã¢ã«ãã«åºãäŸãã°ã¢ã
ãã¡ãã«åºãïŒâã¢ãããšãã«åºãããã¯ïŒâ
ã¢ããâïœâãããã«åºãäœçŽã¢ã«ãã«ã¢ãã
äœçŽã¢ã«ãã«åºãäŸãã°ã¡ãã«ã¢ããã¡ãã«åº
ãããã¯ãšãã«ã¢ããã¡ãã«åºãïŒâã¡ãã«ã¢
ãããšãã«åºããããã¯ïŒâã¡ãã«ã¢ããâïœ
âãããã«åºããžäœçŽã¢ã«ãã«ã¢ããäœçŽã¢ã«
ãã«åºãäŸãã°ãžã¡ãã«ã¢ããã¡ãã«åºããã
ã¯ãžãšãã«ã¢ããã¡ãã«åºãïŒâãžã¡ãã«ã¢ã
ããšãã«åºããããã¯ïŒâãžã¡ãã«ã¢ããâïœ
âãããã«åºãÏâã¢ããâÏâã«ã«ããã·äœ
çŽã¢ã«ãã«åºãäŸãã°ïŒâã¢ããâïŒâã«ã«ã
ãã·ãšãã«åºãããã¯ïŒâã¢ããâïŒâã«ã«ã
ãã·âïœâãããã«åºãããããã·äœçŽã¢ã«ã
ã«åºãäŸãã°ïŒâããããã·ãšãã«åºãããã¯
ïŒïŒïŒâãžããããã·ãããã«åºãäœçŽã¢ã«ã³
ãã·äœçŽã¢ã«ãã«åºãäŸãã°ã¡ããã·ã¡ãã«åº
ãããã¯ãšããã·ã¡ãã«åºãïŒâã¡ããã·âãš
ãã«åºããããã¯ïŒâã¡ããã·âïœâãããã«
åºãåã¯ããã²ã³äœçŽã¢ã«ãã«åºãäŸãã°å¡©å
ã¡ãã«åºãããã¯èåã¡ãã«åºãïŒâã¯ãããš
ãã«åºãããã¯ïŒâããã¢ãšãã«åºãïŒâãã
ãã¯ïŒâã¯ããâïœâãããã«åºããããã¯ïŒ
âãããã¯ïŒâããã¢âïœâãããã«åºã§ã
ãã é©åœãªè¿œå ã®è質ã¯ãäŸãã°ïœãïŒã§ããã
R1åã³R2ãçžäºã«ç¬ç«ã«ãããããççŽ åå
æ°10ã20åã®ã¢ã«ãã«åºãã¢ã«ã±ãã«åºãã¢ã«
ã³ãã·åºåã¯ã¢ã«ã±ãã«ãªãã·åºãåã¯ççŽ å
åæ°10ã20åã®ã¢ã·ã«ãªãã·åºã§ããããããŠ
R3ãæ°ŽçŽ ã§ããã R1ïŒR2åã³R3ã¯åè¿°ã®æå³ãæãããR4ã«
ã¯ããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªåºãäŸãã°ããª
ã¡ãã«ã¢ã³ã¢ããªã«ãã眮æãããäœçŽã¢ã«ã
ã«åºãäŸãã°ïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«
åºïŒã³ãªãã«åºïŒãããã é©åœãªè¿œå ã®è質ã«ã¯ãäŸãã°ãR1åã³R2
ãã¢ã·ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ããã
ãããŠR4ãïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«
åºåã¯ïŒâã¢ãããšãã«åºã§ããåŒ(A)ã®è質ã
ããã ãããã®è¿œå ã®è質ã¯ãR4ãïŒâããªã¡ã
ã«ã¢ã³ã¢ããªãšãã«åºã§ããå Žåã«ã¯å€©ç¶ã¬ã·
ãã³ãäŸãã°åµâã¬ã·ãã³åã¯å€§è±ã¬ã·ãã³ã§
ãããR4ãïŒâã¢ãããšãã«åºã§ããå Žåã«
ã¯å€©ç¶ã±ãã¢ãªã³ãäŸãã°åµâã±ãã¢ãªã³åã¯
倧è±ã±ãã¢ãªã³ã§ããã ãã®ã»ãã«ãè¿œå ã®è質ãšããŠãåŒ(A)ã®åæ
ã¬ã·ãã³é¡ïŒR4ïŒïŒâããªã¡ãã«ã¢ã³ã¢ããª
ãšãã«åºïŒåã³åæã±ãã¢ãªã³é¡ïŒR4ïŒïŒâ
ã¢ãããšãã«åºïŒãæããããšãã§ããããã
ã¯å¥œãŸããã¯ãR1åã³R2ãåäžã®ã¢ã·ã«ãªã
ã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºããªã¬ãªã€ã«
ãªãã·åºããªãã€ã«ãªãã·åºããªãã¬ãªã€ã«ãª
ãã·åºãããã¯ã¢ã©ããã€ã«ãªãã·åºãè¡šãã
äŸãã°ãžã©ãŠãã€ã«âããžããªã¹ãã€ã«âããž
ãã«ããã€ã«âããžã¹ãã¢ãã€ã«âããžã¢ã©ã
ãã€ã«âããžãªã¬ãªã€ã«âããžãªãã€ã«âããž
ãªãã¬ãªã€ã«âããããã¯ãžã¢ã©ããã€ã«ã¬ã·
ãã³ãããã¯âã±ãã¢ãªã³ãR1åã³R2ãç°ã
ã¢ã·ã«ãªãã·åºãäŸãã°R1ããã«ããã€ã«ãª
ãã·åºã§R2ããªã¬ãªã€ã«ãªãã·åºã§ããäŸã
ã°ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«âã¬ã·ã
ã³ãããã¯âã±ãã¢ãªã³ãR1åã³R2ãåäžã®
ã¢ã«ã³ãã·åºãäŸãã°ããã©ãã·ã«ãªãã·åºã
ããã¯ãããµãã·ã«ãªãã·åºã§ããäŸãã°ãžã
ãã©ãã·ã«âãããã¯ãžãããµãã·ã«âã¬ã·ã
ã³ãããã¯âã±ãã¢ãªã³ãR1ãã¢ã«ã±ãã«åº
ã§ããR2ãã¢ã·ã«ãªãã·åºã§ããäŸãã°ãã©
ãºãããŒã²ã³ïŒR4ïŒããªã¡ãã«ã¢ã³ã¢ããªãš
ãã«åºïŒãåã¯R1ãã¢ã·ã«ãªãã·åºãäŸãã°ã
ãªã¹ãã€ã«ãã·åºãããã¯ãã«ããã€ã«ãªãã·
åºã§ããR2ãããããã·ã«åºã§ããäŸãã°å€©
ç¶ãããã¯åæãªãœã¬ã·ãã³ãããã¯ãªãœã±ã
ã¢ãªã³ãäŸãã°ïŒâããªã¹ãã€ã«âãããã¯ïŒ
âãã«ããã€ã«ãœã¬ã·ãã³ãããã¯âã±ãã¢ãª
ã³ã§ããããããã«ãããŠR3ã¯æ°ŽçŽ ã§ããã 奜ãŸããã¯ãæ°Žæ§åæ£äœã«ã¯ãïœãïŒã§ã
ãïŒR1ãã¢ã«ãã«åºãäŸãã°ïœâããã·ã«åº
ïŒã©ãŠãªã«åºïŒãïœâããªãã·ã«åºãïœâããã©
ãã·ã«åºïŒããªã¹ãã«åºïŒãïœâãã³ã¿ãã·ã«
åºãïœâãããµãã·ã«åºïŒã»ãã«åºïŒãïœâã
ãã¿ãã·ã«åºãããã¯ïœâãªã¯ã¿ãã·ã«åºïŒã¹
ãã¢ãªã«åºïŒãã¢ã«ã³ãã·åºãäŸãã°ïœâãã
ã·ã«ãªãã·åºïŒã©ãŠãªã«ãªãã·åºïŒãïœâãã
ã©ãã·ã«ãªãã·åºïŒããªã¹ãã«ãªãã·åºïŒãïœ
âãããµãã·ã«ãªãã·åºïŒã»ãã«ãªãã·åºïŒã
ããã¯ïœâãªã¯ã¿ãã·ã«ãªãã·åºïŒã¹ãã¢ãªã«
ãªãã·åºïŒãåã¯ã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠ
ãã€ã«ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«
ããã€ã«ãªãã·åºãããã¯ã¹ãã¢ãã€ã«ãªãã·
åºã§ããïŒR2ãæ°ŽçŽ åã¯ããããã·åºã§ã
ãïŒR3ãæ°ŽçŽ åã¯äœçŽã¢ã«ãã«åºãäŸãã°ã¡
ãã«åºã§ããïŒãããŠR4ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«åºãäŸãã°ã¡ãã«åºãããã¯ãšãã«åºãã«ã«
ããã·ã«åºåã³ã¢ããåºã«ãã眮æãããäœçŽ
ã¢ã«ãã«åºãäŸãã°Ïâã¢ããâÏâã«ã«ãã
ã·äœçŽã¢ã«ãã«åºãäŸãã°ïŒâã¢ããâïŒâã«
ã«ããã·ãšãã«åºãããã¯ïŒâã¢ããâïŒâã«
ã«ããã·âïœâãããã«åºãããããã·äœçŽã¢
ã«ãã«åºãäŸãã°ïŒâããããã·ãšãã«åºãã
ãã¯ïŒïŒïŒâããããã·ãããã«åºãããã²ã³
åäœçŽã¢ã«ãã«åºãäŸãã°ïŒâã¯ããâããã
ã¯ïŒâããã¢ãšãã«åºã§ããåŒ(A)ã®è質ãåã³
R1åã³R2ãã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€
ã«ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«ãã
ã€ã«ãªãã·åºåã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ã
ãïŒR3ãæ°ŽçŽ ã§ããïŒãããŠR4ãïŒâããªã¡
ãã«ã¢ã³ã¢ããªãšãã«åºãããã¯ïŒâã¢ãããš
ãã«åºã§ããåŒ(A)ã§ç€ºãããè¿œå ã®è質ãå«æ
ãããããåã¯ãæ°Žæ§åæ£äœã«ã¯ãR1åã³R2
ãã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·
åºãããªã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªã
ã·åºãããã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ããã
R3ãæ°ŽçŽ ã§ããããããŠR4ãæ°ŽçŽ ã§ããåŒ(A)
ã®è質ãåã³å Žåã«ãã€ãŠã¯ãR1åã³R2ãã¢
ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãã
ãªã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªãã·åºå
ã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§
ããããããŠR4ãïŒâããªã¡ãã«ã¢ã³ã¢ããª
ãšãã«åºãåã¯ïŒâã¢ãããšãã«åºã§ããåŒ(A)
ã§ç€ºãããè¿œå ã®è質ãå«æããããããšãã§
ããã 奜ãŸããã¯ãæ°Žæ§åªäœã«ã¯ããªãã¹ãã¢ããž
ã³é žãäŸãã°å€©ç¶ãªãœãã¹ãã¢ããžã³é žãäŸã
ã°åµâãªãœãã¹ãã¢ããžã³é žããããã¯åæãª
ãœãã¹ãã¢ããžã³é žãäŸãã°ïŒâã©ãŠãã€ã«â
ãªãœãã¹ãã¢ããžã³é žãïŒâããªã¹ãã€ã«ãªãœ
ãã¹ãã¢ããžã³é žãããã¯ïŒâãã«ããã€ã«ãª
ãœãã¹ãã¢ããžã³é žããªãœãã¹ãã¢ããžã«ã»ãª
ã³ãäŸãã°å€©ç¶ãªãœãã¹ãã¢ããžã«ã»ãªã³ãäŸ
ãã°çè³ãªãœãã¹ãã¢ããžã«ã»ãªã³ããããã¯
åæãªãœãã¹ãã¢ããžã«ã»ãªã³ãäŸãã°ïŒâã
ãªã¹ãã€ã«ãªãœãã¹ãã¢ããžã«ã»ãªã³ãããã¯
ïŒâãã«ããã€ã«ãªãœãã¹ãã¢ããžã«ã»ãªã³ã
ãªãœãã¹ãã¢ããžã«ã°ãªã»ãªã³ãåã¯ãªãœãã¹
ãã¢ããžã«ã€ãã·ããŒã«ããããŠããã«ãã¬ã·
ãã³ãäŸãã°å€©ç¶ã¬ã·ãã³ãäŸãã°åµâã¬ã·ã
ã³ãåäžã®ã¢ã·ã«ãªãã·åºãæããã¬ã·ãã³ã
äŸãã°ãžããªã¹ãã€ã«ã¬ã·ãã³ãããã¯ãžãã«
ããã€ã«ã¬ã·ãã³ãç°ãªãã¢ã·ã«ãªãã·åºãæ
ããã¬ã·ãã³ãäŸãã°ïŒâãã«ããã€ã«âïŒâ
ãªã¬ãªã€ã«ã¬ã·ãã³ãåã¯ããã«ã±ãã¢ãªã³ã
äŸãã°å€©ç¶ã±ãã¢ãªã³ãäŸãã°åµâã±ãã¢ãª
ã³ããããã¯ç°ãªãã¢ã·ã«ãªãã·åºãæããã±
ãã¢ãªã³ãäŸãã°ïŒâãã«ããã€ã«âïŒâãªã¬
ãªã€ã«ã±ãã¢ãªã³ãå«æããããã 奜ãŸããã¯æ°Žæ§åæ£äœã«ã¯ã倩ç¶ãã¹ãã¢ã
ãžã³é žãäŸãã°åµâãã¹ãã¢ããžã³é žãåæã
ã¹ãã¢ããžã³é žãäŸãã°ãžã©ãŠãã€ã«ãã¹ãã¢
ããžã³é žããžããªã¹ãã€ã«ãã¹ãã¢ããžã³é žã
ãžãã«ããã€ã«ãã¹ãã¢ããžã³é žãããã¯ïŒâ
ãã«ããã€ã«âïŒâãªã¬ãªã€ã«ãã¹ãã¢ããžã³
é žããããŠå Žåã«ãã€ãŠã¯ããã«ãã¬ã·ãã³ã
äŸãã°å€©ç¶ã¬ã·ãã³ãäŸãã°åµâã¬ã·ãã³ãå
äžã®ã¢ã·ã«ãªãã·åºãæããã¬ã·ãã³ãäŸãã°
ãžããªã¹ãã€ã«ã¬ã·ãã³ãããã¯ãžãã«ããã€
ã«ã¬ã·ãã³ããããã¯ç°ãªãã¢ã·ã«ãªãã·åºã
æããã¬ã·ãã³ãäŸãã°ïŒâãã«ããã€ã«âïŒ
âãªã¬ãªã€ã«ã¬ã·ãã³ãåã¯ã±ãã¢ãªã³ãäŸã
ã°å€©ç¶ã±ãã¢ãªã³ãäŸãã°åµâã±ãã¢ãªã³ãã
ããã¯ç°ãªãã¢ã·ã«ãªãã·åºãæããã±ãã¢ãª
ã³ãäŸãã°ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«
ã±ãã¢ãªã³ãå«æããããããšãã§ããã åå±€è質é¡ç²ã補é ããããã«ããŸãè質æ
åã®å質局ã調補ãããå質局ã®èª¿è£œã¯ããã
èªäœå ¬ç¥ã®æ¹æ³ã«ããè¡ãããšãã§ãããã®æ
现æžã«ãããŠããè質æåã®å質局ã®èª¿è£œãã®
é ã«è©³çŽ°ã«èšèŒããã å質局ãæ°Žæ§çžã«åæ£ãããããããŠæ¬¡ã«ïŒ
çš®é¡ã®ã¿ã®è質æåãäŸãã°çŽãã¹ãã¢ããžã³
é žãåæ£ããããæ°Žæ§çžã®PHãçŽ11以äžã«äžæ
ããããããã®æäœã¯ãäŸãã°ãæç¹æ³åã¯PH
ã¡ãŒã¿ã«ããPHå€ãç£èŠããªãããçççã«èš±
容ãããå¡©åºæ§æº¶æ¶²ãäŸãã°çŽ0.01ã0.2Nã奜
ãŸããã¯çŽ0.1Nã®æ°Žé žåãããªãŠã åã¯æ°Žé ž
åã«ãªãŠã åžæ°Žæº¶æ¶²ãæ·»å ããããšã«ããè¡
ãã 奜ãŸããæ æ§ã«ãããŠã¯ãè質æåã®å質局
ããïŒããé«ãPHãæããæ°Žæ§çžãäŸãã°çç
çã«èš±å®¹ãããå¡©åºæ§æº¶æ¶²ãäŸãã°çŽ0.01ã
0.2Nãç¹ã«0.1Nã®æ°Žé žåãããªãŠã åã¯æ°Žé ž
åã«ãªãŠã åžæ°Žæº¶æ¶²ã«åæ£ãããããïŒã€ã®è
質æåãäŸãã°çŽãã¹ãã¢ããžã³é žã¯çŽ12以äž
ã®PHãæããæ°Žæ§çžã«åæ£ããããã æ¹æ³b1åã³b2 ïœãïŒã§ãããåºR1åã³R2ã®å ã®ïŒã€ãæ°ŽçŽ
åã¯ããããã·ã«åºã§ãã€ãŠä»æ¹ã®åºãããã
ãççŽ ååæ°10ã20åãæããã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«
ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ããããããŠR4
ãã¢ã³ã¢ããªåºã«ãã眮æãããäœçŽã¢ã«ãã«
åºã§ããåŒ(A)ã®è質ã«ãããŠãR1åã³R2ã¯æ¹
æ³ïŒa1ïŒåã³ïŒa2ïŒã«ãããŠãã§ã«èšèŒãã
æå³ãæããã ã¢ã³ã¢ããªåºã«ãã眮æãããäœçŽã¢ã«ãã«
åºR4ã¯ãäŸãã°ãããªäœçŽã¢ã«ãã«ã¢ã³ã¢ã
ãªåºãäŸãã°ããªã¡ãã«âåã¯ããªãšãã«ã¢ã³
ã¢ããªåºã«ãã眮æãããäœçŽã¢ã«ãã«åºãäŸ
ãã°ïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«åºåã¯ïŒ
âããªãšãã«ã¢ã³ã¢ããªãšãã«åºã§ããã ïœãïŒã§ãããR1åã³R2ãçžäºã«ç¬ç«ã«ã
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºããããã¯ã¢ã«ã±ã
ã«ãªãã·åºãåã¯ççŽ ååæ°10ã20ã®ã¢ã·ã«ãª
ãã·åºã§ãããR3ãæ°ŽçŽ ã§ããããããŠR4ã
ã¢ã³ã¢ããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªåºã«ãã眮
æãããäœçŽã¢ã«ãã«åºã§ããåŒ(A)ã®è質ã«ã
ããŠãR1åã³R2ã¯å¥œãŸããã¯æ¹æ³ïŒa1ïŒåã³
ïŒa2ïŒã«ãããŠè©³çŽ°ã«èšèŒããç¹å®ã®æå³ãæ
ããã ã¢ã³ã¢ããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªåºã«ãã
眮æãããäœçŽã¢ã«ãã«åºã¯ãäŸãã°ãïŒâ
ãïŒïŒ®âãžäœçŽã¢ã«ãã«ââïŒïŒâNâ²ïŒNâ²ïŒ
Nâ²âããªäœçŽã¢ã«ãã«ã¢ã³ã¢ããªãšãã«ïŒâã¢
ã³ã¢ããªãâãšãã«åºãäŸãã°ïŒâãïŒïŒ®âãž
ã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒNâ²âããªã¡ãã«ã¢
ã³ã¢ããªãšãã«ïŒâã¢ã³ã¢ããªãâãšãã«åºã§ã
ãã é©åœãªè¿œå ã®è質ã¯ãæ¹æ³ïŒa1ïŒåã³ïŒa2ïŒ
ã«ãããŠè©³çŽ°ã«èšèŒããè¿œå ã®è質ã§ããã 奜ãŸããã¯ãæ°Žæ§åæ£äœã«ã¯ãïœãïŒã§ã
ããR1ãã¢ã·ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«
ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«ããã€
ã«ãªãã·åºåã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ããã
R2ãããããã·åºã§ãããR3ãæ°ŽçŽ ã§ããã
ãããŠR4ãïŒâããªã¡ãã«ã¢ã³ã¢ããªãšãã«
åºã§ããåŒ(A)ã®è質ã䞊ã³ã«R1åã³R2ãã¢ã·
ã«ãªãã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãããª
ã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªãã·åºåã¯
ã¹ãã¢ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ã
ãããããŠR4ãïŒâã¢ãããšãã«åºåã¯ïŒâ
ããªã¡ãã«ã¢ã³ã¢ããªãšãã«åºã§ããåŒ(A)ã®é©
åœãªè¿œå ã®è質ãå«æãããããåãæ°Žæ§åæ£
äœã«ã¯å¥œãŸããã¯ãR1åã³R2ãã¢ã·ã«ãªãã·
åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãããªã¹ãã€ã«
ãªãã·åºããã«ããã€ã«ãªãã·åºãåã¯ã¹ãã¢
ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ãããã
ããŠR4ãïŒâãïŒïŒ®âãžã¡ãã«ââïŒïŒâ
Nâ²ïŒNâ²ïŒNâ²âããªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒâ
ã¢ã³ã¢ããªãâãšãã«åºã§ããåŒ(A)ã®è質ã䞊
ã³ã«å Žåã«ãã€ãŠã¯ãR1åã³R2ãã¢ã·ã«ãªã
ã·åºãäŸãã°ã©ãŠãã€ã«ãªãã·åºãããªã¹ãã€
ã«ãªãã·åºããã«ããã€ã«ãªãã·åºåã¯ã¹ãã¢
ãã€ã«ãªãã·åºã§ãããR3ãæ°ŽçŽ ã§ãããã
ããŠR4ãïŒâã¢ãããšãã«åºåã¯ïŒâããªã¡
ãã«ã¢ã³ã¢ããªãšãã«åºã§ããåŒ(A)ã®è¿œå ã®è
質ãå«æããããããšãã§ããã 奜ãŸããã¯ãæ°Žæ§åæ£äœã«ã¯ãªãœãã¹ãã¢ã
ãžã«ã³ãªã³ïŒãªãœã¬ã·ãã³ïŒåã³å€©ç¶ã¬ã·ã
ã³ãäŸãã°åµâã¬ã·ãã³ãå«æããããã奜ãŸ
ããã¯ãæ°Žæ§åæ£äœã«ã¯ãã¹ãã¢ããžã«âïŒâ
ãïŒïŒ®âãžã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒNâ²â
ããªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒâã¢ã³ã¢ããªãâ
ãšãã«ã¯ããªããåã³å Žåã«ãã€ãŠã¯å€©ç¶ã¬ã·
ãã³ãäŸãã°åµâã¬ã·ãã³ãå«æããããã åå±€è質é¡ç²ã補é ããããã«ããŸããè質
æåãäŸãã°ãªãœã¬ã·ãã³åã¯ãã¹ãã¢ããžã«
âïŒâãïŒïŒ®âãžã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒ
Nâ²âããªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒâã¢ã³ã¢ã
ãªãâãšãã«ã¯ããªãã®å質局ã調補ããã å質局ã®èª¿è£œã¯ããèªäœå ¬ç¥ã®æ¹æ³ã«ããè¡
ãããšãã§ãããã®æ现æžã®ãè質æåã®å質
å±€ã®èª¿è£œãã®é ã§è©³çŽ°ã«èšèŒããã å質局ãæ°Žæ§çžã«åæ£ãããããããŠãäŸã
ã°æç¹æ³åã¯PHã¡ãŒã¿ã«ããPHå€ã調補ããªã
ããPHãçŽïŒåã¯ããããäœãäžããããã®æ
äœã¯äŸãã°çççã«èš±å®¹ãããé žãäŸãã°é±é ž
ã®åžæ°Žæº¶æ¶²ãäŸãã°ç¡«é žãå¡©é žåã¯çé žã®åžæ°Ž
溶液ãæ·»å ããããšã«ããè¡ãã 奜ãŸããæ æ§ã«ãããŠã¯ãè質æåã®å質局
ããPHçŽïŒåã¯ããããäœãç¯å²ã®æ°Žæ§çžãäŸ
ãã°é±é žåžæ°Žæº¶æ¶²ãäŸãã°ç¡«é žãå¡©é žåã¯çé ž
ã®åžæ°Žæº¶æ¶²ã«ãPHå€ãåæçã«èª¿æŽããªããæ·»
å ããã 次ã«è¡ãæ°Žæ§çžã®äžåã¯ãæ¹æ³ïŒa1ïŒåã³
ïŒa2ïŒã«ãããŠPHå€ã11ããé«ãããå Žåãåã¯
æ¹æ³ïŒb1ïŒåã³ïŒb2ïŒã«ãããŠPHå€ãïŒããäœ
ãããå Žåã«å¿ é ã§ããããã®æäœã¯ãPHå€ã®äž
æåã¯äœäžã®çŽåŸã«å¡©åºæ§åã¯é žæ§æ¡ä»¶äžã§æŽ»æ§
ç©è³ªåã³ïŒåã¯è質é¡ç²ãç Žå£ãããã®ãé²æ¢ã
ãããã«è¡ããå¡©åºæ§åããæ°Žæ§çžã¯ãé©åœãªç
ççã«èš±å®¹ãããé žåã¯ç·©è¡æ¶²ãäŸãã°PHïŒãïŒ
ã®çé žç·©è¡æ¶²ã«ããäžåãããé©åœãªé žãšããŠ
ã¯ãäŸãã°åèšã®é±é žæ°Žæº¶æ¶²åã³åŒ±ææ©é žãäŸã
ã°è»é žãåã¯é ¢é žãæãããããé žæ§æ°Žæ§çžã¯ã
å¡©åºæ§æ°Žæº¶æ¶²ãäŸãã°æ°Žé žåãããªãŠã åã¯æ°Žé ž
åã«ãªãŠã ã®åžæ°Žæº¶æ¶²ãæ·»å ããããšã«ããäžå
ãããäžåã¯PHå€ã®åæç調æŽã®äžã§è¡ãã è質ã¯ãæ°Žæ§çžäžã«70ïŒ ããå€ããŸã§ã®æ¿åºŠã§
åæ£ãããããæ¿åºŠç¯å²ã¯çŽïŒïŒ ãçŽ20ïŒ ãšãã
ã®ã奜ãŸããã宀枩åã¯ããããé«ã枩床ãäŸã
ã°çŽ60âãŸã§ã®æž©åºŠã§è¡ãã®ã奜éœåã§ãããå°
å ¥ãã¹ã掻æ§ç©è³ªã®æåæ§ã®ããã«å¿ èŠãããå Ž
åã«ã¯ãå·åŽäžããããŠå Žåã«ãã€ãŠã¯äžæŽ»æ§æ°
äœé°å²æ°äžãäŸãã°çªçŽ é°å²æ°äžã§è¡ãã æ¹æ³ïŒa1ïŒåã³ïŒa2ïŒäžŠã³ã«ïŒb1ïŒåã³ïŒb2ïŒ
ã®ãããã«ãããŠããåå±€è質é¡ç²ã®åœ¢æã¯èªçº
çã«ïŒèªçºçé¡ç²åœ¢æïŒãããªãã¡å€éšããè¿œå
ã®ãšãã«ã®ãŒãå ããããšãªãããããŠå€§ããªé
床ã§è¡ãããã åŸãããåå±€è質é¡ç²ã¯æ°Žæ§çžäžã§æ¯èŒç倧ã
ãªå®å®æ§ãæãããäŸãã°ãæ°Žæ§çžäžã«ååšãã
åµâãã¹ãã¢ããžã³é žãåã¯åµâãã¹ãã¢ããžã³
é žãšåµâã¬ã·ãã³ãšããæãåå±€è質é¡ç²ã¯ãïŒ
âã«ãŠ14æ¥ä»¥äžçœ®ããŠãå®å®ã«ç¶æãããããã®
çºæã®æ¹æ³ã«åŸã€ãŠè£œé ãããè質é¡ç²ãæãã
æ°Žæ§çžã¯ããšãŒãããç¹èš±åºé¡ç¬¬0065292å·ã«èš
èŒãããŠããæ¹æ³ã«ãã貯èµå®å®ã«ãããã åå±€è質é¡ç²ã®åœ¢æãšæ°Žæ§çžäžã«ããããã®é
ã¯ãããèªäœå ¬ç¥ã®æ¹æ³ã«ãããçš®ã ã®æ¹æ³ãäŸ
ãã°é»åé¡åŸ®é¡ã«ããèŠèŠç芳å¯ãåæçšè¶ é å¿
åé¢ã«ãã質é枬å®ããããŠç¹ã«ã¹ãã¯ãã«æ³ã
äŸãã°æ žå ±é³Žã¹ãã¯ãã«ïŒ1Hã13Cåã³31PïŒã«åº
ããŠæž¬å®ããããšãã§ãããäŸãã°ãæ žå ±é³Žã¹ã
ã¯ãã«ã®éãã·ã°ãã«ã¯å°åœ¢åå±€è質é¡ç²ã®åœ¢æ
ãšé¢é£ãããç³»ã«ãããå°åœ¢åå±€è質é¡ç²ã®æ¯ç
ã¯ã·ã°ãã«ã®åŒ·åºŠããç®åºããããšãã§ãããéœ
åæ žå ±é³Žã¹ãã¯ãã«ã«ãããŠããã¹ãã¢ããžã³é ž
ãã圢æãããå°åœ¢åå±€è質é¡ç²ã®å ŽåÎŽïŒ
1.28ppmã«ãããéãã¡ãã¬ã³ã·ã°ãã«ãšÎŽïŒ
0.89ppmã«ãããéãã¡ãã«ã·ã°ãã«ãç¹ç°çã§
ããããã¹ãã¢ããžã³é žåã³ã¬ã·ãã³ãã圢æã
ããå°åœ¢åå±€è質é¡ç²ããã¯ãåæ§ã«ã¡ãã¬ã³ã·
ã°ãã«åã³ã¡ãã«ã·ã°ãã«ã§ããÎŽïŒ1.28ppmå
ã³0.89ppmã®ã·ã°ãã«ãšãããã«ã¬ã·ãã³ã®ããª
ã¡ãã«ã¢ã³ã¢ããªåºã«åž°å±ããÎŽïŒ3.23ppmã®ã¡
ãã«ã·ã°ãã«ãçããã 圢æãããåå±€è質é¡ç²ã®å€§ããã¯ãç¹ã«è質
æåã®æ§é ãè質æåã®æ··åæ¯ããããã®è質æ
åã®æ°Žæ§çžäžã§ã®æ¿åºŠãåã³å°å ¥ãã¹ã掻æ§ç©è³ª
ã®éãšæ§é ã«äŸåãããåŸã€ãŠãäŸãã°ãæ°Žæ§çž
äžã®è質æåã®æ¿åºŠãå€ããããšã«ãã€ãŠãé«ã
æ¯çã§å°åœ¢åå±€è質é¡ç²åã¯å€§åœ¢åå±€è質é¡ç²ã
補é ããããšãã§ãããäŸãã°ãåæ£çžã«åµâã
ã¹ãã¢ããžã³é žãæ·»å ããããšã«ããå°åœ¢åå±€è
質é¡ç²ïŒKULïŒã®æ¯çãé«ããããšãã§ããã
åãåæ£çžäžã®å€§åœ¢åå±€è質é¡ç²ïŒGULïŒã®æ¯
çã¯ãå¡©ãäŸãã°NaClåã¯KClãæ·»å ããããš
ã«ããé«ããããšãã§ãããäŸãã°ãã¹ãã¢ããž
ã³é žãåã¯ãã¹ãã¢ããžã³é žãšã¬ã·ãã³ãšãã圢
æãããKULã¯çŽ200ã600â«ã®çŽåŸãæããã
ãã®ãããªå€§ãããæããKULã®å°å ¥å®¹éã¯å
ããè質æåã®ïŒã¢ã«åœããçŽ0.5ãïŒã§ããã KULã®ä»ã«å€§åœ¢åå±€è質é¡ç²ïŒGULâçŽåŸçŽ
50000â«ä»¥äžïŒã圢æãããããã®ãã®ã¯å ãã
è質æåïŒã¢ã«åœãããã倧ããªå°å ¥å®¹éãæ
ãããã®ããããã倧ããªåçã§å°å ¥ããã®ã«é©
ãããããŠå®¹ç©ã®å€§ããæéãäŸãã°ãŠã€ã«ã¹ã
现èåã¯çŽ°èåšç®¡ãå°å ¥ããã®ã«é©ããã GULããKULã®åé¢ã¯ãåžžçšã®åé¢æ³ãäŸã
ã°ã²ã«éæ³ãäŸãã°ã»ãã¢ããŒãº4Bãæ äœãš
ããŠäœ¿çšããã²ã«éæ³ãåã¯160000ïœã®è¶ é å¿
ã«ããGULã®æ²éã«ããè¡ãããšãã§ãããäŸ
ãã°ãåèšã®éåå Žã«ãããŠæ°æéãäŸãã°çŽïŒ
æéé å¿åé¢ããããšã«ããGULãæ²éããä»
æ¹KULã¯åé¢ãããŸãŸã§ããããã«ã³ãã«ãã
åãåºãããšãã§ããã ããã«ãã²ã«éã«ãããæ°Žæ§çžäžã«ååšãã
çŽåŸã600â«ãã倧ãããã¹ãŠã®è質é¡ç²ãäŸã
ã°GULåã¯å€å±€è質é¡ç²ã䞊ã³ã«å°å ¥ãããŠã
ãªã掻æ§ç©åã³æ®åãåæ£ããŠããè質ãåé¢
ãããããŠå€§ãããæ¯èŒçåäžãªKULåºåã䌎
ãæ°Žæ§çžãåŸãããšãã§ããã ãã®çºæã®è質é¡ç²ïŒKULåã³GULïŒã¯ãé©
åœãªæ äœç³»ã§ãã€ãŠããã®æ äœç³»ã¯èŠªèæ§ç©è³ªã
äŸãã°è溶æ§è²çŽ ã®æ°Žæ§çžäžãžã®å¯æº¶åãå æ°Žå
解æåæ§ååç©ãäŸãã°ããã¹ã¿ã°ã©ã³ãžã³ã®å®
å®åã害è«é§é€å€ã®å°å ¥ãäŸãã°ãžã¯ãããã¹ã®
掻æ§ã¹ãã¯ãã«ã®å€æŽãé£åæ·»å ç©ã®å°å ¥ãäŸã
ã°ãã¿ãã³ãããã¯è²çŽ ã®åžåæ§ãå€ããããšã
ç®çãšããå Žåãåã¯å°å ¥ããã掻æ§ç©è³ªãäŸã
ã°é µçŽ ãæäœããã«ã¢ã³ãéºäŒåããŠã€ã«ã¹ãã
ã¿ãã³ãããã¯çŽ°èåšå®ã®å¹é€çŽ°èãžã®å°å ¥ã«äœ¿
çšãããã 掻æ§ç©è³ªãå°å ¥ãããã®çºæã®è質é¡ç²ãå«æ
ããæ°Žæ§çžã¯æè¬ç³»ãæ§æããå Žåã«ãã€ãŠã¯ã
äŸãã°è¶ é å¿åé¢ã«ããé¡ç²ã®æ¿çž®åã¯åé¢ãè¡
ã€ãåŸãçµå£ïŒP.OïŒæäžãéçµå£ïŒéèå ãç
èå ããããã¯è ¹è å ïŒæäžãåã¯å±ææäžã®ã
ãã®å»çç®çã«é©ããã çµå£æäžã«ãããŠãè質é¡ç²ã«åºç€ã眮ãæè¬
ç³»ã«ãããæ¶å管äžã§äžå®å®ãªæŽ»æ§ç©è³ªäŸãã°ã€
ã³ã¹ãªã³ã¯ä¿è·ãããåã¯ãã®åžåãæ¹åãã
ãã çµå£æäžã®ããã«ã¯ãè質é¡ç²å«ææ°Žæ§çžã¯ã
å»è¬ãšããŠèš±å®¹ãããåžéå€ãããã¯æ äœãåã¯
åžžçšã®æ·»å å€ãäŸãã°è²çŽ ãããã¯å奜å€ãšæ··å
ããŠãã·ãããåã¯ã«ãã»ã«ã®åœ¢ã§æäžããããš
ãã§ããã éçµå£æäžã®å Žåãè質é¡ç²ã«åºç€ã眮ãæè¬
ç³»ã«ãããäŸãã°ãã¹ããšãªãªããµãã³ãã°ã€ã«
ã¡ããïŒGuilmetleïŒR.AçãLife Sci.22(4)ã313
ã320ã1978幎ãåã¯ã²ã³ã¿ãã€ã·ã³ãã·ãšã«ã
ïŒScheldïŒW.M.çãClin.Res.26ïŒNo.ïŒã59Aã
1978幎ãã®äœå æ»çæéã延é·ããããåæ§ã«ã
å°å ¥ããããã¬ãŒãå€ãäŸãã°EDTAïŒãšãã¬ã³
ãžã¢ãã³ããã©é ¢é žïŒã®äœå æ»çæéãé·ã³ãã
ãã«ããããã¬ãŒã圢æã«ãããç¹ã«èèãèŸ
èãåã¯è èããééå±ãé€å»ããããšãã§ãã
ãã©ãŒãã³ïŒRahmannïŒçãScienceãVol 180ã
300ã302ã1973幎ãåã³J.Lab.Clin.Med.640ã
647ã1974幎ããè質é¡ç²ã«åºç€ã眮ãæè¬æ³ã«ã
ã掻æ§ç©è³ªãå¿çäžã«æ¿çž®ããããšãã§ãããã©
ã³ãã¹ãã³ïŒLandesmannïŒçãScience
Vol.198ã737ã738ã1977幎ããæççäœçšå€ãäŸ
ãã°ã³ãŒããŸã«ïŒNature271ãNo.5643ã372ã73ã
1978幎ïŒãåã¯ãããã¢ãŒãŒé»å®³å€ïŒAnal.
Biochem.89ãNo.ïŒã400ã07ã1978幎ïŒãé¢ç¯æ¶²
äžã«ãé现èå€ãè «ççµç¹äžã«ãCancer
Treatment Reviews8ã27ã50ã1981幎ã®ã«ã€ãš
ïŒKayeïŒSL.B.ã®ç·èª¬ãåã³ããã§åŒçšãããŠã
ãïŒã€ã®æç®ãæ¿çž®ããããšãã§ãããã¬ã³æ²»ç
ã«ãããå€ãã®ååŠçæ³å€ã¯ããããè質é¡ç²ã«
å°å ¥ããŠæäžããå Žåãæ¯æ§ãããå°ãªããªãã
ããã«äœã«å¯ŸããŠç©åã«ãªããäŸãã°è質é¡ç²ã«
å°å ¥ãããã¢ãªãããã€ã·ã³ïŒ€ãã©ãŒãã³
ïŒRahmanïŒçãProceedings of the Society
for Exprimental Biologyãåã³Medicine146ã
1173ã1176ã1974幎ããã¡ãœãã¬ãã»ãŒããã¬ã¶
ãŒãã³ïŒLesermannïŒL.D.çãProc.Natl.Acad.
Sci.77ãNo.ïŒã4089ã93ã1980幎ãããã³ãã©ã¹
ãã³ãããŠããã€ã·ã³åã¯ã·ãã·ã³ã¢ã©ããã·ã
ãããŠãŒã¬ã³ã·ãŒãã³ïŒMušhlensiepenïŒçã
Cancer Res.41ãNo.ïŒã1602ã07ã1981幎ããã
ãã§ãããè質é¡ç²ã¯ã掻æ§æåãäŸãã°é µçŽ ã
ãããããã«ã¢ã³ãéºäŒååã¯ãŠã€ã«ã¹ã®çäœçŽ°
èã®çŽ°è質äžãžã®å°å ¥ã«ãäŸãã°ã¢ã¹ãã©ã®ããŒ
ãŒãJ.Lipid ResearchãVol19ã1978幎ã289ã
303äžã®ãã€ã³ã±ã«ã¹ã¿ã€ã³ïŒFinkelsteinïŒïŒå
ã³ã¯ã€ã¹ãã³ïŒWeismannïŒG.ã®ç·èª¬ããã¢ãã
ã°ã«ã³ã·ããŒãŒãã°ã¬ãŽãªã¢ãžã¹ïŒGregoriadisïŒ
G.åã³ãªãã³ïŒRymanïŒB.E.ãEur.J.
Biochem.24ïŒ1972幎ïŒã481ã491ããåã¯ããŠãŒã
ããããŒãŒãã°ã¬ãŽãªã¢ãžã¹çãBiochem.J.
ïŒ1974幎ïŒ140ã232ã330ãã®å°å ¥ã«ãç¹ç°çèå¥
ååãäŸãã°çš®ã ã®æšç现èã«éžæçã«å°å ¥ãã
ããã®ã¢ãã¯ããŒã³æäœãåºå®ããããã«ãã¬ãŒ
ãŒã«ãã³ïŒLesermannïŒçãNature292ïŒ5829ïŒã
226ã228ã1981幎ããäŸãã°ãªãŒã·ãŠããã¢ã«å¯Ÿ
ããæ¥çš®ã®éã®ã¢ãžãŠãã³ããšããŠå ç«åºæ¿ã®ã
ãã«ãããŠãŒïŒNewïŒR.R.C.çNature272ïŒ5648ïŒ
55ã56ã1978幎ããåã¯ãäŸãã°ççãèµ·ããçµ
ç¹ã«ããã枩床ã®äžæãåã¯PHå€ã®å€åã®ããšã
ä¿¡å·ã«ãã掻æ§ç©è³ªã®éé¢ãèªå°ããããã«äœ¿çš
ããããéçµå£æäžã®ããã«ãæ¿çž®ããåã¯åé¢
ããè質é¡ç²ããé©åœãªæ äœæ¶²ãäŸãã°æ®ºèãã
èžçæ°Žåã¯çççé£å¡©æ°Žæº¶æ¶²äžã«æžæ¿ããããšã
ã§ããã è質æåã®å質局ã®èª¿è£œ è質æåã®å質局ã®èª¿è£œã¯ãããèªäœå ¬ç¥ã®æ¹
æ³ã«ããè¡ãããšãã§ãããäŸãã°ããŸããåŒ(A)
ã®è質åã¯è質混åç©ãäŸãã°çŽç²ãªåµâãã¹ã
ã¢ããžã³é žãåã¯åµâãã¹ãã¢ããžã³é žãšåµâã¬
ã·ãã³ãšã®æ··åç©ããå Žåã«ãã€ãŠã¯ãè質é¡ç²
ã®åœ¢æã®éã«è質局ã«å°å ¥ããã芪èæ§æŽ»æ§ç©
質ãäŸãã°èçœè³ªãšå ±ã«ãææ©æº¶å€äžã«æº¶è§£ã
ãã奜ãŸããã¯ç空äžãåã¯äžæŽ»æ§æ°äœãäŸãã°
çªçŽ ã®éæ°ã«ããææ©æº¶æãé€å»ããããšã«ãã
è質æåã®å質局ãåŸãã 溶å€ã®éžæã¯ãããã«æº¶è§£ããè質æåã®æº¶è§£
床ã«äŸåããŠè¡ããé©åœãªæº¶å€ãšããŠã¯ãäŸãã°
眮æãããŠããªãåã¯çœ®æãããŠãããäŸãã°ã
ãã²ã³åããããèèªæã®ãç°ç¶èèªæã®ãè³éŠ
æã®åã¯è³éŠæâèèªæã®çåæ°ŽçŽ ãäŸãã°ãã³
ãŒã³ããã«ãšã³ãå¡©åã¡ãã¬ã³ããããã¯ã¯ãã
ãã«ã ãã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«ãããã¯
ãšã¿ããŒã«ãäœçŽã¢ã«ã«ã³ã«ã«ãã³é žãšã¹ãã«ã
äŸãã°é ¢é žãšãã«ããšãŒãã«ãäŸãã°ãžãšãã«ãš
ãŒãã«ããžãªããµã³ãããã¯ããã©ããããã©
ã³ãåã¯ãããã®æº¶å€ã®æ··åç©ãæããããšãã§
ããã åèšããè質ã¯å ¬ç¥ã®ãã®ã§ãããåã¯ããã
æ°èŠã®ãã®ã§ããå Žåã«ã¯ããã€ãïŒKnightïŒ
C.G.ã®æšæºçæ¹æ³ïŒLiposomesãElsevier1981
幎ã第ïŒç« ïŒäžã«èšèŒãããŠããåŠæ¹ã«åŸã€ãŠã
ãèªäœå ¬ç¥ã®æ¹æ³ã«ãã補é ããããšãã§ããã
èšèŒãããã¹ãŠã®è質ã¯ãæ°Žæ§åæ£äœäžã§å åŠç
ã«æŽ»æ§ãªèªå°äœåã¯ã©ã»ãäœãšããŠååšãåŸãã
次ã«äŸã«ãããã®çºæã詳现ã«èª¬æãããããã
ã«ãããã®çºæã®ç¯å²ãéå®ãããã®ã§ã¯ãªãã
枩床ã¯ïŒâã§è¡šãããæ··åæ¯ã¯å®¹éæ¯ã§ããã äŸ ïŒ (a) ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
20mlã«ïŒïœã®åµâãã¹ãã¢ããžã³é žã溶解ãã
ãããŠç空æ¡ä»¶äžããŒã¿ãªãŒèžçºè£ 眮ã§æº¶å€ã
èžçºãããããèç¶ã®æ®æž£ããïŒåéæ¹æããª
ãã20mlã®èžçæ°Žã«åæ£ããããPHãçŽïŒã«èª¿
æŽããã次ã«ãåå±€è質é¡ç²ã圢æãããã
ã«ãPHã¡ãŒã¿ãŒã§ç£èŠããªãã宀枩ã«ãããŠã
PHã11ã«ãªããŸã§åæ£çžã«0.1Næ°Žé žåãããª
ãŠã 溶液ãå ããã次ã«ã0.1NHClãæ·»å ã
ãããšã«ããæ°Žæ§çžã®PHã11ããçŽïŒã«èª¿æŽã
ããããããŠèä¹³çœè²ãæããæ°Žæ§çžãåŸãã 圢æãããåå±€è質é¡ç²ã¯é»åé¡åŸ®é¡ã§èŠ³å¯
ããããšãã§ããã次ã«ãè質é¡ç²åæ£äœãåžž
çšã®å·ååé¢æ³ïŒåçµåå¥æ³ïŒã«ããããçŽåŸ
ã«ãã€ãŠæ¬¡ã®ããã«åºå¥ãããåå±€è質é¡ç²ã®
äž»ããïŒçš®é¡ã®éå£ãåŸããããããªãã¡ã ïŒ å°åœ¢åå±€è質é¡ç²ïŒKULïŒïŒçŽåŸçŽ200ã
600â«ãåã³ ïŒ å€§åœ¢åå±€è質é¡ç²ïŒGULïŒïŒçŽåŸçŽ1000ã
10000â«ã ã§ãããKULã¯ãéœåâNMRâã¹ãã¯ãã«ã«
ãããŠã·ã°ãã«ÎŽïŒ1.28ïŒã¡ãã¬ã³ïŒåã³ÎŽïŒ
0.89ppmïŒã¡ãã«ïŒã«ãã確èªããããKULã®
åéã¯ã·ã°ãã«ã®åŒ·åºŠã«ããè©äŸ¡ããããçŽ56
ïŒ ã§ããã (b) äŸïŒ(a)ãšåæ§ã«ããŠãã¯ãããã«ã ïŒã¡ã¿ã
ãŒã«æ··å液ïŒïŒïŒïŒïŒ0.2mlã«10mgã®åµâãã¹
ãã¢ããžã³é žã溶解ãããã®ãïŒåçšæããã
ããŠæº¶å€ãç空èžçºãããããèç¶ã®æ®æž£ãã
ïŒåéæ¹æããªããïŒmlã®èžçæ°Žã«åæ£ããã
ããåå±€è質é¡ç²ã圢æãããããããPHã¡ãŒ
ã¿ã§ç£èŠããªããããããã®åæ£çžã«0.1Næ°Ž
é žåãããªãŠã 溶液ãå ããPHãããããïŒã
ïŒã11.3åã³11.6ãšãããKULã®åçã¯ããã
ãã®PHã«ãããŠïŒïŒ ã24ïŒ ã57ïŒ åã³60ïŒ ã§ã
ãã äŸ ïŒ (a) ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
20mlã«ïŒïœã®åµâãã¹ãã¢ããžã³é žã溶解ãã
ãããŠãã®æº¶å€ãç空èžçºãããããèç¶æ®æž£
ã0.01Næ°Žé žåãããªãŠã 溶液ã«50mlã«æ¹æã
ãªããåæ£ãããããæ°Žæ§çžã®PHã¯çŽ12ãšãª
ãã次ã«æ°Žæ§åæ£äœã®PHã0.1Nå¡©é žæº¶æ¶²ãæ·»
å ããããšã«ããçŽïŒãïŒã«èª¿æŽãããKUL
ã®åçã¯çŽ100ïŒ ã§ããã (b) äŸïŒ(a)ãšåæ§ã«ãã¯ãããã«ã ïŒã¡ã¿ããŒã«
æ··å液ïŒïŒïŒïŒïŒ0.2mlã«10mgã®åµâãã¹ãã¢
ããžã³é žã溶解ããããããïŒåçšæãã溶å€
ãç空èžçºããããããããã®è©Šæããããã
ãPHã7.3ã8.0ã9.4åã³10.0ãšãªãããã«
0.01Næ°Žé žåãããªãŠã 溶液ãšèžçæ°Žãšãæ¹æ
ããªããåæ£ãããããKULã®åçã¯ããã
ãã®PHã«ã€ããŠã33ïŒ ã46ïŒ ã65ïŒ åã³81ïŒ ã§
ããã äŸ ïŒ ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒïŒ
mlã«0.1ïœã®ãžã©ãŠãªã«ãã¹ãã¢ããžã³é žã溶解
ãããããŠæº¶å€ãç空èžçºãããããèç¶æ®æž£ã
50mlã®0.01Næ°Žé žåãããªãŠã 溶液ã«æ¹æããªã
ãåæ£ãããããããã«ããçæããåæ£äœã®PH
ã¯çŽ12ãšãªãã次ã«ã0.1Nå¡©é žæº¶æ¶²ãå ããã
ãšã«ããæ°Žæ§åæ£äœã®PHãçŽïŒãïŒã«èª¿æŽããã
KULïŒçŽåŸçŽ300ã800â«ïŒã®åçã¯73ïŒ ã§ããã äŸ ïŒ (a) ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
0.5mlã«ïŒmgã®åµâãã¹ãã¢ããžã³é žãšïŒmgã®
åµâã¬ã·ãã³ã溶解ãã溶å€ãç空èžçºããã
ãã宀枩ã«ãŠïŒåéæ¹æããããšã«ãããèç¶
ã®æ®æž£ãïŒmlã®èžçæ°Žã«åæ£ãããããããã«
ããPHã¯çŽïŒãšãªãã次ã«åå±€è質é¡ç²ã圢æ
ããããããã«ãPHã¡ãŒã¿ã«ãŠç£èŠããªãã宀
æž©ã«ãããŠãPHãçŽ11.2ã«ãªãããã«0.1Næ°Žé ž
åãããªãŠã 溶液ãå ããã次ã«ãçé žç·©è¡æ¶²
ãå ããããšã«ããæ°Žæ§å±€ã®PHãçŽïŒã«èª¿æŽã
ããããããŠãèãä¹³çœè²ãæããæ°Žæ§çžãåŸ
ããåå±€è質é¡ç²ã®çæã¯ãNMRâã¹ãã¯ã
ã«ã«ãããã·ã°ãã«ÎŽïŒ1.28ïŒã¡ãã¬ã³ïŒãÎŽïŒ
0.89ïŒã¡ãã«ïŒåã³ÎŽïŒ3.23ïŒïŒ®âCH3ïŒã«ãã
確èªããããé»åé¡åŸ®é¡èŠ³å¯ã«ãããçŽåŸã«ã
ã€ãŠåºå¥ãããåå±€è質é¡ç²ã®äž»ããïŒçš®é¡ã®
éå£ã確èªããããããªãã¡ã ïŒ KULïŒçŽåŸçŽ200ã800â«ãåã³ ïŒ GULïŒçŽåŸçŽ1000ã10000â«ã ã§ãããKULã®åçã¯45ïŒ ã§ããã (b) (a)ã«èšèŒããæ¹æ³ã«åŸã€ãŠãã¯ãããã«ã ïŒ
ã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ0.5mlã«çš®ã ã®æ¿
床ã«ãªãããã«åµãã¹ãã¢ããžã³é žåã³åµã¬ã·
ãã³ããããã溶解ãããããŠãããã®æº¶æ¶²ã
ç空æ¿çž®ãããïŒåéæ¯ãšãããããšã«ããã
ããããã®èç¶æ®æž£ãïŒmlã®æ°Žã«åæ£ããã
ããPHã¡ãŒã¿ã§ã®ç£èŠäžã§æ¯ãšãããªãããæ
çµPHãçŽ11.2ã«ããã®ã«ååãªéã®0.1Næ°Žé žå
ãããªãŠã 溶液ãããããã®åæ£çžã«å ããã
ãšã«ããåå±€è質é¡ç²ã圢æãããåµâãã¹ã
ã¢ããžã³é žã®æ¿åºŠãå¢å ããã«åŸã€ãŠKULã®
åçã¯æ¬¡ã®ããã«ãªãã
ãè¡šã
äŸ ïŒ
(a) 0.3ïœã®åµâãã¹ãã¢ããžã³é
žãš0.7ïœã®åµâ
ã¬ã·ãã³ãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液
ïŒïŒïŒïŒïŒ10mlã«æº¶è§£ãããããŠæº¶æ¶²ãç空æ¿
çž®ãããæ¯ãšãããªãããæ®æž£ã0.01Næ°Žé žå
ãããªãŠã 溶液10mlã«åæ£ãããããããããŠ
çæããåæ£äœã¯çŽ12ã®PHå€ãæããã次ã«ã
0.1Nå¡©é žãå ããããšã«ããæ°Žæ§åæ£äœã®PH
ãçŽïŒãïŒã«äžãããKULã®åçã¯çŽ30ïŒ ã§
ããã (b) (a)ã®æ¹æ³ã«åŸã€ãŠãçš®ã ã®éã®åµâãã¹ãã¢
ããžã³é žãšåµâã¬ã·ãã³ã®è©ŠæïŒè質ã®åèšé
10mgïŒãããããã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··
å液ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£ãããããŠæº¶æ¶²ã
ç空æ¿çž®ãããããããã®èç¶æ®æž£ããæ¯ãšã
ããªããïŒmlã®0.01Næ°Žé žåãããªãŠã 溶液ã«
åæ£ããããããã®åæ£äœã®PHã¯çŽ12ã§ããã
åæ°Žæ§åªäœã®PHãçŽïŒãïŒã«äžãããåµâãã¹
ãã¢ããžã³é žã®æ¿åºŠãå¢å ããã«åŸã€ãŠåè©Šæ
ã®KULã®åçã¯æ¬¡ã®ããã«ãªãã
ã¬ã·ãã³ãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液
ïŒïŒïŒïŒïŒ10mlã«æº¶è§£ãããããŠæº¶æ¶²ãç空æ¿
çž®ãããæ¯ãšãããªãããæ®æž£ã0.01Næ°Žé žå
ãããªãŠã 溶液10mlã«åæ£ãããããããããŠ
çæããåæ£äœã¯çŽ12ã®PHå€ãæããã次ã«ã
0.1Nå¡©é žãå ããããšã«ããæ°Žæ§åæ£äœã®PH
ãçŽïŒãïŒã«äžãããKULã®åçã¯çŽ30ïŒ ã§
ããã (b) (a)ã®æ¹æ³ã«åŸã€ãŠãçš®ã ã®éã®åµâãã¹ãã¢
ããžã³é žãšåµâã¬ã·ãã³ã®è©ŠæïŒè質ã®åèšé
10mgïŒãããããã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··
å液ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£ãããããŠæº¶æ¶²ã
ç空æ¿çž®ãããããããã®èç¶æ®æž£ããæ¯ãšã
ããªããïŒmlã®0.01Næ°Žé žåãããªãŠã 溶液ã«
åæ£ããããããã®åæ£äœã®PHã¯çŽ12ã§ããã
åæ°Žæ§åªäœã®PHãçŽïŒãïŒã«äžãããåµâãã¹
ãã¢ããžã³é žã®æ¿åºŠãå¢å ããã«åŸã€ãŠåè©Šæ
ã®KULã®åçã¯æ¬¡ã®ããã«ãªãã
ãè¡šã
äŸ ïŒ
0.7ïœã®åµâã¬ã·ãã³ã0.3ïœã®çè³âãã¹ãã¢
ããžã«ã»ãªã³åã³ïŒïœã®åµâãã¹ãã¢ããžã³é žã
ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ20ml
ã«æº¶è§£ãããããŠãã®æº¶æ¶²ãããŒã¿ãªãŒãšããã¬
ãŒã¿ã«ãŠç空æ¿çž®ããã宀枩ã«ãŠïŒåéæ¯ãšãã
ãããšã«ãããèç¶æ®æž£ã0.01Næ°Žé žåãããªãŠ
ã 溶液100mlã«åæ£ãããããåæ£äœã®PHã¯çŽ12
ã§ããã1Nå¡©é žã«ããæ°Žæ§å±€ã®PHãçŽïŒã«èª¿æŽ
ãããèä¹³çœè²ã®æ°Žæ§çžãåŸãããã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ã®å Žåã®ããã«ã¹
ãã¯ãã«æ³ã«ããäŸãã°NMRåã¯é»åé¡åŸ®é¡ã«
ãã確èªããããšãã§ããã (b) (a)ã®æ¹æ³ã«åŸã€ãŠãçš®ã ã®åµâãã¹ãã¢ããž
ã³é žæ¿åºŠãšåäžéã®åµâã¬ã·ãã³åã³ãã¹ãã¢
ããžã«ã»ãªã³æ¿åºŠãæããè©ŠæïŒè質ã®åèšé
ã¯10mgïŒãããããã¯ãããã«ã ïŒã¡ã¿ããŒã«
æ··å液ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£ãããããŠãã
ãã®æº¶æ¶²ãç空æ¿çž®ãããæ®æž£ã®ããããã
0.1Næ°Žé žåãããªãŠã 溶液1.0mlã«æ¯ãšãåæ£
ãããããçæããåæ£äœã®PHã¯çŽ12ãšãªãã
0.1Nå¡©é žãå ããããšã«ããæ°Žæ§åæ£äœã®PH
ãçŽïŒãïŒã«äžãããåµâãã¹ãã¢ããžã³é žæ¿
床ãäžæããã«åŸã€ãŠåè©Šæã®KULã®åçã¯
次ã®ããã«ãªãã
ããžã«ã»ãªã³åã³ïŒïœã®åµâãã¹ãã¢ããžã³é žã
ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ20ml
ã«æº¶è§£ãããããŠãã®æº¶æ¶²ãããŒã¿ãªãŒãšããã¬
ãŒã¿ã«ãŠç空æ¿çž®ããã宀枩ã«ãŠïŒåéæ¯ãšãã
ãããšã«ãããèç¶æ®æž£ã0.01Næ°Žé žåãããªãŠ
ã 溶液100mlã«åæ£ãããããåæ£äœã®PHã¯çŽ12
ã§ããã1Nå¡©é žã«ããæ°Žæ§å±€ã®PHãçŽïŒã«èª¿æŽ
ãããèä¹³çœè²ã®æ°Žæ§çžãåŸãããã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ã®å Žåã®ããã«ã¹
ãã¯ãã«æ³ã«ããäŸãã°NMRåã¯é»åé¡åŸ®é¡ã«
ãã確èªããããšãã§ããã (b) (a)ã®æ¹æ³ã«åŸã€ãŠãçš®ã ã®åµâãã¹ãã¢ããž
ã³é žæ¿åºŠãšåäžéã®åµâã¬ã·ãã³åã³ãã¹ãã¢
ããžã«ã»ãªã³æ¿åºŠãæããè©ŠæïŒè質ã®åèšé
ã¯10mgïŒãããããã¯ãããã«ã ïŒã¡ã¿ããŒã«
æ··å液ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£ãããããŠãã
ãã®æº¶æ¶²ãç空æ¿çž®ãããæ®æž£ã®ããããã
0.1Næ°Žé žåãããªãŠã 溶液1.0mlã«æ¯ãšãåæ£
ãããããçæããåæ£äœã®PHã¯çŽ12ãšãªãã
0.1Nå¡©é žãå ããããšã«ããæ°Žæ§åæ£äœã®PH
ãçŽïŒãïŒã«äžãããåµâãã¹ãã¢ããžã³é žæ¿
床ãäžæããã«åŸã€ãŠåè©Šæã®KULã®åçã¯
次ã®ããã«ãªãã
ãè¡šã
äŸ ïŒ
ïŒïœã®ã¢ãœã¬ã¯ãã³ïŒäž»ãšããŠã¬ã·ãã³ãã»ã
ãªã³ããã¹ãã¢ããžã«ã»ãªã³åã³ãã¹ãã¢ããžã«
ã€ãã·ããŒã«ãå«ãã§æãçè質ã®æ··åç©ïŒãš
0.2ïœã®åµâãã¹ãã¢ããžã³é žãã¯ãããã«ã ïŒ
ã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ20mlã«æº¶è§£ãããã
ãŠãã®æº¶æ¶²ãç空æ¿çž®ããã宀枩ã«ãŠïŒåéæ¯ãš
ãããããšã«ãããèç¶æ®æž£ã0.01Næ°Žé žåãã
ãªãŠã 溶液100mlã«åæ£ãããããããããŠçæ
ããåæ£äœã®PHã¯çŽ12ã§ããã1Nã®å¡©é žãæ·»å
ããããšã«ããæ°Žæ§çžã®PHãçŽïŒã«äžãããèä¹³
çœè²ã®æ°Žæ§çžãåŸãããã åå±€è質é¡ç²ã®åœ¢æã¯ãäŸïŒ(a)ã®å Žåãšåæ§ã«
ã¹ãã¯ãã«æ³ã«ãããäŸãã°NMRåã¯é»åé¡åŸ®
é¡ã«ãã確èªããããšãã§ãããKULåã³GUL
ã¯é»åé¡åŸ®é¡åçäžã«èŠãããšãã§ããã (b) äŸïŒ(a)ã®æ¹æ³ã«åŸã€ãŠçš®ã ã®æ¿åºŠã®åµâãã¹
ãã¢ããžã³é žãšåäžéã®ã¢ãœã¬ã¯ãã³ïŒè質ã®
åèšé10mgïŒãå«ãè©Šæãããããã¯ãããã«
ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£
ãããããŠãããã®æº¶æ¶²ãç空æ¿çž®ãããåæ®
枣ã0.01Næ°Žé žåãããªãŠã 溶液ïŒmlã«æ¯ãšã
åæ£ããããããã®åæ£äœã®PHã¯çŽ12ã§ããã
0.1Nå¡©é žãå ããããšã«ããæ°Žæ§åæ£äœã®PH
ãçŽïŒãïŒã«äžãããåµâãã¹ãã¢ããžã³é žã®
æ¿åºŠã®å¢å ã«åŸã€ãŠåè©Šæã®KULã®åçã¯æ¬¡
ã®ããã«ãªãã
ãªã³ããã¹ãã¢ããžã«ã»ãªã³åã³ãã¹ãã¢ããžã«
ã€ãã·ããŒã«ãå«ãã§æãçè質ã®æ··åç©ïŒãš
0.2ïœã®åµâãã¹ãã¢ããžã³é žãã¯ãããã«ã ïŒ
ã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ20mlã«æº¶è§£ãããã
ãŠãã®æº¶æ¶²ãç空æ¿çž®ããã宀枩ã«ãŠïŒåéæ¯ãš
ãããããšã«ãããèç¶æ®æž£ã0.01Næ°Žé žåãã
ãªãŠã 溶液100mlã«åæ£ãããããããããŠçæ
ããåæ£äœã®PHã¯çŽ12ã§ããã1Nã®å¡©é žãæ·»å
ããããšã«ããæ°Žæ§çžã®PHãçŽïŒã«äžãããèä¹³
çœè²ã®æ°Žæ§çžãåŸãããã åå±€è質é¡ç²ã®åœ¢æã¯ãäŸïŒ(a)ã®å Žåãšåæ§ã«
ã¹ãã¯ãã«æ³ã«ãããäŸãã°NMRåã¯é»åé¡åŸ®
é¡ã«ãã確èªããããšãã§ãããKULåã³GUL
ã¯é»åé¡åŸ®é¡åçäžã«èŠãããšãã§ããã (b) äŸïŒ(a)ã®æ¹æ³ã«åŸã€ãŠçš®ã ã®æ¿åºŠã®åµâãã¹
ãã¢ããžã³é žãšåäžéã®ã¢ãœã¬ã¯ãã³ïŒè質ã®
åèšé10mgïŒãå«ãè©Šæãããããã¯ãããã«
ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£
ãããããŠãããã®æº¶æ¶²ãç空æ¿çž®ãããåæ®
枣ã0.01Næ°Žé žåãããªãŠã 溶液ïŒmlã«æ¯ãšã
åæ£ããããããã®åæ£äœã®PHã¯çŽ12ã§ããã
0.1Nå¡©é žãå ããããšã«ããæ°Žæ§åæ£äœã®PH
ãçŽïŒãïŒã«äžãããåµâãã¹ãã¢ããžã³é žã®
æ¿åºŠã®å¢å ã«åŸã€ãŠåè©Šæã®KULã®åçã¯æ¬¡
ã®ããã«ãªãã
ãè¡šã
äŸ ïŒ
(a) åµâã¬ã·ãã³ãšã³ã¬ã¹ãããŒã«ãšã®æ··åç©
ïŒã¢ã«æ¯ïŒïŒïŒïŒ0.1ïœãšåµâãã¹ãã¢ããžã³é ž
0.1ïœãšãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液
ïŒïŒïŒïŒïŒ10mlã«æº¶è§£ãããããŠãã®æº¶æ¶²ãç
空æ¿çž®ããã宀枩ã«ãŠïŒåéæ¯ãšãããããšã«
ãããèç¶æ®æž£ã0.01Næ°Žé žåãããªãŠã 10ml
ã«åæ£ãããããããããŠçæããåæ£äœã®PH
ã¯çŽ12ã§ããã次ã«ã1Nå¡©é žã®æ·»å ã«ããæ°Ž
æ§çžã®PHãçŽïŒã«äžãããèä¹³çœè²ã®æ°Žæ§çžã
åŸãããã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ã®å Žåã®ããã«
ã¹ãã¯ãã«æ³çã«ãäŸãã°NMRåã¯é»åé¡åŸ®
é¡ã«ãã確èªããããšãã§ããã (b) äŸïŒ(a)ã®æ¹æ³ã«åŸã€ãŠãçš®ã ã®æ¿åºŠã®åµâã
ã¹ãã¢ããžã³é žãšåäžéã®åµâã¬ã·ãã³åã³ã³
ã¬ã¹ãããŒã«ïŒè質ã®åèšé10mgïŒãšãå«ãè©Š
æãããããã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液
ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£ãããããŠãã®æº¶æ¶²ãç
空æ¿çž®ããã次ã«ãåæ®æž£ã0.01Næ°Žé žåãã
ãªãŠã 溶液1.0mlã«æ¯ãšãåæ£ããããããã®
åæ£äœã®PHã¯çŽ12ã«äžæããã次ã«0.1Nå¡©é ž
ãå ããããšã«ããæ°Žæ§åæ£äœã®PHãçŽïŒãïŒ
ã«äžãããåµâãã¹ãã¢ããžã³é žã®æ¿åºŠãå¢å
ããã«åŸã€ãŠåè©Šæã®KULã®åçã¯æ¬¡ã®ãã
ã«ãªãã
ïŒã¢ã«æ¯ïŒïŒïŒïŒ0.1ïœãšåµâãã¹ãã¢ããžã³é ž
0.1ïœãšãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液
ïŒïŒïŒïŒïŒ10mlã«æº¶è§£ãããããŠãã®æº¶æ¶²ãç
空æ¿çž®ããã宀枩ã«ãŠïŒåéæ¯ãšãããããšã«
ãããèç¶æ®æž£ã0.01Næ°Žé žåãããªãŠã 10ml
ã«åæ£ãããããããããŠçæããåæ£äœã®PH
ã¯çŽ12ã§ããã次ã«ã1Nå¡©é žã®æ·»å ã«ããæ°Ž
æ§çžã®PHãçŽïŒã«äžãããèä¹³çœè²ã®æ°Žæ§çžã
åŸãããã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ã®å Žåã®ããã«
ã¹ãã¯ãã«æ³çã«ãäŸãã°NMRåã¯é»åé¡åŸ®
é¡ã«ãã確èªããããšãã§ããã (b) äŸïŒ(a)ã®æ¹æ³ã«åŸã€ãŠãçš®ã ã®æ¿åºŠã®åµâã
ã¹ãã¢ããžã³é žãšåäžéã®åµâã¬ã·ãã³åã³ã³
ã¬ã¹ãããŒã«ïŒè質ã®åèšé10mgïŒãšãå«ãè©Š
æãããããã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液
ïŒïŒïŒïŒïŒ0.5mlã«æº¶è§£ãããããŠãã®æº¶æ¶²ãç
空æ¿çž®ããã次ã«ãåæ®æž£ã0.01Næ°Žé žåãã
ãªãŠã 溶液1.0mlã«æ¯ãšãåæ£ããããããã®
åæ£äœã®PHã¯çŽ12ã«äžæããã次ã«0.1Nå¡©é ž
ãå ããããšã«ããæ°Žæ§åæ£äœã®PHãçŽïŒãïŒ
ã«äžãããåµâãã¹ãã¢ããžã³é žã®æ¿åºŠãå¢å
ããã«åŸã€ãŠåè©Šæã®KULã®åçã¯æ¬¡ã®ãã
ã«ãªãã
ãè¡šã
äŸ ïŒ
0.5ïœã®åµâãã¹ãã¢ããžã³é
žãš0.5ïœã®ãžããª
ã¹ãã€ã«ã¬ã·ãã³ãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··
å液ïŒïŒïŒïŒïŒ10mlã«æº¶è§£ãããããŠãã®æº¶æ¶²ã
ç空æ¿çž®ãããèç¶æ®æž£ã0.01Næ°Žé žåãããªãŠ
ã 溶液50mlã«åæ£ããããããã®åæ£äœã®PHã¯çŽ
12ã§ããã次ã«0.1Nå¡©é žãå ããŠæ°Žæ§åæ£äœã®
PHãçŽïŒãïŒã«äžãããKULã®åçã¯36ïŒ ã§ã
ãã äŸ 10 äŸïŒã®æ¹æ³ã«åŸã€ãŠã0.5ïœã®åµâãã¹ãã¢ã
ãžã³é žãš0.5ïœã®ãžãã«ããã€ã«ã¬ã·ãã³åã¯ãž
ã¹ãã¢ãã€ã«ã¬ã·ãã³ãšãå«ãè質é¡ç²ã®æ··åç©
ã補é ãããKULã®åçã¯10ïŒ ã§ããã äŸ 11 äŸïŒã®æ¹æ³ã«åŸã€ãŠã0.5ïœã®ãžãã«ããã€ã«
ãã¹ãã¢ããžã³é žãš0.5ïœã®åµâã¬ã·ãã³ãšãå«
ãè質é¡ç²ã®æ··åç©ã補é ãããKULã®åçã¯
10ïŒ ã§ããã äŸ 12 ïŒmgã®ãªãœã¬ã·ãã³ãšïŒmgã®åµâã¬ã·ãã³ãïŒ
mlã®ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
ã«æº¶è§£ãããããŠãã®æº¶æ¶²ãç空æ¿çž®ãããïŒå
éæ¯ãšãããããšã«ããèç¶æ®æž£ãïŒmlã®èžçæ°Ž
ã«åæ£ãããããåæ£äœã®PHã¯çŽïŒãïŒã§ããã
æ°Žæ§çžã®PHã0.5ã«äžããã®ã«ååãªéã®0.1Nå¡©
é žãPHã¡ãŒã¿ã§ç£èŠããªãã宀枩ã«ãŠæ°Žæ§åæ£äœ
ã«å ããããšã«ããåå±€è質é¡ç²ãçæãããã
ãã«ç¶ããŠã0.1Næ°Žé žåãããªãŠã 溶液ãå ã
ãããšã«ããPHãïŒã«äžããã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ãšåæ§ã«ããŠã¹ã
ã¯ãã«æ³ã«ãããäŸãã°NMRåã¯é»åé¡åŸ®é¡ã«
ãã確èªããããšãã§ãããKULãšGULãé»å
é¡åŸ®é¡åçäžã«èŠ³å¯ããããKULã®åçã¯50ïŒ
ã§ããã äŸ 13 äŸ12ã®æ¹æ³ã«åŸã€ãŠãå¡©åãã¹ãã¢ããžã«ïŒâ
ãïŒïŒ®âãžã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒNâ²âã
ãªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒã¢ã³ã¢ããªããšãã«
ïŒãã®è£œé æ¹æ³ã¯C.G.ãã€ããLiposomesã第ïŒ
ç« ãElsevier1981幎ã«èšèŒãããŠããïŒãšïŒmgã®
åµâã¬ã·ãã³ãšãå«ãè質é¡ç²ã®æ··åç©ã補é ã
ãã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ã®ããã«ã¹ãã¯ã
ã«æ³ã«ãããäŸãã°NMRåã¯é»åé¡åŸ®é¡ã«ãã
確èªããããšãã§ãããé»åé¡åŸ®é¡ã«ãããçŽåŸ
250â«ã®KULãšçŽåŸçŽ600ã10000â«ã®GULã芳
å¯ããããšãã§ãããKULã®åçã¯50ïŒ ã§ããã äŸ 14 (a) äŸïŒ(a)åã³ïŒ(b)ã®æ¹æ³ã«åŸã€ãŠãåµâãã¹ã
ã¢ããžã³é žãå«ã¿ãKULã®æ¯çã66ïŒ ã§ãã
è質é¡ç²ã®æ··åç©ã調補ãããè質é¡ç²æ··åç©
äžã®GULã®æ¯çãå¢å ããããããã«ãæ°ã
ã«èª¿è£œããåå±€è質é¡ç²ãå«æããåæ£çžã«
0.5Mã®å¡©åãããªãŠã 溶液ãå ãããKULã®
å«æéã¯ãåæ£çžäžã®NaClã®æ¿åºŠãå¢å ãã
ã«åŸã€ãŠæ¬¡ã®ããã«äœäžããã
ã¹ãã€ã«ã¬ã·ãã³ãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··
å液ïŒïŒïŒïŒïŒ10mlã«æº¶è§£ãããããŠãã®æº¶æ¶²ã
ç空æ¿çž®ãããèç¶æ®æž£ã0.01Næ°Žé žåãããªãŠ
ã 溶液50mlã«åæ£ããããããã®åæ£äœã®PHã¯çŽ
12ã§ããã次ã«0.1Nå¡©é žãå ããŠæ°Žæ§åæ£äœã®
PHãçŽïŒãïŒã«äžãããKULã®åçã¯36ïŒ ã§ã
ãã äŸ 10 äŸïŒã®æ¹æ³ã«åŸã€ãŠã0.5ïœã®åµâãã¹ãã¢ã
ãžã³é žãš0.5ïœã®ãžãã«ããã€ã«ã¬ã·ãã³åã¯ãž
ã¹ãã¢ãã€ã«ã¬ã·ãã³ãšãå«ãè質é¡ç²ã®æ··åç©
ã補é ãããKULã®åçã¯10ïŒ ã§ããã äŸ 11 äŸïŒã®æ¹æ³ã«åŸã€ãŠã0.5ïœã®ãžãã«ããã€ã«
ãã¹ãã¢ããžã³é žãš0.5ïœã®åµâã¬ã·ãã³ãšãå«
ãè質é¡ç²ã®æ··åç©ã補é ãããKULã®åçã¯
10ïŒ ã§ããã äŸ 12 ïŒmgã®ãªãœã¬ã·ãã³ãšïŒmgã®åµâã¬ã·ãã³ãïŒ
mlã®ã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··å液ïŒïŒïŒïŒïŒ
ã«æº¶è§£ãããããŠãã®æº¶æ¶²ãç空æ¿çž®ãããïŒå
éæ¯ãšãããããšã«ããèç¶æ®æž£ãïŒmlã®èžçæ°Ž
ã«åæ£ãããããåæ£äœã®PHã¯çŽïŒãïŒã§ããã
æ°Žæ§çžã®PHã0.5ã«äžããã®ã«ååãªéã®0.1Nå¡©
é žãPHã¡ãŒã¿ã§ç£èŠããªãã宀枩ã«ãŠæ°Žæ§åæ£äœ
ã«å ããããšã«ããåå±€è質é¡ç²ãçæãããã
ãã«ç¶ããŠã0.1Næ°Žé žåãããªãŠã 溶液ãå ã
ãããšã«ããPHãïŒã«äžããã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ãšåæ§ã«ããŠã¹ã
ã¯ãã«æ³ã«ãããäŸãã°NMRåã¯é»åé¡åŸ®é¡ã«
ãã確èªããããšãã§ãããKULãšGULãé»å
é¡åŸ®é¡åçäžã«èŠ³å¯ããããKULã®åçã¯50ïŒ
ã§ããã äŸ 13 äŸ12ã®æ¹æ³ã«åŸã€ãŠãå¡©åãã¹ãã¢ããžã«ïŒâ
ãïŒïŒ®âãžã¡ãã«ââïŒïŒâNâ²ïŒNâ²ïŒNâ²âã
ãªã¡ãã«ã¢ã³ã¢ããªãšãã«ïŒã¢ã³ã¢ããªããšãã«
ïŒãã®è£œé æ¹æ³ã¯C.G.ãã€ããLiposomesã第ïŒ
ç« ãElsevier1981幎ã«èšèŒãããŠããïŒãšïŒmgã®
åµâã¬ã·ãã³ãšãå«ãè質é¡ç²ã®æ··åç©ã補é ã
ãã åå±€è質é¡ç²ã®åœ¢æã¯äŸïŒ(a)ã®ããã«ã¹ãã¯ã
ã«æ³ã«ãããäŸãã°NMRåã¯é»åé¡åŸ®é¡ã«ãã
確èªããããšãã§ãããé»åé¡åŸ®é¡ã«ãããçŽåŸ
250â«ã®KULãšçŽåŸçŽ600ã10000â«ã®GULã芳
å¯ããããšãã§ãããKULã®åçã¯50ïŒ ã§ããã äŸ 14 (a) äŸïŒ(a)åã³ïŒ(b)ã®æ¹æ³ã«åŸã€ãŠãåµâãã¹ã
ã¢ããžã³é žãå«ã¿ãKULã®æ¯çã66ïŒ ã§ãã
è質é¡ç²ã®æ··åç©ã調補ãããè質é¡ç²æ··åç©
äžã®GULã®æ¯çãå¢å ããããããã«ãæ°ã
ã«èª¿è£œããåå±€è質é¡ç²ãå«æããåæ£çžã«
0.5Mã®å¡©åãããªãŠã 溶液ãå ãããKULã®
å«æéã¯ãåæ£çžäžã®NaClã®æ¿åºŠãå¢å ãã
ã«åŸã€ãŠæ¬¡ã®ããã«äœäžããã
ãè¡šã
(b) è質é¡ç²æ··åç©äžã®GULã®å«æéãå¢å ã
ãããããã«ãåµâãã¹ãã¢ããžã³é žã®ã¿ãã
ãªãæ°ãã«èª¿è£œããåå±€è質é¡ç²ãå«æããå
æ£çžã«0.5Må¡©åã«ãªãŠã 溶液ãå ãããåæ£
çžäžã®KClæ¿åºŠãå¢å ããã«åŸã€ãŠKULã®æ¿
床ã¯æ¬¡ã®ããã«äœäžããã
ãããããã«ãåµâãã¹ãã¢ããžã³é žã®ã¿ãã
ãªãæ°ãã«èª¿è£œããåå±€è質é¡ç²ãå«æããå
æ£çžã«0.5Må¡©åã«ãªãŠã 溶液ãå ãããåæ£
çžäžã®KClæ¿åºŠãå¢å ããã«åŸã€ãŠKULã®æ¿
床ã¯æ¬¡ã®ããã«äœäžããã
ãè¡šã
äŸ 15
äŸïŒã14ã®æ¹æ³ã«åŸã€ãŠããžããªã¹ãã€ã«ãã¹
ãã¢ããžã³é žãšãžããªã¹ãã€ã«ã¬ã·ãã³ããžãã«
ããã€ã«ãã¹ãã¢ããžã³é žãšïŒâãã«ããã€ã«â
ïŒâãªã¬ãªã€ã«ã¬ã·ãã³ãïŒâãã«ããã€ã«âïŒ
âãªã¬ãªã€ã«ãã¹ãã¢ããžã³é žãšãžãã«ããã€ã«
ã¬ã·ãã³ãïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«ã
ã¹ãã¢ããžã³é žãšïŒâãã«ããã€ã«âïŒâãªã¬ãª
ã€ã«ã¬ã·ãã³ãåµâãªãœãã¹ãã¢ããžã³é žãšåµâ
ã¬ã·ãã³ãïŒâããªã¹ãã€ã«âãªãœãã¹ãã¢ããž
ã³é žãšïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«ã¬ã·ã
ã³ãïŒâãã«ããã€ã«âãªãœãã¹ãã¢ããžã³é žãš
ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«ã¬ã·ãã³ãç
è³âãªãœãã¹ãã¢ããžã«ã»ãªã³ãšåµâã¬ã·ãã³ã
ïŒâãã«ããã€ã«âãªãœãã¹ãã¢ããžã«ã»ãªã³ã
ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«âãã¹ãã¢ã
ãžã«ã»ãªã³ãšïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«
ã¬ã·ãã³ãåã³çè³âãªãœãã¹ãã¢ããžã«ã»ãªã³
ãšåµâã±ãã¢ãªã³ããåå±€è質é¡ç²ã補é ããã
ãšãã§ããã äŸ 16 0.1mgã®ïŒ®âã¢ã»ãã«ã©ãã«ââã¢ã©ãã«â
âã€ãœã°ã«ã¿ãã«ââã¢ã©ãã³âïŒâïŒ1â²ïŒ
2â²âãžãã«ããã€ã«âsnâã°ãªã»ãâ3â²âãã¹ã
ãªãªã«ïŒãšãã«ã¢ãããïŒmgã®ã¯ãããã°ã©ãç
ã«çŽç²ãªåµâã¢ã«ããã³ã¬ã·ãã³åã³ïŒmgã®åµâ
ãã¹ãã¢ããžã³é žãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··
å液ïŒïŒïŒïŒïŒïŒmlã«æº¶è§£ããããã®æº¶æ¶²ãç空
æ¿çž®ãããããŠæ®æž£ãšããŠéæãªè質èãæ®çã
ããæ¯ãšãããããšã«ãããã®èãç¡èèžçæ°ŽïŒ
mlã«åæ£ãããããããŠ0.1ïŒ ãã¢ãŒã«ãã¿ã¬ã€
ã³æº¶æ¶²ïŒæ»Žã滎å ãããè²ãå€ãããŸã§0.1Næ°Ž
é žåãããªãŠã 溶液ãå ãããããã«ããèªçºç
ãªé¡ç²åãçããã次ã«ãçé žç·©è¡åïŒæ³šå°çšç
é žç·©è¡æ¶²ïŒå¡©åãããªãŠã ç匵液ã®10åæ¿åºŠã®ã
ã®0.2mlãå ããããšã«ããPHã7.4è¿ãã«ç·©è¡å
ãããããããŠåŸãããåæ£äœã¯çŽ°èå¹é€äžåã¯
ã©ããã®çäœå ã§èç¶ãã¯ããã¢ãŒãžã掻æ§åã
ãã®ã«çŽæ¥äœ¿çšããã®ã«é©ããã äŸ 17 0.15ïœã®ïŒ®âã¢ã»ãã«ã ã©ãã«ââã¢ã©ãã«
ââã€ãœã°ã«ã¿ãã«ââã¢ã©ãã«âïŒâïŒ1â²ïŒ
2â²âãžãã«ããã€ã«âsnâã°ãªã»ãâ3â²âãã¹ã
ãªãªã«ïŒãšãã«ã¢ããã97ïŒ ã®ãã¹ãã¢ããžã«ã³
ãªã³ãå«ãåµâã¬ã·ãã³27ïœãåã³ïŒïœã®åµâã
ã¹ãã¢ããžã³é žã200mlã®ã¯ãããã«ã ãš20mlã®
ã¡ã¿ããŒã«ã®æ··åç©ã«æº¶è§£ãã200mlã®tertâã
ã¿ããŒã«ãå ãããããŠæº¶æ¶²ã180mlã«æ¿çž®ããã
ãã®æº¶æ¶²ããç¡èæ¡ä»¶äž0.2ÎŒïœã®ãã€ã«ã¿ãŒã§
éãããšã¿ããŒã«ïŒãã©ã€ã¢ã€ã¹æ··åç©äžã§æ¥æ¿
ã«åçµãããããŠæ¬¡ã«åçµä¹Ÿç¥ãããæ¿ããæ¹æ
ããªããã现ç ããåçµä¹Ÿç¥ç©ã300mlã®ç¡èã®
0.01Næ°Žé žåãããªãŠã 溶液ã«å ãããããŠå®å š
ã«åæ£ãããããæ°Žæ§çžã0.1NHClã§äžåãã
ä¹³çœè²ã®åæ£äœããéå€éæ¿ã®ä»£ãã«ãããªã«
ãŒãããŒã補ã®ååŸ0.1ÎŒïœã®åäžåéæ¿ããã¯
ã¬ãªãã¢ïŒNucleoporeïŒ ãïŒç²åãä»çããŠã
ãªãããã«æŽæµãããã®ïŒãè£ çããæ¹æéå€
éã»ã«ãã¢ãã³ã³ïŒAmiconïŒ ãã«å ¥ãããã
ãããªå å§äžã§ãããŠã«ãã³ïŒDuL beccoïŒã®
ç¡èç·©è¡æº¶æ¶²ïŒPH7.4ãCaåã³Mgãå«ãŸãªãïŒ
ããã»ã«äžã®æ¶²éã300mlããå°ãªããªããªãã
ãã«é£ç¶çã«å ããªããåæ£äœãéãããïŒ
ã®æ¶²ãééããåŸããã¹ãŠã®KULãåé¢ããã
äžã«æ®ã€ãGULã®åæ£äœã¯ã¢ã³ãã«ã«è©°ããã
ããŠæ²»çè©Šéšã«äœ¿çšããããšãã§ããã äŸ 18 15mgã®ïŒ®âã¢ã»ãã«ã ã©ãã«ââã¢ã©ãã«â
âã€ãœã°ã«ã¿ãã«ââã¢ã©ãã«âïŒâïŒ1â²ïŒ
2â²âãžãã«ããã€ã«âsnâã°ãªã»ãâ3â²âãã¹ã
ãªã«ïŒãšãã«ã¢ããã0.6ïœã®çŽåµâã¬ã·ãã³å
ã³2.4ïœã®åµâãã¹ãã¢ããžã³é žã20mlã®ã¯ãã
ãã«ã ãšïŒmlã®ã¡ã¿ããŒã«ãšã®æ··å液ã«æº¶è§£ã
ãããã®æº¶æ¶²ãã0.2ÎŒïœã®ãã€ã«ã¿ãŒãéããŠç¡
èæ¡ä»¶äžã§éãããããŠç¡èãã€ã«ã¿ãŒã§ç©ºæ°
ãé®æãããããŠç²åãä»çããŠããªãããã«æŽ
æµããããŒã¿ãªãŒãšããã¬ãŒã¿ãŒãçšããŠã500
mläžžåãã©ã¹ã³äžã§æ¿çž®ãããã©ã¹ã³ã®å£ã«å¥œãŸ
ããã¯åäžã®èã圢æãããããã«è質混åç©ã
也ç¥ãããæ®æž£ãé«ç空äžã§äžå€ä¹Ÿç¥ããåŸãç¡
èã®0.01Næ°Žé žåãããªãŠã 30mlãå ãããããŠ
ãã©ã¹ã³ãå°ããïŒåéæ¯ãšããããããããŠåŸ
ãä¹³çœè²ã®æ°Žæ§çžã®PHããç¡èã®0.1Nå¡©é žãå
ããããšã«ãã7.4ã«èª¿æŽããããã®åæ£äœãäŸ
23ã«èšèŒããããã«æ¹æãã€ã«ã¿ãŒã»ã«ïŒå šå®¹
100mlïŒã«å ¥ãããããŠéããããã®éã«ãç²
åãå«æããªããªããŸã§éããç¡èæ°Žãã液
ã500mlåŸããããŸã§å ããããã®æ¶²ããéå€
éæ¿ãäŸãã°ã¢ãã³ã³ïŒAmiconïŒU10 ãè£
çããæ¹æéã»ã«ã«é£ç¶çã«äŸçµŠãããããŠ30
mlãŸã§æ¿çž®ãããæ¿çž®ãããåæ£äœã¯å°åœ¢åå±€è
質é¡ç²ãå«æããŠããããããŠããŠã«ãã³ã®çé ž
ç·©è¡æ¶²ïŒPH7.4ãCaåã³Mgãå«æããªãïŒãå
ããåŸã¢ã³ãã«ã«è©°ãããããŠæ²»çè©Šéšã«äœ¿çšã
ãã
ãã¢ããžã³é žãšãžããªã¹ãã€ã«ã¬ã·ãã³ããžãã«
ããã€ã«ãã¹ãã¢ããžã³é žãšïŒâãã«ããã€ã«â
ïŒâãªã¬ãªã€ã«ã¬ã·ãã³ãïŒâãã«ããã€ã«âïŒ
âãªã¬ãªã€ã«ãã¹ãã¢ããžã³é žãšãžãã«ããã€ã«
ã¬ã·ãã³ãïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«ã
ã¹ãã¢ããžã³é žãšïŒâãã«ããã€ã«âïŒâãªã¬ãª
ã€ã«ã¬ã·ãã³ãåµâãªãœãã¹ãã¢ããžã³é žãšåµâ
ã¬ã·ãã³ãïŒâããªã¹ãã€ã«âãªãœãã¹ãã¢ããž
ã³é žãšïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«ã¬ã·ã
ã³ãïŒâãã«ããã€ã«âãªãœãã¹ãã¢ããžã³é žãš
ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«ã¬ã·ãã³ãç
è³âãªãœãã¹ãã¢ããžã«ã»ãªã³ãšåµâã¬ã·ãã³ã
ïŒâãã«ããã€ã«âãªãœãã¹ãã¢ããžã«ã»ãªã³ã
ïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«âãã¹ãã¢ã
ãžã«ã»ãªã³ãšïŒâãã«ããã€ã«âïŒâãªã¬ãªã€ã«
ã¬ã·ãã³ãåã³çè³âãªãœãã¹ãã¢ããžã«ã»ãªã³
ãšåµâã±ãã¢ãªã³ããåå±€è質é¡ç²ã補é ããã
ãšãã§ããã äŸ 16 0.1mgã®ïŒ®âã¢ã»ãã«ã©ãã«ââã¢ã©ãã«â
âã€ãœã°ã«ã¿ãã«ââã¢ã©ãã³âïŒâïŒ1â²ïŒ
2â²âãžãã«ããã€ã«âsnâã°ãªã»ãâ3â²âãã¹ã
ãªãªã«ïŒãšãã«ã¢ãããïŒmgã®ã¯ãããã°ã©ãç
ã«çŽç²ãªåµâã¢ã«ããã³ã¬ã·ãã³åã³ïŒmgã®åµâ
ãã¹ãã¢ããžã³é žãã¯ãããã«ã ïŒã¡ã¿ããŒã«æ··
å液ïŒïŒïŒïŒïŒïŒmlã«æº¶è§£ããããã®æº¶æ¶²ãç空
æ¿çž®ãããããŠæ®æž£ãšããŠéæãªè質èãæ®çã
ããæ¯ãšãããããšã«ãããã®èãç¡èèžçæ°ŽïŒ
mlã«åæ£ãããããããŠ0.1ïŒ ãã¢ãŒã«ãã¿ã¬ã€
ã³æº¶æ¶²ïŒæ»Žã滎å ãããè²ãå€ãããŸã§0.1Næ°Ž
é žåãããªãŠã 溶液ãå ãããããã«ããèªçºç
ãªé¡ç²åãçããã次ã«ãçé žç·©è¡åïŒæ³šå°çšç
é žç·©è¡æ¶²ïŒå¡©åãããªãŠã ç匵液ã®10åæ¿åºŠã®ã
ã®0.2mlãå ããããšã«ããPHã7.4è¿ãã«ç·©è¡å
ãããããããŠåŸãããåæ£äœã¯çŽ°èå¹é€äžåã¯
ã©ããã®çäœå ã§èç¶ãã¯ããã¢ãŒãžã掻æ§åã
ãã®ã«çŽæ¥äœ¿çšããã®ã«é©ããã äŸ 17 0.15ïœã®ïŒ®âã¢ã»ãã«ã ã©ãã«ââã¢ã©ãã«
ââã€ãœã°ã«ã¿ãã«ââã¢ã©ãã«âïŒâïŒ1â²ïŒ
2â²âãžãã«ããã€ã«âsnâã°ãªã»ãâ3â²âãã¹ã
ãªãªã«ïŒãšãã«ã¢ããã97ïŒ ã®ãã¹ãã¢ããžã«ã³
ãªã³ãå«ãåµâã¬ã·ãã³27ïœãåã³ïŒïœã®åµâã
ã¹ãã¢ããžã³é žã200mlã®ã¯ãããã«ã ãš20mlã®
ã¡ã¿ããŒã«ã®æ··åç©ã«æº¶è§£ãã200mlã®tertâã
ã¿ããŒã«ãå ãããããŠæº¶æ¶²ã180mlã«æ¿çž®ããã
ãã®æº¶æ¶²ããç¡èæ¡ä»¶äž0.2ÎŒïœã®ãã€ã«ã¿ãŒã§
éãããšã¿ããŒã«ïŒãã©ã€ã¢ã€ã¹æ··åç©äžã§æ¥æ¿
ã«åçµãããããŠæ¬¡ã«åçµä¹Ÿç¥ãããæ¿ããæ¹æ
ããªããã现ç ããåçµä¹Ÿç¥ç©ã300mlã®ç¡èã®
0.01Næ°Žé žåãããªãŠã 溶液ã«å ãããããŠå®å š
ã«åæ£ãããããæ°Žæ§çžã0.1NHClã§äžåãã
ä¹³çœè²ã®åæ£äœããéå€éæ¿ã®ä»£ãã«ãããªã«
ãŒãããŒã補ã®ååŸ0.1ÎŒïœã®åäžåéæ¿ããã¯
ã¬ãªãã¢ïŒNucleoporeïŒ ãïŒç²åãä»çããŠã
ãªãããã«æŽæµãããã®ïŒãè£ çããæ¹æéå€
éã»ã«ãã¢ãã³ã³ïŒAmiconïŒ ãã«å ¥ãããã
ãããªå å§äžã§ãããŠã«ãã³ïŒDuL beccoïŒã®
ç¡èç·©è¡æº¶æ¶²ïŒPH7.4ãCaåã³Mgãå«ãŸãªãïŒ
ããã»ã«äžã®æ¶²éã300mlããå°ãªããªããªãã
ãã«é£ç¶çã«å ããªããåæ£äœãéãããïŒ
ã®æ¶²ãééããåŸããã¹ãŠã®KULãåé¢ããã
äžã«æ®ã€ãGULã®åæ£äœã¯ã¢ã³ãã«ã«è©°ããã
ããŠæ²»çè©Šéšã«äœ¿çšããããšãã§ããã äŸ 18 15mgã®ïŒ®âã¢ã»ãã«ã ã©ãã«ââã¢ã©ãã«â
âã€ãœã°ã«ã¿ãã«ââã¢ã©ãã«âïŒâïŒ1â²ïŒ
2â²âãžãã«ããã€ã«âsnâã°ãªã»ãâ3â²âãã¹ã
ãªã«ïŒãšãã«ã¢ããã0.6ïœã®çŽåµâã¬ã·ãã³å
ã³2.4ïœã®åµâãã¹ãã¢ããžã³é žã20mlã®ã¯ãã
ãã«ã ãšïŒmlã®ã¡ã¿ããŒã«ãšã®æ··å液ã«æº¶è§£ã
ãããã®æº¶æ¶²ãã0.2ÎŒïœã®ãã€ã«ã¿ãŒãéããŠç¡
èæ¡ä»¶äžã§éãããããŠç¡èãã€ã«ã¿ãŒã§ç©ºæ°
ãé®æãããããŠç²åãä»çããŠããªãããã«æŽ
æµããããŒã¿ãªãŒãšããã¬ãŒã¿ãŒãçšããŠã500
mläžžåãã©ã¹ã³äžã§æ¿çž®ãããã©ã¹ã³ã®å£ã«å¥œãŸ
ããã¯åäžã®èã圢æãããããã«è質混åç©ã
也ç¥ãããæ®æž£ãé«ç空äžã§äžå€ä¹Ÿç¥ããåŸãç¡
èã®0.01Næ°Žé žåãããªãŠã 30mlãå ãããããŠ
ãã©ã¹ã³ãå°ããïŒåéæ¯ãšããããããããŠåŸ
ãä¹³çœè²ã®æ°Žæ§çžã®PHããç¡èã®0.1Nå¡©é žãå
ããããšã«ãã7.4ã«èª¿æŽããããã®åæ£äœãäŸ
23ã«èšèŒããããã«æ¹æãã€ã«ã¿ãŒã»ã«ïŒå šå®¹
100mlïŒã«å ¥ãããããŠéããããã®éã«ãç²
åãå«æããªããªããŸã§éããç¡èæ°Žãã液
ã500mlåŸããããŸã§å ããããã®æ¶²ããéå€
éæ¿ãäŸãã°ã¢ãã³ã³ïŒAmiconïŒU10 ãè£
çããæ¹æéã»ã«ã«é£ç¶çã«äŸçµŠãããããŠ30
mlãŸã§æ¿çž®ãããæ¿çž®ãããåæ£äœã¯å°åœ¢åå±€è
質é¡ç²ãå«æããŠããããããŠããŠã«ãã³ã®çé ž
ç·©è¡æ¶²ïŒPH7.4ãCaåã³Mgãå«æããªãïŒãå
ããåŸã¢ã³ãã«ã«è©°ãããããŠæ²»çè©Šéšã«äœ¿çšã
ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ a1ïŒ æ¬¡ã®åŒ(A) ãåŒäžãïœã¯ïŒã§ããïŒåºR1åã³R2ã®å ã®
ïŒã€ã¯æ°ŽçŽ åã¯ããããã·åºã§ããä»æ¹ã®åºã¯
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«
ãªãã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«ãª
ãã·åºã§ããïŒR3ã¯æ°ŽçŽ ã§ããïŒãããŠR4ã¯
æ°ŽçŽ ãççŽ ååæ°ïŒãïŒåã®ã¢ã«ãã«åºãåã¯
ççŽ ååæ°ïŒãïŒåã®ã¢ã«ãã«åºïŒã«ã«ãã
ã·ãã¹ã«ããã¢ãããäœçŽã¢ã«ãã«ã¢ããããž
âäœçŽã¢ã«ãã«ã¢ãããã«ã«ããã·åã³ã¢ã
ããéé¢ãããã¯ãšã¹ãã«åããããããã
ã·ãããã²ã³ãäœçŽã¢ã«ã³ãã·ã«ã«ããã«ãå
ã¯äœçŽã¢ã«ã«ã³ã¹ã«ããã«ã«ãã眮æãããŠã
ãïŒã§ãããã§è¡šããããè質åã³é©åœãªè¿œå
ã®è質ãPHå€ã11ããé«ãæ°Žæ§çžã«åæ£ãã
ãããããã¯ã a2ïŒ ïœãïŒã§ããïŒR1åã³R2ãçžäºã«ç¬ç«ã
ãŠãããããççŽ ååæ°10ã20åã®ã¢ã«ãã«
åºãã¢ã«ã±ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«
ã±ãã«ãªãã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢
ã·ã«ãªãã·åºã§ããïŒR3åã³R4ãæ°ŽçŽ ã§ãã
åŒ(A)ã®è質åã³å Žåã«ãã€ãŠã¯é©åœãªè¿œå ã®è
質ãPHå€ã11ããé«ãæ°Žæ§çžã«åæ£ããããã
ããã¯ã b1ïŒ ïœãïŒã§ããïŒåºR1åã³R2ã®å ã®ïŒã€ã
æ°ŽçŽ åã¯ããããã·åºã§ãã€ãŠä»æ¹ã®åºããã
ããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢ã«ã±
ãã«åºãã¢ã«ã³ãã·åºãããã¯ã¢ã«ã±ãã«ãªã
ã·åºãåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«ãªãã·
åºã§ããïŒR3ãæ°ŽçŽ ã§ããïŒãããŠR4ã¯ã¢ã³
ã¢ããªåºã§çœ®æãããäœçŽã¢ã«ãã«åºã§ããåŒ
(A)ã®è質ãåã³å Žåã«ãã€ãŠã¯è¿œå ã®è質ãPH
å€ãïŒããäœãæ°Žæ§çžã«åæ£ããããããã
ã¯ã b2ïŒ ïœãïŒã§ããïŒR1åã³R2ãçžäºã«ç¬ç«ã«ã
ããããççŽ ååæ°10ã20åã®ã¢ã«ãã«åºãã¢
ã«ã±ãã«åºãããã¯ã¢ã«ã±ãã«ãªãã·åºãåã¯
ççŽ ååæ°10ã20åã®ã¢ã·ã«ãªãã·åºã§ããïŒ
R3ãæ°ŽçŽ ã§ããïŒãããŠR4ãã¢ã³ã¢ããªäœçŽ
ã¢ã«ãã«ã¢ã³ã¢ããªåºã§çœ®æãããäœçŽã¢ã«ã
ã«åºã§ããåŒ(A)ã®è質ãåã³é©åœãªè¿œå ã®è質
ãPHå€ãïŒããäœãæ°Žæ§çžã«åæ£ãããã ãããŠå¿ èŠã§ããã°ãåèša1ïŒïŒa2ïŒïŒb1ïŒå
ã¯b2ïŒæ®µéã®åŸãæ°Žæ§çžãäžåãããããŠææ
ã«ããåŸãããåå±€è質é¡ç²ãæ¿çž®ããããŠïŒå
ã¯åé¢ããããšãç¹åŸŽãšããåå±€è質é¡ç²ã®è£œé
æ¹æ³ã ïŒ æ°Žæ§åæ£äœããïœãïŒã§ãããR1ãççŽ å
åæ°10ã20åã®ã¢ã«ãã«åºãççŽ ååæ°10ã20å
ã®ã¢ã«ã³ãã·åºåã¯ççŽ ååæ°10ã20åã®ã¢ã·ã«
ãªãã·åºã§ãããR2ãæ°ŽçŽ åã¯ããããã·åºã§
ãããR3ãæ°ŽçŽ ã§ããããããŠR4ãæ°ŽçŽ ãççŽ
ååæ°ïŒãïŒåã®äœçŽã¢ã«ãã«åºãã«ã«ããã·å
ã³ã¢ããåºã«ãã眮æãããççŽ ååæ°ïŒãïŒå
ã®äœçŽã¢ã«ãã«åºãããããã·âäœçŽã¢ã«ãã«
åºãäœçŽã¢ã«ãã¬ã³ãžãªãã·âäœçŽã¢ã«ãã«åºã
åã¯ããâäœçŽã¢ã«ãã«åºã§ããåŒ(A)ã®è質ã䞊
ã³ã«R1åã³R2ãççŽ ååæ°10ã20åã®ã¢ã·ã«ãª
ãã·åºã§ãããR3ãæ°ŽçŽ ã§ããããããŠR4ãïŒ
âããªã¡ãã«ã¢ã³ã¢ããªãšãã«åºåã¯ïŒâã¢ãã
ãšãã«åºã§ããåŒ(A)ã®è¿œå ã®è質ãå«æããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®a1ã®æ¹æ³ã ïŒ æ°Žæ§åæ£äœããR1åã³R2ãã©ãŠãã€ã«ãªã
ã·åºãããªã¹ãã€ã«ãªãã·åºããã«ããã€ã«ãªã
ã·åºãããã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ãããR3
ãæ°ŽçŽ ã§ããããããŠR4ãæ°ŽçŽ ã§ããåŒ(A)ã®è
質ãåã³å Žåã«ãã€ãŠã¯ãR1åã³R2ãã©ãŠãã€
ã«ãªãã·åºãããªã¹ãã€ã«ãªãã·åºããã«ããã€
ã«ãªãã·åºåã¯ã¹ãã¢ãã€ã«ãªãã·åºã§ããã
R3ãæ°ŽçŽ ã§ããããããŠR4ãïŒâããªã¡ãã«ã¢
ã³ã¢ããªãšãã«åºãïŒâã¢ãããšãã«åºãåã¯Ï
âã¢ããâÏâã«ã«ããã·äœçŽã¢ã«ãã«åºã§ãã
åŒ(A)ã§ç€ºãããè¿œå ã®è質ãå«æããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®a2ã®æ¹æ³ã ïŒ æ°Žæ§åæ£äœã倩ç¶ãªãœãã¹ãã¢ããžã³é žãã
ãã¯åæãªãœãã¹ãã¢ããžã³é žã倩ç¶ãªãœãã¹ã
ã¢ããžã«ã»ãªã³ãããã¯åæãªãœãã¹ãã¢ããžã«
ã»ãªã³ãåã¯ãªãœãã¹ãã¢ããžã«ã°ãªã»ããŒã«ã
ãããŠããã«å€©ç¶ã¬ã·ãã³ãåäžã®ã¢ã·ã«ãªãã·
åºãæããåæã¬ã·ãã³ãç°ãªãã¢ã·ã«ãªãã·åº
ãæããåæã¬ã·ãã³ãåã¯ããã«å€©ç¶ã»ãã¢ãª
ã³ãããã¯ç°ãªãã¢ã·ã«ãªãã·åºãæããåæã»
ãã¢ãªã³ãå«æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
a1ã®æ¹æ³ã ïŒ æ°Žæ§åæ£äœã倩ç¶ãã¹ãã¢ããžã³é žãåæã
ã¹ãã¢ããžã³é žåã³å Žåã«ãã€ãŠã¯ãããã«å€©ç¶
ã¬ã·ãã³ãåäžã®ã¢ã·ã«ãªãã·åºãæããåæã¬
ã·ãã³ãããã¯ç°ãªãã¢ã·ã«ãªãã·åºãæããå
æã¬ã·ãã³ãåã¯å€©ç¶ã»ãã¢ãªã³ãããã¯ç°ãªã
ã¢ã·ã«ãªãã·åºãæããåæã»ãã¢ãªã³ãåã¯å€©
ç¶ãã¹ãã¢ããžã«ã»ãªã³ãããã¯åæãã¹ãã¢ã
ãžã«ã»ãªã³ãå«æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®a2ã®æ¹æ³ã
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH98182 | 1982-02-17 | ||
CH981/82-4 | 1982-02-17 | ||
CH237/83-2 | 1983-01-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58152812A JPS58152812A (ja) | 1983-09-10 |
JPH0379059B2 true JPH0379059B2 (ja) | 1991-12-17 |
Family
ID=4199693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2298983A Granted JPS58152812A (ja) | 1982-02-17 | 1983-02-16 | æ°Žæ§çžäžåå±€è質é¡ç²ã®è£œé æ¹æ³ |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS58152812A (ja) |
ZA (1) | ZA831053B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4789633A (en) * | 1984-04-19 | 1988-12-06 | University Of Tennessee Research Corporation | Fused liposome and acid induced method for liposome fusion |
WO2016025401A1 (en) * | 2014-08-09 | 2016-02-18 | Avanti Polar Lipids, Inc. | Oral composition for delivery of drugs and other substances |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52143218A (en) * | 1976-03-19 | 1977-11-29 | Ici Ltd | Pharmaceutical composition |
JPS56132564A (en) * | 1980-02-04 | 1981-10-16 | Koraboreiteibu Research Inc | Product for and method of immunity analysis |
US4356167A (en) * | 1978-01-27 | 1982-10-26 | Sandoz, Inc. | Liposome drug delivery systems |
-
1983
- 1983-02-16 ZA ZA831053A patent/ZA831053B/xx unknown
- 1983-02-16 JP JP2298983A patent/JPS58152812A/ja active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52143218A (en) * | 1976-03-19 | 1977-11-29 | Ici Ltd | Pharmaceutical composition |
US4356167A (en) * | 1978-01-27 | 1982-10-26 | Sandoz, Inc. | Liposome drug delivery systems |
JPS56132564A (en) * | 1980-02-04 | 1981-10-16 | Koraboreiteibu Research Inc | Product for and method of immunity analysis |
Also Published As
Publication number | Publication date |
---|---|
ZA831053B (en) | 1985-03-27 |
JPS58152812A (ja) | 1983-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4619794A (en) | Spontaneous preparation of small unilamellar liposomes | |
US4235871A (en) | Method of encapsulating biologically active materials in lipid vesicles | |
US4241046A (en) | Method of encapsulating biologically active materials in lipid vesicles | |
JP3026271B2 (ja) | 掻æ§è¬å€ã®å¶åŸ¡æŸåºã«çšããå€å°èãªããœãŒã ã®èª¿è£œ | |
FI86371C (fi) | Foerfarande foer framstaellning av farmaceutiska liposomkompositioner. | |
US5277914A (en) | Preparation of liposome and lipid complex compositions | |
US6200599B1 (en) | Ortho ester lipids | |
KR20010112301A (ko) | 늬í¬ì¢ëŽì ìíì± ë³µí©ì²Žì í¬ì§ | |
Karathanasis et al. | Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery | |
CN1044093C (zh) | äœæ¯æ§è¯ç©ç±»èå¶å | |
EP1426044A1 (en) | Use of esters of L-carnitine or alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds | |
JPH02167218A (ja) | ãªããœãŒã 調補çšè質ç²æ«ã®è£œé æ³åã³ãªããœãŒã ã®è£œé æ³ | |
US6965049B2 (en) | Zwitterionic lipid compound and uses thereof | |
US20050008664A1 (en) | Compositions and methods related to lipid:emodin formulations | |
EP0422543A1 (en) | pH-sensitive liposomes | |
EP0850646B1 (en) | Liposome preparations of indolocarbazole derivatives | |
JPH0379059B2 (ja) | ||
JP2003513901A (ja) | ã¿ã³ãã¯è³ªåã¯ããããããªããœãŒã ã«å°å ¥ããããã®æ¹æ³åã³ãã®æ¹æ³ã§èª¿è£œããããªããœãŒã åã³ãã®äœ¿çš | |
JPH03501732A (ja) | å€éã©ã¡ã©ãªããœãŒã ã®èªçºçå°èåæ¹æ³ | |
JP2705175B2 (ja) | äœæ¯æ§è¬å€âè質系 | |
AU646520B2 (en) | Phospholipid analogue vesicle with a succinimidyl moiety | |
GB1575344A (en) | Method for the manufacture of liposome composition | |
JPH06329533A (ja) | ãªããœãŒã 補å€ã®è£œé æ³ | |
JP3667779B2 (ja) | åæè質ãªããœãŒã | |
Naaz et al. | International Journal of Modern Pharmaceutical Research |